Instituto Natural · Translational Research
International Research Overview · British English

Translational Research Programme in Neuroscience and Traditional, Complementary and Integrative Medicine (TCIM)

A scientific architecture for turning complex questions into progressively testable research: linking problem formulation, Research Design, Evidence Architecture, Data Quality, governance, safety and translational decision-making across clinical, population, territorial and systems levels.

Version V4.20T0/T1 core · T2–T4 horizon Translation to Action (T2A)Scientific Observatory

The scientific problem

How can complex problems in TCIM and Neuroscience — including interfaces with neurotechnology, ageing, complex preparations, Data Science and AI, living systems, territory, biodiversity, Planetary Health and health systems — be transformed into researchable questions, valid measurements, auditable evidence and proportionate translational decisions?

Current maturity. The programme architecture, progression criteria, Data Quality logic and governance are already structured. Executable study protocols are under progressive development and qualification.
Problem→Question→Design→Evidence→Decision→Next translational step

Research Design & Evidence Architecture

Epistemological orientation. The programme uses New-Paradigmatic Systems Thinking as a transversal reference through three linked dimensions: complexity, by examining relations, contexts, levels of organisation and non-reducible interactions; instability, by treating change, uncertainty, temporality and revision as constitutive of inquiry; and intersubjectivity, by making the observer's position, language, participation and conditions of knowledge production visible where they materially affect interpretation and design.

The programme begins with the scientific question and the concrete situation in which the phenomenon occurs. What enters the design is what materially changes what needs to be understood, compared, measured or decided.

Situate before measuring

Define population or context, unit of analysis, relevant levels of organisation and the social, environmental, regulatory or institutional conditions that modify exposure, vulnerability, access, response or outcome.

Preserve before translating

Traditional, complementary and integrative systems are first characterised within their own references. Comparison and translation are used when they improve validity, safety or explanatory capacity without erasing meaningful differences.

Integrate only when the question requires it

Methods, scales and data sources are combined only when they add explanatory power, safety, quality or translational utility. Multiplicity of techniques is not treated as integration by itself.

Match inference to design

Association, prediction, causal explanation and implementation evaluation are treated as distinct inferential tasks requiring compatible designs, assumptions and analytical strategies.

Treat heterogeneity as information

Differences across populations, territories, products, health systems, regulations and implementation conditions can inform external validity, effect heterogeneity and transportability.

Make progression auditable

Provenance, integrity, completeness, traceability, safety, ethical requirements, limits of inference and decision gates are made explicit as a line moves towards empirical execution.

Translational architecture

Four priority research lines (H1–H4), three discovery platforms (P1–P3) and four transversal domains (D1–D4) connect questions, measurement, safety, data, governance, technology and implementation. Disciplines and technologies are mobilised by the information required by the question.

ComponentScientific focusCurrent function
H1Acupuncture: neurophysiology, clinical response and multimodal signaturesPriority line; progressively protocol-oriented.
H2Territory, environmental exposures and human outcomesPriority line; contextual and exposure architecture under specification.
H3Individualised care plans (PTS), care networks and TCIM integration modelsPriority line linking care, services, continuity and implementation.
H4Deprescribing, medication safety and functional capacityPriority line connecting pharmacology, ageing, safety and function.
P1Phytocomplexes, whole preparations and complex natural productsTranslational pharmacology discovery platform.
P2Gerontechnology, telehealth, digital inclusion and safetyPlatform in maturation.
P3Altered states of consciousness and interventional psychopharmacologyProspective Translational Neuroscience platform in maturation.

Four transversal domains

D1 · Ageing, Function and Safety of Care

Diagnostic and cognitive safety; medication safety; intrinsic and functional capacity; autonomy and participation; dignity and rights; environment and care networks.

D2 · Public/Collective Health, Territory and Planetary Health

Social and territorial determinants, environmental exposures, biodiversity, health systems, implementation, One Health and Planetary Health.

D3 · Knowledge Governance, TCIM, Rights and Cooperation

Research integrity, legal and ethical frameworks, meaningful participation, reciprocity, cultural integrity, shared governance and comparative international references.

D4 · Translational Neuroscience, Data and Multimodal Integration

Neuroscience, biomedical engineering, measurement technologies, brain mapping, neurophysiology, neurotechnology, Data Science, AI, Data Quality and longitudinal integration.

Data Quality, governance and Translation to Action

Data are treated as part of the design rather than as an afterthought. The programme links measurement quality and provenance to the decisions that evidence is expected to support.

Data specification

Minimum datasets, variable dictionaries, essential metadata, temporal structure and versioning.

Quality & provenance

Integrity, completeness, traceability, measurement adequacy and explicit limits of use and inference.

Safety

Pharmacovigilance, adverse-event logic, incidental findings where relevant, ethical and regulatory requirements.

Analytical planning

Methods and computational models are selected according to the question, design, data structure and assumptions.

Decision gates

Advance, replicate, refine, simplify, suspend or stop according to pre-specified evidence and readiness conditions.

T2A

Each line asks what it needs to know, how it could know it, what would change if the answer were obtained, and what the next executable step would be.

Curation · Ecosystem reading · Scientific reference

Scientific Observatory

Scientific Observatory — an organised space for observation, contextualisation and reference. It brings together knowledge, practices, experiences, trajectories, agendas, institutions, networks and ecosystems relevant to the scientific problems examined by the Programme, while preserving the nature and context specific to each reference. Selection is based on scientific, methodological, historical, social, territorial or epistemological relevance. The section is referential in nature; professional, academic or institutional relationships are identified when documentarily established.

Foundations, collection and reading of the Observatory
What the Observatory follows

Transversal themes observed. The Observatory follows themes that cut across different scales of research and health: evidence production, quality and translation; safety and quality of care; mechanisms and heterogeneity of responses; integration of TCIM into health systems; neurological and mental health; ageing and functional capacity; pharmacovigilance and complex preparations; Data Science, Data Quality, interoperability and artificial intelligence; implementation; equity and access; and relationships among human health, communities, territory, biodiversity and the environment.

2030 Agenda and sustainability. The 2030 Agenda is one of the international references used to contextualise observed objects when relevant. Its five axes — the 5 Ps — enable a multidimensional reading of the relationships among health, society and the environment:

People — health, well-being, dignity, equity, education, care and reduction of inequalities.

Planet — climate, biodiversity, ecosystems, territory, natural resources and relationships between human health and environmental integrity.

Prosperity — human development, science, innovation, technologies and forms of development compatible with sustainability and well-being.

Peace — rights, justice, institutions, protection, participation and social conditions required for health and a dignified life.

Partnerships — cooperation and coordination among actors, institutions, sectors and countries as a principle of the 2030 Agenda itself. In this Observatory, the term retains this conceptual meaning; specific institutional relationships are indicated when documentarily established.

Scientific, Normative and Regulatory Collection

Scientific, Normative and Regulatory Collection

China · Policy and System

Traditional Chinese Medicine Revitalization and Development Plan · 15th Five-Year Plan (2026–2030)

Jurisdiction: China · Authority: State Council / NATCM / NDRC · Status: current national policy, published in 2026 · Nature: national plan · Force: programmatic.

Core elements: TCM service system covering the population and the full life course by 2030; equal importance accorded to TCM and Western medicine; preservation of TCM's own characteristics; strengthening of basic research; high-quality datasets; digital infrastructure; smart hospitals; internationalisation.

National Health 15th Five-Year Plan (2026–2030)

Jurisdiction: China · Authority: State Council · Status: current, published in 2026 · Nature: national health plan · Force: programmatic.

Core elements: life expectancy target of 80 years by 2030 (from 79.25 in 2025); health services across the full life course; geriatric medicine; home/community care for older people; rehabilitation; prevention in primary care.

NSFC Guide to Programs 2026 · H32 Chinese Materia Medica

Jurisdiction: China · Authority: National Natural Science Foundation of China · Status: current, 2026 · Nature: scientific funding guide · Force: scientific-institutional.

Core elements: H32 is a distinct and active scientific discipline within the NSFC system, with 19 sub-directions (H3201–H3219) funding resources, identification, substances, quality, processing, pharmacology and toxicology of Chinese Materia Medica. Within the same NSFC scientific classification system, Traditional Chinese Medicine (H31), Chinese Materia Medica (H32) and Integrated Chinese and Western Medicine (H33) constitute distinct fields for framing Health Sciences research. The guide further directs that oncology research in Chinese medicine be submitted under the corresponding secondary H31, H32 or H33 codes, demonstrating their effective use in the classification and evaluation of scientific projects.

China · Clinical Research Quality

GB/T 47336-2026 · Specification for quality control in traditional Chinese medicine clinical trials

Jurisdiction: China · Authority: SAMR / Standardization Administration, NATCM · Status: in force since 01/07/2026 (published 31/03/2026) · Nature: recommended national standard.

Core elements: national specification for quality control in TCM clinical trials — quality components, documentation and traceability.

20262859-T-468 · Good Clinical Practice of Acupuncture and Moxibustion Research Management

Jurisdiction: China · Authority: TC475 / National Administration of Traditional Chinese Medicine · Status: DRAFT UNDER DEVELOPMENT — NOT IN FORCE · Nature: draft standard · Force: none yet; documented institutional direction.

Confirmed drafting institutions: Institute of Acupuncture and Moxibustion (China Academy of Chinese Medical Sciences), Guang'anmen Hospital, First Teaching Hospital of Tianjin University of TCM, Beijing University of Chinese Medicine, Chengdu University of TCM, Xiyuan Hospital.

China · Preparations and Materia Medica

Pharmacopoeia of the People's Republic of China · 2025 Edition

Jurisdiction: China · Authority: NMPA (National Medical Products Administration / China's national medicines regulator), the national regulatory agency responsible for medicines, medical devices and cosmetics · Status: in force since 01/10/2025 · Nature: national pharmacopoeia · Force: binding as a legal technical standard for R&D, production/importation, distribution, use and supervision; the Pharmacopoeia Guidelines constitute recommended technical requirements.

Special Provisions for TCM Registration (2023)

Jurisdiction: China · Authority: NMPA · Status: in force since 01/07/2023 (issued 10/02/2023) · Nature: NMPA-specific regulatory provisions · Application: current and normative for the registration of TCM medicines · Structure: 11 chapters, 82 articles.

Core elements: rational application of "human use experience" in TCM registration/approval; classical formulas; post-marketing changes; evidence generation.

Good Agricultural Practice for Chinese Crude Drugs

Jurisdiction: China · Authorities: NMPA, Ministry of Agriculture and Rural Affairs, National Forestry and Grassland Administration, NATCM · Status: in force since 01/03/2022 · Nature: national good practices for the production of Chinese crude drugs · Application: basic requirement for standardised production covered by GAP; adoption along the subsequent chain is encouraged and becomes mandatory where provided for in the applicable approval documents.

Core elements: cultivation/collection → quality control → traceability of plant raw material.

China · 食养 · food–medicine · fungi and safety

食养 (shíyǎng) · health-oriented diet · prevention and management of chronic conditions

Contemporary Chinese health policy uses 食养 (shíyǎng) as a health-oriented dietary approach, connecting modern nutrition with Chinese food traditions. In 2023–2024, the National Health Commission published guides for hypertension, hyperlipidaemia, diabetes, obesity and other conditions; in 2026, it expanded the series with guides for stroke in adults, osteoporosis and sarcopenia.

The guides integrate nutritional composition, individual characteristics, season and region, meal examples and, where relevant, 食药物质 and novel food ingredients. The guidance is presented as support for prevention, everyday management and health education, with reference to professional follow-up where necessary.

Translational relevance: diet, prevention, functional capacity and follow-up of chronic diseases can constitute an infrastructure for care and research spanning community care, ageing and rehabilitation, without turning food into medicine or replacing indicated treatment.

Official source: NHC (National Health Commission / China's National Health Commission) · 2026 食养 guides · stroke, osteoporosis and sarcopenia ↗.

Stroke in adults · recovery, dysphagia, nutrition, rehabilitation and recurrence prevention

The 2026 食养 Guide for Stroke in Adults is primarily directed at the recovery and sequelae phases, for clinically stable people able to eat orally, with individualised referral for acute or severe cases or significant dysphagia. The document integrates nutrition, biomedical stroke classification and TCM pattern differentiation without conflating these levels.

Its eight recommendations cover energy and protein, fats and carbohydrates, potassium/calcium/vitamins, dietary diversity, texture and swallowing safety, hydration, selection of 食药物质 according to constitution/pattern, activity and rehabilitation, psychological support and longitudinal monitoring. The guide itself includes appendices for dysphagia screening/assessment and food texture classification.

Translational relevance: post-stroke care appears as a multicomponent system: nutrition + swallowing safety + rehabilitation + psychological support + self-care + monitoring of risk and recurrence. This offers a concrete case for investigating how traditional and contemporary components can coexist in a longitudinal pathway without one replacing the other.

Key concept for study: post-stroke eating is not merely "diet". Texture, swallowing capacity, functional status, comorbidities, disease phase and self-care capacity modify exposure, safety and implementation feasibility.

Official source: NHC · 成人脑卒中食养指南 · 2026 ↗.

Osteoporosis · bone–muscle · life course · exercise · monitoring

The 2026 食养 Guide for Osteoporosis in Adults adopts a life-course perspective and combines nutrition, sunlight exposure, exercise, body weight, screening and monitoring. Its eight recommendations include adequate calcium and vitamin D intake, protein quantity and quality, nutrient-dense foods, regular physical activity, moderation of alcohol/sugars/caffeine, food preparation, individualised selection of 食药物质 and periodic screening.

The document explicitly connects bone and muscle: it discusses protein as a structural component, IGF-1 and the role of sarcopenia in osteoporotic fracture risk. For people with osteoporosis, it cites as a Chinese reference protein intake of 1.2–1.5 g/kg/day, with at least 50% high-quality protein, alongside attention to calcium, vitamin D and physical activity.

Translational relevance: osteoporosis ceases to be viewed solely as bone mineral density and is instead observed within a bone–muscle–mobility–falls–sunlight exposure–nutrition–medication–environment system. This brings prevention, Gerontology, rehabilitation and safety of care closer together without erasing the specific diagnosis.

Key concept for study: fracture risk arises from more than one biomarker. Bone mass/quality, muscle strength, balance, falls, medicines, nutritional intake, mobility and environment may form different causal pathways and need to be distinguished in the design.

Official source: NHC · 成人骨质疏松症食养指南 · 2026 ↗.

Sarcopenia · strength, mass and function · nutrition + exercise + early screening

The 2026 食养 Guide for Sarcopenia in Adults treats sarcopenia as a public-health problem associated with ageing, characterised by progressive reduction in muscle mass, strength and/or function. The approach combines clinical medicine, nutrition, TCM and exercise medicine and is intended for health services, long-term care institutions, community settings and the home.

Its seven recommendations organise: sufficient quantities of quality protein distributed throughout the day; increased nutrient density and texture adaptation; supplementation when indicated; active movement and resistance exercise; regulation of spleen/stomach and scientific selection of 食药物质; control of underlying diseases; and early screening, diagnosis and intervention. For people with preserved renal function, the guide recommends 1.2–1.5 g/kg/day of protein, seeking a high proportion from high-quality sources.

Translational relevance: sarcopenia offers a directly measurable model of functional ageing: nutritional exposure, strength, muscle mass, physical performance, underlying disease, medicines, activity, adherence and environment can be followed together longitudinally.

Key concept for study: muscle mass, muscle strength and physical performance are related but non-equivalent constructs. Interventions should state which component they aim to modify and which functional outcome constitutes a relevant benefit.

Sources: NHC · 成人肌少症食养指南 · 2026 ↗ · Chinese Nutrition Society · technical interpretation of the guide ↗.

食药物质 · substances traditionally used as both food and medicinal material

In China, 食药物质 is a defined regulatory category: the substance must have a tradition of use as food, be included in the Pharmacopoeia of the People's Republic of China, have a compatible safety assessment and comply with rules for protection of medicinal resources, wildlife, flora and ecological protection. The National Health Commission reported 106 substances in the national directory in 2025.

Key concept for study: "food and medicine share the same origin" does not mean that food, medicinal material, supplement, extract and medicine are equivalent. Contemporary Chinese administration establishes distinct criteria for identity, part used, safety, contaminant limits, food use and pharmacopoeial inclusion.

Transversal learning: the food–medicine boundary can be researched as a system of classification, safety, quality, tradition of use and evidence generation, while preserving different regulatory statuses.

Official sources: NHC · definition and management of 食药物质 ↗ · NHC · 106 substances and development of the field ↗.

Lingzhi / 灵芝 · Ganoderma · dual regulatory positioning and clinical evidence

In 2023, China formally included 灵芝 (Lingzhi) in the 食药物质 directory. The official document identifies Ganoderma lucidum and Ganoderma sinense and specifies the fruiting body as the part used, with safety limits for contaminants.

The same object also circulates within other Chinese regulatory categories, including medicinal material and raw materials authorised for certain health products. Classification therefore depends on species, part, preparation, purpose and regime of use.

State of human evidence: a 2025 meta-analysis brought together 17 randomised trials and 971 participants. Some parameters showed statistically significant differences, whereas blood pressure, glycaemia, lipid profile, inflammatory markers and liver enzymes showed no significant aggregate benefit. Heterogeneity by dose, duration, population and preparation remains scientifically relevant.

Translational relevance: Lingzhi is a useful model for studying how tradition, taxonomic identification, part used, preparation, safety, claims and clinical evidence may diverge even when a common name appears to denote a single "product".

Sources: NHC/SAMR · inclusion of Lingzhi in 食药物质 · 2023 ↗ · Jafari et al. · meta-analysis of clinical trials · 2025 ↗.

Hericium erinaceus · Lion's Mane / 猴头菇 · food, standardisation and neurocognitive research

Hericium erinaceus (Lion's Mane; 猴头菇) has a clear contemporary status as an edible fungus in China. The national standard GB/T 45882-2025, in force since 1 January 2026, establishes a specific product standard for Lion's Mane mushroom within food technology. The species also appears in Chinese agricultural standards for edible fungi.

This food classification should not be automatically converted into membership of the national 食药物质 directory or into a therapeutic claim. The literature and local standards also record uses as medicinal material, reinforcing the need to state part used, origin, processing and regulatory category in each study.

State of neurocognitive evidence: human evidence remains promising but limited and heterogeneous. A 2025 double-blind trial in healthy young adults found no significant overall improvement in cognition or mood after an acute dose, although differences were observed in individual tasks. A 2025 systematic review found few human clinical trials and a strong predominance of preclinical evidence. A randomised study published as a preprint in 2026, with 109 adults aged 40–75 years and eight weeks of use, reported improvements in some measures of attention/working memory, subjective sleep and mood; because it remains a preprint, confirmation through peer-reviewed publication and independent replication is required.

Processing is part of the object: fruiting body and mycelium have different chemical profiles; aqueous extraction, hydroalcoholic extraction, drying and processing modify the composition under investigation. Thus, "Lion's Mane" does not constitute a sufficiently defined experimental exposure without characterisation of the raw material and preparation.

Key concept for study: traditional food, whole fungus, powder, fruiting-body extract, mycelial biomass and isolated compound are not equivalent interventions.

Sources: SAMR · GB/T 45882-2025 · 猴头菇 ↗ · Surendran et al. · RCT · 2025 ↗ · Menon et al. · systematic review · 2025 ↗ · Daoust et al. · RCT preprint · 2026 ↗.

China · Cannabis · Materia Medica · cannabinoids and contemporary regulation

Textual and archaeobotanical history · one plant, different uses and parts

Cannabis sativa has a long history of cultivation and use in China as fibre, food and medicinal material. Specialist literature on the history of Chinese medicine records references to different parts of the plant over approximately two millennia; precise identification of ancient terms, plant parts and purposes varies across texts and periods and requires contextualised philological reading.

Archaeobotanical evidence adds an independent layer to the texts: Han-dynasty findings in Chengdu include a large quantity of Cannabis fruits in a secular context, interpreted by the authors in association with possible medicinal uses. Other Chinese archaeological sites document ritual or psychoactive uses, showing that “Cannabis in ancient China” does not constitute a single historical practice.

Transversal learning: textual history, archaeobotany, contemporary pharmacology and regulation are distinct lines of evidence. Botanical proximity between ancient and modern materials does not automatically transform a historical indication into a contemporary clinical indication.

Scientific sources: Brand & Zhao · Cannabis in Chinese Medicine · 2017 ↗ · Bai et al. · archaeobotanical evidence · 2021 ↗.

Huo Ma Ren (火麻仁) · Cannabis sativa in contemporary Materia Medica

Contemporary identity: Huo Ma Ren (火麻仁) corresponds to the dried mature fruit of Cannabis sativa L. in the Chinese Materia Medica system. Current public procurement and standardisation documents for traditional medicines explicitly reference the 2025 edition of the Pharmacopoeia of the People's Republic of China for this medicinal material.

The presence of Cannabis sativa in the Pharmacopoeia therefore occurs through a defined medicinal material, defined plant part and defined preparation. It should not be confused with general authorisation for THC-rich inflorescences, CBD products or “medical cannabis” in the regulatory sense used in other countries.

The Chinese system also has a national standard for formula granules prepared from Huo Ma Ren after processing, reinforcing the distinction between a standardised traditional medicinal material and isolated cannabinoids.

Key concept for study: shared botanical species does not mean shared therapeutic object. Plant part, processing, composition, dosage form, rationale for use and regulatory regime define distinct objects.

Sources: Chinese Pharmacopoeia · 2025 edition ↗ · public procurement document · 2025 Pharmacopoeia standard · 火麻仁 ↗ · national standard · processed Huo Ma Ren granules ↗.

CBD · chemical control and preclinical research for medical purposes

Since 1 September 2024, cannabidiol (CBD) has been included in China in the second category of controlled precursor chemicals. Production, sale, purchase, transport and import/export follow the corresponding regime for non-pharmaceutical precursor chemicals.

The joint act of six authorities additionally establishes that preclinical CBD research for medical purposes must also comply with Article 10 of China's regulation on narcotic and psychotropic substances. This framing is particularly informative because it distinguishes the possibility of biomedical research from free commercial circulation or recognition as a medicine for clinical use.

Translational relevance: the Chinese case shows that the same molecule may simultaneously occupy a field of pharmacological interest and a strict regime controlling production, circulation and research. Scientific evaluation and health-authority authorisation remain different stages.

Official source: Ministry of Emergency Management + co-issuing authorities · CBD as a controlled precursor · 2024 ↗.

Cosmetics · Cannabis-derived ingredients under prohibition

In 2021, the NMPA updated the catalogues of raw materials prohibited in cosmetics. The update covered CBD and ingredients derived from Cannabis sativa, within a broader framework for cosmetic safety and registration.

Transversal learning: “Cannabis use” must always be disaggregated by regulated sector. A material present in traditional Materia Medica does not automatically inherit the same status in cosmetics, foods, pharmaceutical products or clinical research.

Official source: NMPA · Catalogue of Raw Materials Banned for Cosmetics · 2021 ↗.

Industrial hemp · licensed cultivation · agricultural research

China maintains specific subnational regimes for industrial hemp. In Yunnan, regulation defines industrial hemp as having a THC content below 0.3% in dry matter and requires licences for cultivation and processing. The regulation itself distinguishes cultivation for scientific research, seed production and industrial production.

This infrastructure remains active in 2026: Yunnan Provincial Public Security publishes cultivation licences, including licences for cultivation for scientific research granted to institutions such as the Yunnan Academy of Agricultural Sciences. Heilongjiang also maintains regulated development of the industrial-hemp chain in its 2026 agricultural planning.

Translational relevance: industrial hemp opens another scale of investigation — plant genetics, fibres, biomass, materials, agriculture, production chains and sustainability — which should not be confused with cannabinoid pharmacotherapy.

Official sources: Yunnan · industrial-hemp licensing rules ↗ · Yunnan Public Security · scientific cultivation licence · 2026 ↗ · Heilongjiang · 2026 agricultural plan · industrial hemp ↗.

China · TCM as a comprehensive clinical system · prevention · treatment · rehabilitation

TCM beyond Acupuncture · a set of technologies, practices and clinical rationale

Chinese care documentation treats Traditional Chinese Medicine as a broader clinical and preventive system, not as a synonym for Acupuncture. Primary and older-person care services combine pattern differentiation and health status with Chinese medicines, acupuncture, moxibustion, tuina, cupping, gua sha, fumigation/washing, health-cultivation practices, dietary guidance, emotional regulation, traditional exercises, prevention, rehabilitation and follow-up.

Community-service standards also provide for the joint delivery of multiple TCM technologies and dedicated Chinese-medicine pharmacy structures, including decoctions and preparation, as well as health education and rehabilitation. The institutional logic is one of continuity across prevention, treatment, rehabilitation and health maintenance, with resources selected according to clinical situation, service capacity and professional scope.

Transversal learning: studying TCM only through Acupuncture, Phytotherapy or Diet Therapy in isolation loses a relevant part of the object. Each resource may be investigated separately when the question requires it, but clinical rationale, combinations of methods, temporality of care and criteria for individualisation are also legitimate scientific objects.

Official sources: NHC · integrated home/community services · TCM for older people ↗ · NHC/NATCM · TCM services in community care ↗ · NATCM · 治未病 / prevention and health cultivation ↗.

China · Universities and Hospitals under Documentary Observation

Shanghai University of Traditional Chinese Medicine · Prof. Lei Fang's group

Coordinating institution, commissioned by the WHO Collaborating Center for Traditional Medicine, for the 2026 international Acupuncture guideline for insomnia — a Guideline Development Group of 26 members/11 countries (13 TCM and Western clinicians, 5 physiotherapists, 2 sleep neurologists, 4 policy-makers, 2 methodologists), using GRADE and a modified Delphi process.

Beijing Hospital of Traditional Chinese Medicine / Capital Medical University

TCM teaching hospital with active mechanistic research lines (fMRI, GABA) in chronic insomnia, observed through public clinical-trial records.

Tianjin University of Traditional Chinese Medicine

Institution with observed RWE production in insomnia (including post-stroke and chronic urticaria), using standard clinical scales (PSQI, ISI) alongside TCM syndrome differentiation.

Brazil · SUS · TCM/Acupuncture · multiprofessional practice

PNPIC · TCM as a system of care, not an isolated technique

The National Policy on Integrative and Complementary Practices describes Traditional Chinese Medicine/Acupuncture as a system that includes diagnosis through clinical history-taking, pulse palpation, observation of the face and tongue and different therapeutic approaches, including Chinese phytotherapy, diet therapy, body and mind practices, acupuncture, moxibustion and cupping. The policy itself situates PICS as a multiprofessional field, emphasising comprehensiveness, therapeutic relationships, self-care, prevention and health promotion.

The historical SUS registry also distinguished Acupuncture, Phytotherapy and “other techniques in Traditional Chinese Medicine”, recognising that the care system is not reduced to a single procedure. This breadth provides a documentary basis for studying TCM through its rationale, diagnostic methods and different care technologies.

Transversal learning: recognising TCM as a system does not prevent each technology from being researched separately; it only prevents confusing a part with the whole.

Official sources: CNS/MS · PNPIC ↗ · SUS/CNES · Acupuncture, Phytotherapy and other TCM techniques ↗.

Law No. 15,345/2026 · national framework for professional practice of Acupuncture

Law No. 15,345 of 12 January 2026 regulates the professional practice of Acupuncture nationally. Article 3 assures this practice, among other cases, to higher-education health professionals holding a specialist qualification in Acupuncture recognised by their respective federal professional councils. The law also recognises a specific higher-education degree in Acupuncture and a transition rule for proven practice.

Among the stated competences are observing and assessing signs, symptoms and energetic syndromes; consulting, assessing and treating through Acupuncture; organising and directing services; providing audit and consultancy; issuing technical opinions; and participating in the planning and evaluation of health-care actions and plans.

Relevance to policies and services: the 2026 national regulation updates the context for organisation of the workforce, professional qualifications and provision of Acupuncture services. Its implementation interacts with the legally recognised responsibilities of different health professions, their respective professional councils and the specific requirements of each service and function in the health system.

Official sources: Presidency of the Republic · Law No. 15,345/2026 ↗ · Ministry of Health · PICS legislation and Technical Commission for Acupuncture Regulation ↗.

Brazil · Medicinal Plants · Phytotherapy · Biodiversity

National Policy and Programme on Medicinal Plants and Phytotherapeutics · SUS

National framework: the National Policy on Medicinal Plants and Phytotherapeutics (PNPMF) links safe access and rational use, sustainable use of biodiversity, development of the production chain and strengthening of national capacity. The National Programme, established by Interministerial Ordinance No. 2,960/2008, translates this policy into actions spanning SUS, research and innovation, popular and traditional practices, family farming, good cultivation practices, handling and production, technical-scientific training and biodiversity conservation.

Translational relevance: the Brazilian framework connects care, science, production, territory and social development within a single public chain. Phytotherapy therefore appears not only as a therapeutic modality but also as infrastructure for research, pharmaceutical services, quality, innovation and local development.

Official source: Ministry of Health · National Policy and Programme on Medicinal Plants and Phytotherapeutics ↗.

ReniSUS · 71 species · monographs as knowledge infrastructure

The National List of Medicinal Plants of Interest to SUS (ReniSUS), created in 2009, brings together 71 species to guide studies, research and development of the production chain. The monographs systematise botanical identification, characterisation and quality control, safety, efficacy and references; the Ministry of Health records 33 published monographs in the Virtual Health Library in the source consulted on 24 Aug. 2026.

Key concept for study: inclusion in ReniSUS or the existence of a monograph characterises knowledge infrastructure and prioritisation; demonstrations of efficacy and safety depend on the corresponding evidence. The scientific value of the infrastructure lies precisely in organising available knowledge, making uncertainties visible and directing research, regulatory evaluation and incorporation processes.

Translational relevance: the monographs may support Conitec, Rename, regulation, mementos and therapeutic formularies, as well as guide managers, professionals and new investigations.

Official sources: Ministry of Health · ReniSUS ↗ · Monographs of Medicinal Plants of Interest to SUS ↗.

Official source: Ministry of Health · Monographs of Medicinal Plants of Interest to SUS. Accessed: 24 Aug. 2026.

Brazilian academic network · standardised monographs · federal universities and Fiocruz

The Ministry of Health itself documents a cooperative process for developing ReniSUS monographs with researchers, postgraduate students and undergraduates from different regions. Institutions mobilised include UNIFAP, UFPB, UFPR, UFRGS, UFRN, UFSM and UnB, alongside stages conducted with Fiocruz/Brasília. Participants are guided by standardised drafting procedures.

Transversal learning: this arrangement shows a distributed national infrastructure for producing and systematising evidence on medicinal plants, combining public policy, scientific training, university research and SUS needs.

At UnB, for example, there is academic work devoted to health regulation and monograph models for species officially recognised in Brazil, alongside characterisation studies of ReniSUS species. These experiences are relevant for observing the transition between available knowledge → standardisation → quality → research question → health-authority decision.

Sources: Ministry of Health · ReniSUS-oriented studies ↗ · UnB · health regulation and monograph model ↗.

Farmácias Vivas · from university experience to technical-care infrastructure within SUS

The Farmácias Vivas Programme was conceived by Prof. Francisco José de Abreu Matos at the Federal University of Ceará (UFC) in 1983, linking popular knowledge, botanical identification, scientific investigation, cultivation and safe use of medicinal plants. The UFC garden maintains a certified living collection and a scientific collection associated with the programme's trajectory.

Within SUS, Farmácia Viva designates a structure that may encompass cultivation → harvesting → processing → storage → preparation → dispensing, respecting regional, municipal and territorial particularities. This continuity makes visible, within a single infrastructure, questions of botanical identity, raw-material quality, preparation, safety, continuity of supply, guidance and care.

Translational relevance: Farmácia Viva offers a particularly fertile model for investigating how territorial and traditional knowledge can engage with botany, pharmacognosy, quality control, pharmaceutical services and public health systems without losing its provenance.

Sources: UFC · Farmácia Viva Programme ↗ · Ministry of Health · Farmácia Viva ↗.

Genetic heritage · associated traditional knowledge · SisGen · benefit-sharing

Law No. 13,123/2015 and Decree No. 8,772/2016 structure, in Brazil, access to genetic heritage and associated traditional knowledge, their protection and benefit-sharing. The framework recognises rights of Indigenous peoples, traditional communities and traditional farmers, including recognition of contribution, indication of the origin of knowledge, participation in decisions and benefit-sharing under the applicable terms.

The prior informed consent and the community protocols form part of this legal architecture for associated traditional knowledge of identifiable origin. SisGen organises registration of access activities and the corresponding procedures.

Translational relevance: biodiversity and traditional knowledge are not merely sources of raw material or information. Provenance, rights, governance, conservation, participation and fair and equitable sharing of benefits are part of the ethical and scientific quality of the research trajectory itself.

International comparability: the Nagoya Protocol provides the international framework for access and benefit-sharing; its interpretation in Brazil must be articulated with the applicable national legal regime, preserving rights, context and autonomy of knowledge holders.

Official sources: Law No. 13,123/2015 ↗ · Biodiversity Law · SisGen ↗ · legislation and Nagoya Protocol ↗.

Brazil · Cannabis and Psychedelic Science — Institutional Case

UNILA · Laboratory of Medicinal Cannabis and Psychedelic Science (LCP)

Jurisdiction: Brazil · Institution: Federal University for Latin American Integration · Nature: university research laboratory linked to the Centre for Studies in Medicinal Cannabis and Psychedelic Science (NECP), of the Mercosur Institute for Advanced Studies (IMEA/UNILA), coordinated by Prof. Dr Francisney Pinto do Nascimento.

Core elements observed: On 05/02/2026, UNILA and the Santa Catarina Medicinal Cannabis Association (Santa Cannabis) signed a Technical Cooperation Agreement, signed by Rector Diana Araujo Pereira and the association's president. Within this cooperation, the study "Fridinha" (Open Label, CBD+THC medicinal Cannabis in fibromyalgia, 36 women, 6 months, Foz do Iguaçu/Cascavel) investigates clinical response in a defined population. The study COONFIA CANNABIS — National Cohort with Children of Patients with Alzheimer's Disease — evaluates prolonged use of Cannabis sativa as a preventive strategy in a risk group in Brazil, with planned 20-year follow-up and 40 volunteers. The published design comprises four groups, including a randomised, double-blind, placebo-controlled comparison, with clinical follow-up, examinations, cognition and biological markers. Within the Postgraduate Programme in Biosciences, COONFIA 1 investigates biomarkers and components of the endocannabinoid system in children of patients with Alzheimer's disease treated with Cannabis sativaextract. Also within the Postgraduate Programme in Biosciences, in partnership with the Foz do Iguaçu Medical Specialities Centre and Santa Cannabis, the CBDermis study investigates Cannabis sativa (topical cream and oral oil, CBD:THC:CBG ratio 1:1:1) in the treatment of psoriasis vulgaris, with 120 days of follow-up. The RESPA — Extension and Social Observation Network on Psychoactive Substances in the Brazil–Paraguay–Argentina Triple Frontier — formalised by UNILA institutional ordinance (SACT No. 9/2026), links the LCP to extension work, social observation and drug policy. Finally, cooperation with the Federal University of Santa Catarina (UFSC) supports a clinical trial of phytocannabinoids for Parkinson's and Alzheimer's diseases (70 participants each), coordinated by Prof. Dr Rui Prediger (UFSC) with Prof. Nascimento as deputy coordinator — described by the study coordination as one of the world's largest trials in this area involving phytocannabinoids.

Translational relevance: a documented Brazilian case of public university + patient association + clinical research + extension + social observation + evidence generation, under formal public agreements, bringing medicinal Cannabis and psychedelic science under the same academic infrastructure without merging the two fields.

Reading key and transversal learning

Function of this key. The Observatory uses documents, policies, standards, institutional experiences and knowledge systems as sources of comparative learning, preserving context, jurisdiction, purpose, provenance and their own rationales.

How comparison is conducted. Convergences make recurring principles or problems visible; divergences reveal distinct institutional, regulatory or epistemological choices; complementarities show dimensions that one reference makes more visible than another; specificities remain circumscribed to the context that produces them.

Transversal learning · territory, biodiversity and knowledge systems. A combined reading of Brazilian policies, Chinese standards, biodiversity frameworks and international references shows that territory and biodiversity cease to be ornamental context when they modify the unit of analysis, exposure, intervention, risk assessment, provenance, participation, governance or distribution of benefits. Legal regimes, peoples, traditions and institutional models remain contextualised within their own foundations.

Comparative learning · China ↔ Brazil/SUS. The Chinese standards studied make the longitudinal governance of scientific activity especially visible — risk assessment from the design stage, monitoring, reassessment and traceability of decisions. The Brazilian tradition of Clínica Ampliada, Reference Teams, Matrix Support, Co-management and Projeto Terapêutico Singular makes the longitudinal governance of care especially visible — responsibility, agreed goals, coordination, co-responsibility and reassessment. Reading them in parallel reveals different ways of organising continuity, responsibility and decision-making.

China ↔ Brazil · comparison between research and care contexts

Comparability across contexts. China and Brazil are knowledge-producing contexts with their own historical, institutional, regulatory and epistemological trajectories. Comparative reading examines convergences, differences, conditions of transferability and limits of external validity in both directions.

Clínica Ampliada and Projeto Terapêutico Singular. Within SUS, Clínica Ampliada and PTS constitute care architectures oriented towards multiprofessional composition, singularity, negotiation of objectives, co-responsibility, follow-up and reassessment.

Transversal learning. Experiences of institutional coexistence, clinical integration, terminological interoperability and organisation of care show that transferability depends on context, regulation, professional training, organisation of services, population, outcomes and governance. Comparison preserves differences between the systems observed.

Mentions, sources and contact

References and context. People, institutions, initiatives and knowledge systems are presented from public sources and retained in their own natures, contexts and jurisdictions. Specific professional, academic or institutional relationships are indicated when documentarily established.

Corrections and updates. Requests for correction, clarification, updating or removal of a reference may be sent to biomedicagloriamoura@gmail.com.

Authorship. Scientific and authorial programme by Prof. Glória Moura Alves, developed at Instituto Natural.

Global, national and health-cooperation architectures

WHO · GTMC · global strategy and evidence generation

WHO · Global Strategy 2025–2034 · WHO Global Traditional Medicine Centre — GTMC

EVIDENCE · SAFETY AND REGULATION · INTEGRATION · INTERSECTORAL VALUE · RIGHTS · BIODIVERSITY · DATA AND INNOVATION

The World Health Organization (WHO) organises its contemporary agenda for Traditional, Complementary and Integrative Medicine (TCIM) through the Global Traditional Medicine Strategy 2025–2034, adopted by the 78th World Health Assembly in 2025, and the WHO Global Traditional Medicine Centre (GTMC), a global knowledge centre established in Jamnagar, India. The Strategy defines policy direction and objectives for Member States and other actors; the GTMC develops technical and scientific work in research and evidence, health systems, sustainability and equity, innovation and technology, biodiversity, Indigenous knowledge and data.

2025–2034 Strategy · four objectives and nine principles

The Strategy organises the next decade around four objectives: strengthen the evidence base; support the provision of safe and effective TCIM through appropriate regulatory mechanisms; integrate safe and effective TCIM into health systems; and optimise the intersectoral value of TCIM and strengthen communities.

Its implementation is guided by nine principles: evidence base; holism and health; sustainability and biodiversity; right to health and autonomy; rights, culture and health of Indigenous Peoples; people-centred care and community engagement; integrated health services; and health equity. These principles show that the agenda is not limited to the clinical efficacy of isolated interventions: it includes rights, systems, natural resources, culture, participation and intersectoral consequences.

Key concept for study. The four objectives distinguish scientific and public-policy problems that are often conflated: generating evidence is not the same as demonstrating regulatory safety; demonstrating safety and effectiveness is not the same as appropriately integrating care into a system; and health-system integration does not exhaust the social, environmental, cultural and economic effects related to TCIM.

Research and evidence · gaps → priorities → methods → decision

The GTMC Research and Evidence unit works on identifying gaps, defining national, regional and global priorities, evidence synthesis, development and evaluation of methods and mapping research funding. The agenda recognises that the diversity of practices, products, knowledge systems and contexts of use requires methods appropriate to the questions under investigation.

The WHO Global Report on Traditional, Complementary and Integrative Medicine 2024, published in 2025 with data from 106 Member States, establishes an international baseline on governance, financing, workforce, herbal medicines, research, service models and access. This baseline makes it possible to follow implementation of the 2025–2034 Strategy over time.

Transversal learning. An evidence agenda can operate at different scales: study of an intervention, literature synthesis, priority-setting, funding mapping, systems data and international monitoring. “Generating evidence” is therefore an architecture of related scientific functions rather than a single study design.

WHO · delirium, polypharmacy and medication safety in older people

In 2026, WHO began developing a specific guideline for prevention, diagnosis and management of delirium in older people, including medication safety and deprescribing. WHO characterises delirium as a common, serious and underdiagnosed condition associated with morbidity, mortality and functional decline, and highlights medication-related factors, polypharmacy, infections, dehydration and other acute physiological disturbances.

The global programme Medication Without Harm prioritises polypharmacy, high-risk situations and transitions of care, with person-centred review and multiprofessional participation. These references are used as sources of learning on safety of care, not as substitutes for individual diagnostic assessment.

Integration into health systems · coordination, decision and continuity

The Strategy treats integration as an objective in its own right and conditions implementation on safety, effectiveness, context and organisation of health systems. In 2025, WHO also published a conceptual framework for integrating TCIM into health systems, broadening the discussion beyond the mere simultaneous presence of conventional and traditional services.

This approach makes it possible to examine integration across dimensions such as governance, financing, workforce, service delivery, information, products and technologies, people's participation and links with primary health care and universal health coverage. The question ceases to be only “does the practice work?” and begins to include “under what conditions, for whom, by whom, with which safeguards and within what care architecture?”.

Key concept for study. Integration is not synonymous with coexistence. It is a relational property of the system: it depends on interfaces among people, practices, professions, services, data, regulation, financing and governance. This formulation brings integration closer to the analysis of interfaces observed in other ecosystems, without assuming that institutional models are equivalent.

Safety · quality · regulation

The second strategic objective explicitly separates safety and effectiveness from the mere availability of practices or products. The regulatory agenda covers products, practices and professionals and connects quality, appropriate use, competence, monitoring and protection of people.

For products of natural origin and complex therapeutic systems, this perspective makes product identity and quality, composition, supply chain, variability, dose and mode of use, interactions, adverse events, pharmacovigilance and the proportionality of regulatory requirements to risk and context scientifically relevant.

Transversal learning. Safety is not a single check performed before implementation. It can be followed throughout the life cycle of products, practices and services, linking regulation, quality, surveillance, data and learning after use.

Biodiversity · Indigenous knowledge · rights · benefit-sharing

The Strategy recognises sustainability and biodiversity, the right to health and autonomy, the rights of Indigenous Peoples, culture and health as guiding principles. The World Health Assembly highlighted protection of traditional knowledge, Indigenous rights and responsible use of natural resources as components of the TCIM agenda.

The GTMC theory of change connects the use of natural resources in traditional medicine and biomedicine with biodiversity preservation, legislation on traditional knowledge and intellectual property, equitable access and benefit-sharing. In this way, the chain linking knowledge, biological resources, research, innovation and products can also be examined as a problem of governance and justice.

Key concept for study. Biodiversity does not appear merely as a source of molecules or raw materials. It integrates relationships among ecosystems, knowledge, rights, production chains, sustainability and distribution of benefits — dimensions that may require units of analysis and indicators different from those used for clinical outcomes.

Intersectoral value · health of people and planet

The fourth objective of the Strategy explicitly broadens the agenda to the intersectoral value of TCIM. The GTMC theory of change includes outcomes related to economic and sustainable development, biodiversity, legislation, research and innovation, systems integration and access to evidence-based information.

This framework makes it possible to study consequences that cut across health, environment, biodiversity, culture, production, economy and communities, provided that each relationship is formulated as a researchable question and followed with indicators appropriate to the level analysed.

Transversal learning. An object or practice may produce effects in more than one system without all such effects belonging to the same study. Intersectoral analysis requires distinguishing levels, mechanisms and outcomes and making explicit when an empirically researchable relationship exists between them.

2026 update. On 31 July 2026, WHO opened a call for development and application of a TCIM Macroeconomic, Social, Environmental and Biodiversity Analysis Framework, explicitly defining as an object of analysis the connections of TCIM with economic, social, environmental and biodiversity dimensions, including biodiversity preservation, science and technology. The GTMC Annual Report 2025, published in July 2026, also situates traditional medicine in the context of sustainable health systems, primary health care, population ageing and Planetary Health.

WHO · TCIM macroeconomic, social, environmental and biodiversity framework · 31 Jul. 2026 ↗ · WHO GTMC · Annual Report 2025 · 21 Jul. 2026 ↗

Data · innovation · technology · global knowledge

The GTMC combines evidence generation and synthesis with data networks, a global traditional-medicine library, digital applications and emerging technologies. The theory of change published by the Centre connects research, health and biodiversity data systems, innovation and collaboration among countries.

The digital agenda increases requirements for methodological quality, provenance, interoperability, adequate representation of different knowledge systems, data governance and explicit criteria for the use of analytical technologies and artificial intelligence.

Transversal learning. Digitalisation can expand scale, connection and analytical capacity, but it also makes problems of classification, context and governance more visible. The greater the integration of heterogeneous data, the greater the importance of knowing where they came from, what they represent and under what conditions they may be compared.

Comparison among related frameworks · convergences and differences

Thematically related frameworks may converge without sharing the same scale, purpose or architecture. Comparative reading distinguishes what each source formulates, where substantive approximations exist, where differences remain and which new questions emerge from comparison.

Criterion for comparative consistency. An observation retains scientific value when it is supported by its own source, context and evidence. Lexical or thematic similarity alone does not demonstrate equivalence between architectures.

Transversal learning. Comparing related frameworks requires observing agreements as well as differences in scale, emphasis, purpose and operationalisation. Well-characterised divergences can be as informative as convergences.

Key official sources for study

China · scientific, regulatory and translational system

Science policy, health and research ecosystems · China

China is observed here at multiple scales — national, regional, territorial and institutional — because its recent policies connect science and technology, health, Traditional Chinese Medicine, Western medicine, digital transformation, population ageing and technological development. Comparative reading preserves the specificities of each scale, policy and institutional ecosystem.

Reading route · scales and capacities

National policy and health: science and technology priorities, health planning, TCM, ageing and digital transformation.

Quality, regulation and standardisation: clinical research, terminology, Materia Medica, traceability and regulatory infrastructure.

Territories and institutions: Hefei/USTC, Hangzhou/Zhejiang University and Ningbo make it possible to observe distinct combinations of basic science, engineering, hospitals, training and local organisation of services.

Biodiversity and knowledge: provenance, medicinal resources, conservation, traceability and protection regimes constitute another scale of governance.

Transversal learning. Comparison across scales gains precision when each document, institution or territory is read through the function it performs — priority-setting, regulation, knowledge production, training, care, infrastructure or governance — and through empirically observable relationships among these functions.

National Level

China national · 15th Five-Year Plan 2026–2030

BIOMEDICINE · BCI · BIOMANUFACTURING · QUANTUM TECHNOLOGIES · TECHNOLOGY TRANSFER

China's 15th Five-Year Plan (2026–2030) places biomedicine among the strategic sectors and explicitly includes brain–computer interfaces (BCI), quantum technologies, biomanufacturing and embodied intelligence among future development fronts. The plan combines fundamental and frontier research, technological development, application demonstration, innovation infrastructure and transfer mechanisms.

In parallel, the National Health Plan for 2026–2030, approved by the State Council in July 2026, establishes digital transformation and collaboration between Chinese and Western medicine as key axes. The document includes applications of artificial intelligence in diagnosis, precision medicine, health management and ageing care, alongside targets for prevention, primary care and services for the older population.

Reading key. The documentation makes it possible to follow three complementary scales: the Five-Year Plan organises national development priorities; the National Health Plan details objectives and instruments for the health system; and the specific TCM revitalisation plan deepens policies particular to Traditional Chinese Medicine. Reading them together shows how national directions can acquire specific sectoral, regulatory, scientific and care forms.

Transversal learning. The National Health Plan makes particularly visible a life-course and systems-oriented conception of health: prevention, primary care, chronic diseases, mental health, rehabilitation, ageing, data sharing, artificial intelligence, biomedical innovation and collaboration between Chinese and Western medicine appear within the same national health-development architecture.

Translational Neuroscience · Neurotechnology · BCI — national policy

ELECTRODES · SENSORS · SIGNAL ACQUISITION · CHIPS · NEUROSTIMULATION · REHABILITATION

The national policy specifically addressing BCI, published in 2025, was jointly issued by seven authorities: Ministry of Industry and Information Technology (MIIT), National Development and Reform Commission, Ministry of Education, National Health Commission, State-owned Assets Supervision and Administration Commission, Chinese Academy of Sciences and National Medical Products Administration. The document establishes targets for 2027 and 2030 and covers implantable and non-implantable electrodes, optical, electrical, magnetic, ultrasonic and chemical sensors, chips, signal acquisition and processing, encoding and decoding software, devices and applications.

Key concept for study. The policy makes it possible to understand BCI as a technological system composed of neural sensing → signal acquisition → processing and decoding → hardware and software → interaction or neuromodulation → application → performance and safety assessment. From this perspective, neurotechnology simultaneously involves physical components, data, algorithms, human–machine interaction, validation, safety and regulation.

Transversal learning. The analytical value of this chain lies in making visible the interfaces among Neuroscience, Biomedical Engineering, Data Science, artificial intelligence, clinical research and technology governance. The translational question no longer concerns only whether a technology exists, but also signal quality, measurement validity, performance, safety, context of use and implementation conditions.

Normative finding. The annex to China's national science-and-technology ethics review rules (国科发监〔2023〕167号) includes, among activities subject to additional expert review, clinical research involving invasive brain–machine interfaces intended for treatment of neurological and psychiatric diseases. The list is dynamic and published by the Ministry of Science and Technology. The record makes visible design, ethics, safety and regulatory issues that accompany clinical research involving invasive neurotechnologies.

AI + health · data, models, validation and monitoring

Recent Chinese documents treat applications of Artificial Intelligence in health as systems combining data, infrastructure, models, validation, application and monitoring. The science-and-technology ethics rule 国科发监〔2023〕167号 requires, for activities involving data and algorithms, security, personal-information protection and criteria of fairness, equity, transparency, reliability and controllability. Later sectoral guidance for AI in health expands attention to high-quality datasets, testing and validation environments, model evaluation, authorisation for use of clinical data and monitoring according to risk and purpose.

Transversal learning. Algorithmic quality is not reducible to predictive accuracy. For translational research, performance, representativeness, safety, oversight, controllability and conditions of use belong to the same chain of executability when a model participates in decision-making.

MOST · 科技伦理审查办法(试行)· 国科发监〔2023〕167号 ↗ · National Health Commission · AI + health · 2025 ↗

TCM + Western medicine · clinical integration and evidence generation

FLAGSHIP HOSPITALS · MULTIDISCIPLINARY TEAMS · STANDARDISED PROTOCOLS · NATCM

Contemporary integration between Traditional Chinese Medicine and Western medicine appears in national documents as policy, organisation of care, research and standardisation. Guidelines for severe and difficult-to-treat diseases describe interdisciplinary collaboration, shared research infrastructure, basic and clinical investigation and development of evidence-based protocols.

Useful distinction. Chinese documentation makes it possible to recognise different dimensions of integration — preservation of TCM's own characteristics, cooperation among professionals, organisation of care, clinical integration, basic and clinical research, terminological standardisation and evidence generation — and to understand how these dimensions may coexist within a policy of integrated development.

Transversal learning. Integration can be studied as a multidimensional phenomenon. The scientific question may concern mechanisms, clinical outcomes, organisation of care, terminology, safety, patient experience, implementation or governance. This decomposition preserves the specificity of medical systems while creating comparable and measurable objects.

This infrastructure already has substantial care scale: the National Health Commission recorded 62 "flagship" hospitals and 559 departments dedicated to collaboration between TCM and Western medicine, alongside dozens of integrated clinical plans and more than 150 projects addressing major and complex diseases.

National Administration of Traditional Chinese Medicine — NATCM

The National Administration of Traditional Chinese Medicine (NATCM) is China's national authority responsible for areas of policy, supervision and standardisation of Traditional Chinese Medicine. Its documents make it possible to follow the transition from national guidance to technical standards, organisation of services, research and implementation.

中西医协同"旗舰"医院 · Flagship Hospitals — integration in real-world services

NATCM maintains projects for 中西医协同"旗舰"医院 ("flagship" hospitals for collaboration between Chinese and Western medicine) focused on integrated care models, priority specialties, professional training and research. In May 2026, NATCM itself highlighted their role in tiered care, improved service delivery and scientific and technological innovation.

Documented procedures. Official implementation documents describe mechanisms such as multidisciplinary Chinese-and-Western-medicine teams, joint consultations and clinics, joint rounds, joint case discussions and bidirectional training between professionals. These elements describe concrete forms of organising clinical integration in the Chinese context.

Clinical integration as a measurable object

Chinese Flagship Hospitals and Flagship Departments provide a documented case of organisation of clinical integration. For comparative reading, these models can be described through observable components: team composition and training, mechanisms for joint consultation and decision-making, flows among specialties, protocols by clinical condition, governance, indicators, safety and outcomes.

Key concept for study. Integration can be studied through structure, process, experience, safety and outcomes. Structure includes teams, services, competencies and governance; process includes joint consultation, pathways, protocols and decision-making; experience includes acceptability and continuity of care; safety includes adverse events, interactions and pharmacovigilance; outcomes include clinical, functional and care-related results and, where relevant, service use and costs. This approach supports respectful comparison among different forms of integration and health systems.

The specific 15th Plan for revitalisation and development of TCM (Guo Han [2026] No. 71), approved by the State Council on 7 July 2026, maintains this direction: advancing Flagship Hospitals and Departments, developing specialist networks, expanding integrated multidisciplinary teams (MDT) and concentrating efforts on complex, rare and difficult-to-manage diseases, while preserving the principle of equal importance between Chinese and Western medicine. In 2026, local implementations — such as in Shanghai — require stable collaboration mechanisms, joint consultations and rounds, cross-training, quantifiable indicators and links with at least ten partner institutions or services, including dissemination to primary care.

Clinical research quality · terminology · information integration

TC476 · TC478 · GB/T 47336-2026 · GB/Z 112-2026 · WS/T 901-2026 · NSFC H33

In 2026, national standards and technical documents made three methodological problems particularly visible: clinical research quality, data governance and traceability, and terminological interoperability between medical systems.

TC476 — Integrative Medicine · Chinese national technical standardisation committee

National committee specifically for Integrative Medicine, distinct from TC478. Its official scope includes integrated diagnostic and therapeutic terminology, clinical guidelines and efficacy evaluation. The committee documents how China formalises terminology, guidelines and efficacy evaluation at the interface between distinct clinical systems, preserving the conceptual and clinical identity specific to each rationale.

TC478 + GB/T 47336-2026 — clinical research quality in TCM

TC478 is the national TCM standardisation committee responsible for GB/T 47336-2026 — Specification for quality control in traditional Chinese medicine clinical trials, published on 31 March and in force since 1 July 2026, establishing a national specification for quality control in TCM clinical trials, with quality components, documentation and traceability.

GB/Z 112-2026 — clinical terminology for integration

Published on 4 January 2026, GB/Z 112-2026 — Traditional Chinese medicine—Categories of clinical terminological system to support the integration of clinical terms from traditional Chinese medicine and Western medicine — establishes a classification structure for clinical terminology systems intended to support integration of clinical terms from the two medical systems. It is particularly relevant for understanding how terminological mapping can build communication between medical systems while preserving the conceptual specificity of their constructs.

WS/T 901-2026 — institutional clinical-research quality-management system

Published by the National Health Commission on 10 June 2026, with entry into force planned for 1 December 2026, WS/T 901-2026 — Specification for quality management system of clinical research in medical institutions — General Principles — is a recommended standard for building quality-management systems for investigator-initiated clinical research in medical institutions. Its object is institutional: it defines responsibilities, infrastructure, processes and improvement mechanisms capable of supporting quality research, not merely rules for a database or an isolated protocol.

The standard organises management into five domains: system construction; research design; compliance; implementation; and results management. It provides for an institutional committee for investigator-initiated research, a responsible department, cooperation among ethics, information technology, finance and other areas, continuous internal auditing and explicit responsibilities for the principal investigator and team.

At the design stage, it requires a protocol, CRF, consent form, statistical plan, implementation plan and data-governance and/or data-management plan. For historical or retrospective multi-source data, it requires planning for security, extraction, cleaning, missing data, transformation, common standards/models, normalisation, natural-language processing, coding, transmission, storage and quality control. For prospective data, it requires a variable dictionary with definition, time and mode of measurement, origin and coding.

During implementation, it establishes a quality-assurance system centred on dynamic risk assessment. For data transformations, it requires preservation of content and meaning between original and transformed data and that the process be traceable, visible and verifiable. Document management includes uniform naming, version control with date, change and responsible person, updating, distribution, backup, recovery and retention; at the end, data and analytical programmes must be archived in a way that supports reproducibility and verifiability.

Transversal learning. WS/T 901-2026 reinforces that scientific quality is also a property of the institutional system that produces and follows the study. In comparative dialogue, while preserving normative specificities, with the findings on PTS, ethics governance, AI and multicentricity, it supports the principle of Quality Throughout the Evidence Cycle: design, execution, transformation, decision and outcome need to remain connected through responsibilities, records and verification mechanisms compatible with risk and purpose.

Project 20261029-T-468 — integrated Chinese and Western medicine guidelines

National draft project under TC476/NATCM, dedicated to formulation and evaluation of integrated diagnosis and treatment guidelines. The process chain can be described as: clinical question → protocol → evidence → grading → recommendation → implementation → evaluation.

National Natural Science Foundation of China — H33 Integrative Medicine

The National Natural Science Foundation of China (NSFC) uses the code H33 · Integrative Medicine for research on integrated Chinese and Western medicine. The official 2026 programme guide describes three major scopes: basic theory of integration, clinical foundations of integration and new research technologies and methods. The classification makes integration visible as a formal domain of scientific investigation and funding, alongside its care and institutional expression.

Transversal learning. The simultaneous presence of basic investigation, clinical foundations and methodological development within the same funding area offers an example of how an integrative field can organise questions at different degrees of maturity, with development trajectories of their own and rhythms compatible with each scientific object.

National clinical-research networks · multicentre collaboration · translation

NATIONAL CLINICAL RESEARCH CENTERS · COLLABORATIVE NETWORKS · SHARED DATA/SAMPLES

The Chinese organisation of National Clinical Research Centers adds a relevant layer between national science policy and local institutional ecosystems. The regulatory model defines these centres as national platforms oriented towards clinical application, supported by collaborative networks and linked to medical institutions in different regions. Their responsibilities include building collaborative innovation networks, conducting large-scale and multicentre evidence-evaluation studies, translational research integrating basic and clinical investigation, and maintaining shared platforms for health data and sample resources. The regulation also provides for attention to regional balance and the possibility of subcentres in different regions.

For Neuroscience, the China National Clinical Research Center for Neurological Diseases provides a concrete example of this architecture. The Centre defines itself as a national platform for clinical and translational research supported by a collaborative network and conducts research in cerebrovascular and neurodegenerative diseases, epilepsy, tumours, neuromodulation and other neurological fields. Its operational structure coordinates multicentre studies and research networks distributed nationally.

The documented distribution of network units of the National Clinical Research Centers reaches different provinces and regions and, within the present observation, includes institutions in Anhui and Zhejiang. The arrangement records multicentre clinical research distributed across distinct institutions and territories.

Documented components include multicentre networks, distributed coordination, shared platforms, data and sample governance, minimum standardisation and distributed institutional responsibilities.

Inter-university cooperation and distributed scientific infrastructure

The C9 brings together research-intensive Chinese universities, including USTC and Zhejiang University, and provides a reference for observing inter-university cooperation, scientific circulation and coordination among institutions with distinct specialisations and infrastructures. This inter-university scale differs from the regional multicentricity of health systems and from international cooperation among countries.

Regional / Ecosystem Level

Yangtze River Delta · inter-regional integration and multicentre research

SHANGHAI · JIANGSU · ZHEJIANG · ANHUI · COLLABORATIVE ETHICS REVIEW

Between the national scale and individual institutional ecosystems there is a distinct regional layer. Shanghai, Jiangsu, Zhejiang and Anhui are part of the Yangtze River Delta development strategy, in which science, technology, innovation and health research cross administrative boundaries and require common coordination mechanisms.

In clinical research, the health authorities of the three provinces and Shanghai published, in December 2025, the Consensus on Collaborative Ethics Review of Multicentre Clinical Research in the Yangtze River Delta. The document derives from the regional alliance created in 2021 and defines lead review and collaborative review, responsibilities of the coordinating investigator and participating centres, communication among committees and maintenance of local responsibilities for participants, safety and feasibility.

In June 2026, the mechanism entered operation with publication of 59 institutions initially recognised as lead-review committees. The model also established reference timelines for initial review — up to 15 working days in the lead committee and up to 5 working days in collaborating committees — and advanced towards a regional information platform.

Key concept for study. The Yangtze Delta case illustrates a form of distributed governance: regional coordination of assessment coexists with each institution's own responsibilities for local execution, participant protection and study follow-up.

Transversal learning. Multicentre networks gain consistency through coordination rules, explicit responsibilities, procedural interoperability, communication, timelines and trust mechanisms among institutions, in addition to the distribution of centres itself. Governance thus becomes an observable component of the capacity to produce multicentre evidence. In multicentre networks, a common core — question, outcomes, safety criteria, minimum ontology, analytical rules and versioning — can coexist with a verifiable local layer — population, service, team capacity, resources and cultural, territorial and regulatory context — without confusing harmonisation with homogenisation.

Territorial + Institutional Level

Anhui · Hefei · USTC — fundamental science, neuroscience, engineering and clinical investigation

BRAIN FUNCTION & BRAIN DISEASES · STRUCTURAL BIOLOGY · MOLECULAR MEDICINE · AGEING BIOMEDICINE

The University of Science and Technology of China (USTC) has an institutional configuration that brings life sciences, medicine, engineering and a university hospital into close proximity. The current Division of Life Sciences and Medicine derives from the Department of Biophysics created in 1958 and comprises four schools — Life Sciences, Basic Medical Sciences, Clinical Medicine and Biomedical Engineering — together with the First Affiliated Hospital of USTC, formerly Anhui Provincial Hospital, with more than 5,000 beds. The Division holds doctoral authorisations in four first-level disciplines — Biology, Ecology, Clinical Medicine and Biomedical Engineering — alongside professional programmes in Clinical Medicine and Biology & Medicine. Institutional documentation records shared scientific platforms, specialties authorised for clinical drug trials, clinical stem-cell research and structures oriented towards clinical research and new-drug development.

Neuroscience and clinical translation. Neuroscience research spans scales from molecular and cellular mechanisms to neural circuits, neuroimaging and clinical investigation. The Division itself lists, among its laboratories and structuring areas, brain function and brain diseases, structural biology, molecular medicine and ageing biomedicine.

Key concept for study. Institutional proximity among basic science, biomedical engineering and the hospital environment favours interfaces among mechanistic investigation, technological development, measurement and clinical research. USTC's configuration makes it possible to observe how different scientific and care competencies are articulated within an ecosystem oriented towards research and translational innovation.

Transversal learning. For reading translational ecosystems, it becomes particularly useful to map, in addition to disciplines, interfaces: mechanism↔biomarker, biomarker↔measurement, measurement↔engineering, engineering↔validation and clinical investigation↔service. This interface-based reading helps to understand where different scientific competencies meet.

USTC · ethics, biosafety and research governance

USTC maintains its own Charter of the Science and Technology Ethics Committee (中国科学技术大学科技伦理委员会章程, trial version), approved at the University's Presidency work meeting on 11/10/2023 and discussed and approved by the Standing Party Committee on 18/10/2023. The institutional document expressly states that it is based on national rules 国科发监〔2023〕167号 and 国卫科教发〔2023〕4号, the Laboratory Animal Administration Regulation, the Ethical Norms for New-Generation Artificial Intelligence, the Guide for the Construction of Clinical Research Ethics Review Committees (2023) and the Guide for Standardisation of AI Ethics Governance (2023).

Within the documented institutional ecosystem, ethics review, scientific rigour, biosafety and governance of materials and data form part of research-executability requirements where applicable to the object and design.

USTC · Documented chain in neuroscience and brain diseases

Institutional documentation brings together molecular and cellular investigation, neuroimmunology, brain-disease models, single-celltechnologies, mass spectrometry, biomarkers, pharmacological screening, drug-delivery systems and clinical research. The affiliated hospital adds the care and clinical dimension to this set.

Together, these areas make it possible to observe different levels of investigation within the same institutional ecosystem and documented interfaces among basic science, technological development, measurement and clinical research.

USTC · intestinal immunity and microbiota · Prof. Shu Zhu · LIIM

Within the Division of Life Sciences and Medicine, Prof. Shu Zhu, Executive Director, leads the Lab of Intestinal Immune and Microbiota (LIIM). This research line investigates intestinal immune recognition and homeostasis, including responses to pathogens, food antigens and microbial metabolites, with interest in tolerance, inflammation, cancer and microbiota-directed therapeutic strategies.

Interface with the Programme. The documented institutional capacity broadens the comparative horizon for mechanistic and translational questions concerning microbiota, immunity, inflammation and systemic effects, in interface with the eCBome–microbiota–brain axis when the question and design establish researchable relationships among these systems.

USTC · Prof. Shu Zhu · LIIM ↗ · LIIM · Faculty ↗

USTC · Bioinformatics · Genomics · AI · single-cell and spatial omics · QULAB

The QULAB, led by Prof. Kun Qu, integrates Bioinformatics, Immunology, Genomics and Artificial Intelligence in the development of single-cell multi-omicstechnologies, spatial transcriptomics, algorithms and software for large-scale biomedical data analysis. Institutional documentation explicitly describes applications in cancer and autoimmune diseases, precision medicine and integration of deep learning into omics-data analysis.

Interface with the Programme. The comparative interest lies in the articulation among multimodal acquisition, data quality and structure, computational modelling and biomedical interpretation. The scientific question, design, provenance and fitness of data for the intended use guide the selection and application of AI methods.

USTC · Prof. Kun Qu · QULAB ↗ · USTC · Biomedical Engineering · research lines ↗

USTC · clinical translation · CMC · regulation · quality · GMP · Yucai Wang Lab

The laboratory of Prof. Yucai Wang, within the Division of Life Sciences and Medicine and the National Key Laboratory of Immune Response and Immunotherapy, describes an integrated clinical-translation strategy for drug-delivery systems: pharmaceutical development and Chemistry, Manufacturing and Controls (CMC), regulatory planning, clinical-trial execution, interdisciplinary teams, scalable manufacturing processes, quality control and production compatible with Good Manufacturing Practice (GMP).

Interface with the Programme. The value for translational reading lies in the explicit chain connecting mechanism, development, quality, regulation, clinical trial, operational readiness and patient benefit. It is an institutional reference for studying how scientific and operational requirements may be connected across a translational trajectory, with method selection guided by the characteristics of each object of investigation.

USTC · Wang Research Lab · Research ↗ · USTC · Wang Research Lab · Translation ↗

USTC — cannabinoids · neurobiology · Prof. Wei Xiong and Xiong Lab

USTC documents a research line on cannabinoids linked to neurobiology, neural circuits and ion channels. Prof. Wei Xiong is Professor and Executive Dean of the School of Life Sciences at USTC and leads the Xiong Lab · Neurobiology; institutional documentation describes among its axes mechanisms of ion-channel regulation, ageing and neurodegenerative diseases, neural circuits and development of mass-spectrometry technologies applied to neuroscience.

Works documented by USTC itself include studies on glycine-receptor-mediated analgesia, cholesterol dependence in cannabinoid modulation, reversal of glycine-receptor dysfunction in a model of cocaine-induced seizures, restoration of an important GABA receptor isoformA by the synthetic cannabinoid dehydroxylcannabidiol in a cellular model of hyperekplexia; in 2022, mechanisms of synergistic toxicity from combined alcohol and cannabinoid exposure in cerebellar Purkinje cells; and, in 2023, suppression of neuropathic pain by dehydroxylcannabidiol associated with a compensatory mechanism mediated by spinal glycine receptors.

Transversal learning. The set is particularly informative for the Programme because it brings together, within the same ecosystem, cannabinoid pharmacology, inhibitory receptors, neural circuits, analgesic mechanisms, safety/toxicity, experimental models and interfaces with clinical and biomedical investigation. For the Programme, this line constitutes documented scientific capacity for formulating mechanistic, safety and translational-research questions involving cannabinoid pharmacology, inhibitory receptors, neural circuits, analgesia and toxicity.

Microbiota–brain and cannabinoid convergence. Prof. Wei Xiong's institutional page at USTC itself documents, among representative publications, the article Microbiota-Gut-Brain Axis Drives Overeating Disorders (Cell Metabolism, 2023), the study on the cannabinoid dehydroxylcannabidiol (DH-CBD) and spinal glycine-receptor-mediated neuropathic pain (Journal of Biological Chemistry, 2023) and, in 2024, From gut microbiota to brain: implications on binge eating disorders (Gut Microbes). Together, these works document, within the same scientific programme, interfaces among microbiota–gut–brain, neurobiology, metabolism, eating behaviour, cannabinoid pharmacology, glycine receptors and pain mechanisms.

USTC · Prof. Wei Xiong profile ↗ · Xiong Lab · Neurobiology · team ↗ · JBC · dehydroxylcannabidiol / GABAA · 2020 ↗ · Nature Metabolism · alcohol + cannabinoids · 2022 ↗ · JBC · dehydroxylcannabidiol / neuropathic pain · 2023 ↗

Cryo-ET

USTC documents a line of cryo-electron tomography (cryo-electron tomography, cryo-ET) applied to synaptic structure and dynamics. In 2025, a team led by Guo-Qiang Bi published in Science a cryo-ET method with millisecond temporal resolution to investigate synaptic-vesicle release and recycling. The work integrates structural and temporal resolution into mechanistic investigation of synapses.

QDM and quantum sensing

USTC has documented research on diamond NV centres, nanoscopy and quantum metrology. These lines place quantum sensing at the interface among quantum technologies, biophysics, metrology and biomedical investigation.

Ozone therapy in association with acupuncture

The Chinese Clinical Trial Registry records a study conducted at the Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine, in Hefei, investigating ozonated-water injection in association with acupuncture. This evidence documents a specific clinical intersection between ozone therapy and TCM in Anhui, while keeping the techniques as distinct categories.

Anhui · Hefei · ecology, entomology and biodiversity — complementary regional ecosystem

ECOLOGY · ENTOMOLOGY · BIODIVERSITY · INVASIVE SPECIES · PLANT–INSECT INTERACTIONS · ENVIRONMENTAL HEALTH

The Anhui Agricultural University (AAU), a provincial public university located in Hefei and jointly established by the Anhui Provincial Government, the Ministry of Agriculture and Rural Affairs and the National Forestry and Grassland Administration, broadens the regional scientific ecosystem observed by the Programme beyond USTC.

The School of Plant Protection maintains departments of plant pathology, entomology and pesticide science; Agricultural Entomology and Pest Control is a provincial key discipline, with doctoral training and documented lines in insect systematics and biodiversity, development and immunity, crop–pest–natural-enemy interactions, toxicology and resistance, green control and use of insects as a resource. The university also maintains a Department of Ecology, with doctoral and postdoctoral training and research integrating environment, life sciences, agriculture and resources.

Transversal learning. For the Programme, this set also makes Hefei observable as a research territory in biodiversity, ecology, entomology, biological control, invasive species, agriculture and environment. These capacities are relevant to questions in One Health, Planetary Health, living systems and interfaces among biodiversity, territory and health, without presuming institutional cooperation.

Anhui Agricultural University · General Information ↗ · AAU · Agricultural Entomology and Pest Control ↗ · AAU · Ecology ↗

Zhejiang · Hangzhou · Zhejiang University — Translational Neuroscience, BCI and international cooperation

NEUROBIOLOGY · BRAIN-MACHINE INTERFACES · NEUROPHARMACOLOGY · NEUROIMAGING

Zhejiang University documents an organisation in which neurobiological research, technological development and clinical work are brought into relationship. The Department of Neurobiology describes basic and translational research in cerebral ischaemia, epilepsy, depression, social behaviour and sleep disorders, as well as interfaces with neuropharmacology, imaging and clinical specialties of affiliated hospitals.

In 2015, the Zhejiang University Brain Research Consortium brought together neuroscience, computing and optical-sciences teams. Its institutional page describes emotions, brain–machine interfaces and neural-signal acquisition as areas of emphasis, providing an example of interdisciplinarity organised around brain problems and technologies for measurement and interaction.

Key concept for study. Institutional interdisciplinarity and clinical translation are complementary dimensions: the former highlights articulation among fields and teams; the latter follows pathways from scientific question to development, validation and application. The Zhejiang ecosystem provides documented elements for studying both dimensions.

Transversal learning. The joint presence of neuroscience, computing, optics, neuropharmacology, signal acquisition and brain–machine interfaces shows how a scientific problem can mobilise distinct languages and instruments. Integration gains density when each contribution retains its specificity and connects through a shared question, measurement or problem.

The translational dimension is institutionally explicit: Zhejiang University and the University of Melbourne established a Joint Translational Neuroscience Research Center, with collaborative research and doctoral training and convergence in emotion/affect, stroke, epilepsy, brain–computer interfaces and neuroimaging.

In Hangzhou/Zhejiang University, documentation brings together neuroscience, neuroengineering, brain–machine interfaces, signal acquisition, neuroimaging, neuropharmacology, affiliated hospitals and international scientific cooperation. This configuration differs from that observed in Hefei and allows comparison of distinct forms of articulation among basic science, technology and clinical work.

Hangzhou · Neuroscience20 · Babak Kateb

Hangzhou · Neuroscience20 · international cooperation in neuroscience. On 4 September 2016, Hangzhou hosted the 3rd Neuroscience20 Summit, dedicated to building a global alliance in brain mapping and therapeutics, chaired by Dr Babak Kateb, with Dr Dong Zhou as vice-chair. The antecedent documents a historical interface among Zhejiang/Hangzhou, Neuroscience20 and international translational-neuroscience networks.

SBMT · official profile ↗

Zhejiang · Ningbo — university, TCM, clinical networks and territorial implementation

ZCMU · TCM HOSPITAL · CLINICAL SCHOOL · MUNICIPAL GOVERNANCE

Ningbo is observed as a territorial node distinct from Hangzhou within Zhejiang, where university, Traditional Chinese Medicine hospital, clinical training, health innovation and municipal public administration appear together.

In March 2024, Zhejiang Chinese Medical University, the Health Commission of Ningbo and Ningbo Hospital of Traditional Chinese Medicine formalised a tripartite agreement to establish the Ningbo TCM Hospital Affiliated to Zhejiang Chinese Medical University and the Ningbo School of Clinical Medicine of Zhejiang Chinese Medical University. The arrangement covers hospital management, education and teaching, discipline development, scientific research and team training, creating a direct institutional interface among a university specialised in TCM, the municipal health system, hospital and clinical training.

Ningbo adds to the Observatory a territorial scale of organisation: a university specialised in TCM, hospital, clinical school and municipal administration appear within the same territory of training, research, care and public management.

Transversal learning. The territorial scale makes it possible to observe dimensions that an exclusively laboratory- or hospital-based reading may render less visible: professional training, circulation among institutions, implementation, service organisation and the relationship between public policy and local capacity. Territory, in this sense, can also constitute a unit of scientific analysis.

Hefei/USTC concentrates biophysics, molecular and cellular mechanisms, neuroscience, biomedical engineering, technologies and clinical investigation; Hangzhou/Zhejiang University articulates neuroscience, BCI, neuroimaging, pharmacology, hospitals and international scientific cooperation; Ningbo highlights territorial articulation among universities, hospitals, TCM, clinical training and health administration. The three ecosystems are described in their specificities and complementarities, preserving the configuration specific to each institutional and territorial arrangement.

Biodiversity · medicinal resources · traditional knowledge — protection and traceability

The China National Biodiversity Conservation Strategy and Action Plan (2023–2030) integrates conservation, monitoring, restoration, sustainable use, governance of genetic resources and fair and equitable benefit-sharing. The plan includes specific action for protection and transmission of traditional knowledge related to biodiversity, covering, among other fields, ethnic medicine and Traditional Chinese Medicine, and provides mechanisms for access and benefit-sharing involving genetic resources, digital-sequence information and associated traditional knowledge.

The Traditional Chinese Medicine Law adds a layer specific to medicinal resources: it establishes quality monitoring and source traceability of medicinal materials and requires protection, dynamic monitoring and periodic surveys of wild medicinal plant and animal resources, with conservation of genetic resources and support for protection and research of rare or threatened species. Transversal learning: quality of medicinal material, provenance and ecological sustainability may belong to the same governance chain. This reading is confined to the Chinese framework and is not presented as equivalent to Brazilian or international regimes concerning the rights of Indigenous peoples and traditional communities.

China · Biodiversity Conservation Strategy and Action Plan 2023–2030 ↗ · Traditional Chinese Medicine Law ↗

Synthesis · Configurations of the Chinese scientific-health ecosystem

The documents observed show different mechanisms of articulation among tradition, innovation, basic research, clinical research and implementation: preservation of TCM's own characteristics; principle of equal importance between TCM and Western medicine; scientific modernisation; basic and clinical research; service integration; digital transformation; ageing and life-course care.

The three ecosystems have their own and complementary configurations. Hefei highlights institutional proximity among basic science, biomedical engineering and hospital; Hangzhou brings together neuroscience, neuroengineering, BCI, signal acquisition and clinical interfaces; Ningbo highlights a territorial scale of articulation among TCM, hospital, clinical training and public administration. At regional scale, the Yangtze Delta adds multicentre governance; at national scale, policies, standards and funding structure other layers of the system.

Together, these scales make it possible to study an important methodological principle: translational systems can articulate multiple layers. Policies, funding, standards, basic research, technological development, clinical investigation, services, territory and governance can compose distinct and complementary configurations for knowledge translation.

What the China block makes especially visible. The combined reading of these entries reveals eight recurring analytical dimensions: (1) transition from national priority to sectoral instruments; (2) coexistence of different degrees of scientific maturity; (3) integration as a measurable and multidimensional phenomenon; (4) data quality and governance incorporated into design; (5) multicentre networks also as a governance problem; (6) interfaces among neuroscience, engineering, data and clinical work; (7) territory as a scale of implementation; and (8) preservation of TCM's own characteristics in processes of innovation, investigation and integration with Western medicine.

Synthesis for study. The main learning lies in the possibility of observing, with precision, how different levels of a scientific-health system may articulate: policy → standard → funding → infrastructure → method → data → research → clinical work → service → territory → governance. This sequence functions as an analytical map; the concrete relationships among its components vary according to the object, institution and scale observed.

Principle for institutional reading. The policies, standards, universities, hospitals and networks referenced here are presented according to their own documentation and in respectful comparative language. The analysis seeks to understand forms of organisation, integration and knowledge translation while preserving context, official terminology and institutional specificities.

Keys for comparative reading. The Chinese case offers a particularly rich opportunity to understand, in its specificities, different layers of organisation: national science and technology policy; health policy; specific TCM policy; technical standardisation; scientific funding; service organisation; multicentre networks; regional governance; and institutional ecosystems. Reading these layers together reveals the diversity of mechanisms through which science, health, innovation and implementation may articulate.

Key official sources for study
Neurotechnology · BCI · policy, regulation and clinical translation
China · public policy for development of the BCI industry

Jurisdiction: China · Authorities: seven ministries and agencies, including the Ministry of Industry and Information Technology, National Development and Reform Commission, National Health Commission and Chinese Academy of Sciences · Status: dated 23/07/2025 and published 30/07/2025 · Nature: implementation opinion (industrial policy) · Force: programmatic.

Core elements: 2027 targets (core technological advances, advanced technical standards) and 2030 targets (2–3 companies with global influence, mature industrial ecosystem), linking research, industry, standardisation and clinical application of BCI.

NEO · translational BCI case approved by NMPA

Jurisdiction: China · Developer: Neuracle Technology (Shanghai), in partnership with Tsinghua University · Status: commercial approval granted by NMPA on 13/03/2026, Class III (implantable medical device).

Approved indication: tetraplegia due to cervical spinal-cord injury (C2–C6), compensation of hand-grasp function via a system associated with a pneumatic glove. Epidural implantation (ECoG), described in the technical literature as a semi-invasive approach — regulatory nomenclature (implantable device) preserved without independent reclassification.

Documented translational trajectory: research/engineering → clinical evaluation → NMPA approval (13/03/2026) → health-insurance system code assigned by the National Healthcare Security Administration on 15/03/2026 → eligibility for subsequent implementation and financing stages.

Translational relevance: a concrete and recent case of a regulatory translational trajectory — from research and engineering to approval, coding in the insurance system and subsequent implementation stages — relevant to spine, spinal-cord injury, function and rehabilitation.

Brazil · SUS · Public/Collective Health and national policies

Brazil · SUS · Public/Collective Health · PNPIC

HEALTH–DISEASE PROCESS · RIGHT TO HEALTH · TERRITORY · FAMILY · PHC/ESF · COMPREHENSIVENESS · PARTICIPATION · PICS · DATA · ONE HEALTH

Brazil organises a universal public system from a broadened conception of health: illness, protection, care and production of health are not exhausted by disease or the isolated individual. Biological processes relate to living conditions, work, income, environment, culture, relationships, family, access, territory and social organisation. Public/Collective Health provides a scientific and political field for investigating these relationships in populations, services and systems, while preserving the specificity of different levels of analysis.

The Unified Health System (SUS), constitutionally established in 1988 and regulated by Laws No. 8,080/1990 and No. 8,142/1990, materialises health as a right within a regionalised and hierarchical public network. Universality, comprehensiveness and equity guide access and care; decentralisation, regionalisation, social participation and shared responsibility among the Federal Government, states, Federal District and municipalities organise its governance.

Health–disease process · Public/Collective Health · determination and context

A broadened reading of the health–disease process asks not only which biological alteration is present, but how it emerges, is perceived, distributed and cared for under concrete living conditions. Environmental exposure, work, food, housing, social relationships, discrimination, income, education, culture, access to policies and services, and territorial characteristics may modify risks, vulnerabilities, protection, experience of illness and possibilities for care.

This does not dissolve biological mechanisms into social explanations, nor reduce social phenomena to biomarkers. The scientific question defines which levels need to be observed and which relationships can be tested. Person, family, community, population, service and territory may constitute different and complementary units of analysis or intervention.

Key concept for study. The health–disease process is simultaneously biological and situated. Investigation of context identifies conditions that modify exposure, vulnerability, response, access, outcomes and implementation, incorporating them into causal design where relevant.

SUS · health as a right · universality, comprehensiveness and equity

SUS encompasses promotion and prevention, Primary Health Care, specialised and hospital care, urgent and emergency care, epidemiological, health and environmental surveillance, pharmaceutical services, rehabilitation and other public-health functions. Governance is interfederative: responsibilities and financing are shared across three levels of government, while regionalised networks seek to articulate services of different technological densities.

Universality refers to the right of access; comprehensiveness, to articulation of the actions required by different health needs; and equity, to consideration of inequalities and distinct needs so that the universal right is not applied indifferently to the concrete conditions of people and populations.

Key concept for study. Universality and territorialisation are complementary dimensions of the same system: a system can uphold a common right while organising differentiated responses according to needs, vulnerabilities, available networks and local characteristics.

Territory · Primary Health Care · Family Health Strategy

Primary Health Care (PHC) constitutes the first level of care and performs functions of access, longitudinal follow-up, care coordination and articulation with the Health Care Network. The Family Health Strategy (ESF) — the designation that succeeded the former Family Health Programme — is the priority model for care and reorganisation of PHC in the country.

Multiprofessional teams develop individual, family and collective actions for populations in defined territories and assume health responsibility for them. Knowledge of local reality, home visits, therapeutic relationships, continuity and identification of factors and determinants of health needs bring care, family, community and territory closer together.

Learning for study. Territory does not function merely as a geographical coordinate or adjustment variable. In ESF, it participates in the organisation of health responsibility itself, observation of needs and design of care.

Comprehensiveness in practice · Clínica Ampliada · PTS · matrix support · Balint-Paideia

The National Humanisation Policy developed devices to make comprehensiveness operational in the encounter among people, teams and services. The Clínica Ampliada e Compartilhada broadens the object of work beyond isolated disease, recognising singularity, autonomy, relationships, context and the limits of professional classifications and interventions.

The Projeto Terapêutico Singular (PTS) organises care offers around the needs of a person — and, where relevant, their family or collective — in the real context of life. It may articulate biological, pharmacological, psychosocial, family, socio-educational and community dimensions, with objectives, responsibilities, reference professional or team, follow-up and periodic reassessment. PTS is dynamic: outcomes and changes in context may require revision of the plan itself.

The matrix support and reference teams make it possible to share knowledge and responsibilities among professionals and services without automatically fragmenting care into independent referrals. The Balint-Paideia, developed in the Brazilian context from Balint groups and the Paideia Method, uses meetings of health workers as spaces for reflection and learning about knowledge, power, relationships and affects present in care; it dialogues with Clínica Ampliada, PTS, reference teams, matrix support and co-management.

Key concept for study. Comprehensiveness ceases to be only an abstract principle when there are devices that make objectives, relationships, responsibilities, networks and care decisions observable and revisable.

Participation and social control · Health Councils and Health Conferences

Community participation forms part of the constitutional architecture of SUS. Law No. 8,142/1990 organises Health Councils and Health Conferences as bodies for participation and social control. The Councils are permanent and deliberative; the Conferences bring together government, workers, providers and users to assess the health situation and propose guidelines for public policies.

This design makes the population participants in formulation, monitoring and control of policies, not merely recipients of services. National and thematic conferences also produce public records of priorities, tensions and proposals that may be studied as material on social participation and policy formulation.

Transversal learning. In complex public systems, participation can constitute a mechanism of governance and information production on needs and priorities, provided that representation, decision-making processes, feedback and effects of participation are concretely analysed.

SUS Digital · RNDS · interoperability, continuity and data governance

Decree No. 12,560/2025 defines the National Health Data Network (RNDS) as the national interoperability platform for the SUS data ecosystem. The envisaged processing spans care, surveillance, management, research and public policy and explicitly relates the infrastructure to continuity and comprehensiveness of care. The decree also establishes proportionality, data-subject rights, a data-protection impact report before data sharing and prohibition of secondary use incompatible with legally established purposes.

The National Policy on Information and Digital Health, approved by the National Health Council in August 2026, broadens this agenda to integration of clinical data, telehealth, capacity-building, research and innovation, with attention to reducing regional inequalities and digital literacy. Transversal learning. Technical interoperability is not treated as synonymous with continuity of care: it is infrastructure whose utility needs to be tested through effective use of information, coordination of decisions, equity of access and protection of rights.

Brazil · Decree No. 12,560/2025 · RNDS and SUS Digital Platforms ↗ · Ministry of Health · National Policy on Information and Digital Health · 2026 ↗

Diagnostic safety in ageing · delirium, dementia and medicines

The Ministry of Health Care Pathways advise that, in the presence of cognitive dysfunction, delirium — an acute, fluctuating and potentially reversible syndrome — should be ruled out, and cite relevant causes including infections, acute renal failure, hyponatraemia and adverse effects of medicines, including benzodiazepines and neuroleptics. Brazilian safe-medication policy also treats polypharmacy as a risk requiring follow-up and individualised review.

Transversal learning. Diagnostic safety and medication safety become inseparable when an acute cognitive change can lead to a new prescription, intensification of treatment or neurodegenerative labelling. Pre-existing dementia does not eliminate investigation of superimposed acute causes.

PNPIC · PICS · therapeutic plurality in the public system

The National Policy on Integrative and Complementary Practices in SUS (PNPIC), established by GM/MS Ordinance No. 971 of 3 May 2006, initially incorporated Traditional Chinese Medicine/acupuncture, homeopathy, medicinal plants and phytotherapy, anthroposophic medicine and social thermalism/crenotherapy; subsequent expansions brought the institutional list to 29 practices. The policy emphasises continuous, humanised and comprehensive care, with a strong presence in Primary Health Care.

Traditional Chinese Medicine · Acupuncture

Within the PNPIC framework, Traditional Chinese Medicine is recognised as a complex medical system, of which acupuncture constitutes a health-intervention technology. This distinction is didactically important: diagnostic rationale, medical theory, body practices, dietary practices and therapeutic practices are not reducible to needle insertion. In research, each component needs to be characterised according to the question, intervention or exposure, comparison strategy where applicable, outcomes and care context.

Medicinal plants · Phytotherapy · Farmácia Viva · Cannabis interface

The National Policy on Medicinal Plants and Phytotherapeutics and Farmácia Viva make visible, within SUS, a chain connecting territory and biodiversity → botanical identification → cultivation/collection → raw material → processing/preparation → quality control → dispensing → rational use → pharmacovigilance. Anvisa RDC No. 18/2013 establishes good-practice requirements for Farmácias Vivas.

Cannabis sativa L. appears here as a contemporary comparative object for questions concerning botanical identity, phytochemical variability, preparation, traceability, safety, access and evidence generation. Its analysis preserves the specific legal, regulatory and care regime applicable to Cannabis-based products and preparations.

The ozone therapy is included in the Brazilian list of PICS as a category in its own right. Each practice or system requires characterisation of the object, scientific question and evidence criteria compatible with its nature and use.

Countryside · forest · waters · equity and territories

The National Policy for Comprehensive Health of Countryside, Forest and Water Populations (PNSIPCFA) explicitly states that access, promotion, surveillance, popular education, participation and social control need to consider specific ways of life, work, exposures and territorial conditions. Its design connects comprehensiveness and equity to populations whose relationships with land, water, forest, production and mobility modify needs and barriers to access.

This policy dialogues with traditional knowledge and practices but does not reduce them to therapeutic resources. Territory may involve environment, subsistence, work, identity, community relationships, exposure and rights — dimensions that require their own questions and indicators.

PNPS · territoriality · genetic heritage and traditional knowledge

The National Health Promotion Policy (PNPS) treats territoriality as an operational strategy: planning should consider territorial singularities and specificities, articulate sectors and networks and produce actions attentive to equity, rights and health determinants. The policy also includes research, production and dissemination of knowledge and evidence among its guidelines, allowing territory to be studied not merely as location but as a dimension that may modify planning, implementation and evaluation.

When the question reaches genetic heritage or associated traditional knowledge, another legal layer applies. Law No. 13,123/2015 protects associated traditional knowledge of Indigenous populations, traditional communities and traditional farmers against illicit use and exploitation; for knowledge of identifiable origin, it conditions access on prior informed consent and recognises rights relating to origin, participation in decision-making and benefit-sharing. These requirements have their own legal scope and should not be generalised to every form of community knowledge. Community protocols and traditional forms of organisation and representation should be respected where applicable.

Transversal learning. Territory may simultaneously inform exposure, organisation of care, implementation and rights. The design needs to state which of these functions is being mobilised and which regimes of participation, consent, knowledge protection and benefit-sharing are triggered by the concrete object.

Ministry of Health · PNPS ↗ · Law No. 13,123/2015 ↗

Health information · Data Quality · implementation research

Information production in SUS occurs through systems with distinct purposes, units of record, coverage and forms of access. In Primary Health Care, the Information System for Primary Health Care (Siaps) succeeds the SISAB architecture and organises information originating, among other sources, from records produced in e-SUS APS. The Outpatient Information System (SIA/SUS) records components of outpatient production; the National Registry of Health Establishments (CNES) characterises facilities, services and installed capacity; and TABNET is a public interface for querying different datasets made available by DATASUS.

These systems do not constitute a single or interchangeable database: each serves specific administrative and care purposes, with specific possibilities and limits of coverage, completeness, granularity, temporality, comparability and linkage among records. Source selection follows the scientific question and design.

Use in research. Public and aggregated data may support descriptive, territorial and service analyses. Studies using individual-level data, linkage or restricted access follow their own governance and data-protection requirements and, where applicable, ethics review.

Functional chain. Care record → assessment of completeness and consistency → standardisation/data dictionary → semantic harmonisation → population and denominators → exposure/intervention → territorial and temporal linkage → source integration where admissible → implementation analysis → safety/equity → real-world evidence compatible with design and quality.

Data Quality. Completeness, consistency, validity, temporality, duplication, granularity, provenance, interoperability, missingness, recording and selection biases, and linkage limits should be assessed before inference. Individual longitudinality is not automatically available merely because a system produces data over time.

Implementation Science. Brazilian federative heterogeneity is simultaneously a challenge for comparability and a scientific object: why is an intervention adopted, sustained, adapted or discontinued in certain territories? Which contextual, organisational, workforce, access and population factors modify its implementation? Which components remain transportable and which depend strongly on context?

One Health · human · animal · plant · environment

Brazil has institutionalised a One Health agenda that recognises the interdependence of human, animal, plant and environmental health. The Interinstitutional Technical Committee, established by Decree No. 12,007/2024, coordinates different sectors to prepare, review and support implementation of the National One Health Action Plan.

The Brazilian strategic version organises lines related to institutional capacities, emerging and re-emerging diseases, zoonoses and vectors, food safety, antimicrobial resistance, the environment and social participation. It is an intersectoral approach in its own right: it dialogues with Public/Collective Health and Planetary Health but is not synonymous with either.

Key concept for study. Public/Collective Health emphasises population, social, political and territorial processes and health systems; One Health focuses on human–animal–plant–environment interdependencies; Planetary Health examines relationships between human health and transformation of natural systems at a broader scale. Interfaces are researchable without erasing conceptual differences.

SUS observed internationally · right, public good and outcomes

SUS is also an object of international observation. On 27 July 2026, upon receiving an honorary doctorate from Fiocruz, the Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, stated that Brazil's commitment to universal coverage through SUS demonstrated that health can be treated as a right and public good. The statement is recorded as institutional recognition, not as a comprehensive scientific assessment of the system.

Another type of evidence should be distinguished from this recognition: in December 2025, WHO validated Brazil for elimination of mother-to-child transmission of HIV and related the outcome to the long-term commitment to universal and free access through SUS, strong Primary Health Care and a human-rights-based approach. Political-institutional recognition and validation of a health outcome are different categories and should not be conflated.

Transversal learning. Health systems can be studied through their normative and organisational architecture as well as through specific outcomes, distribution of those outcomes, learning capacity and implementation experiences. None of these dimensions, in isolation, describes the entire system.

Key official sources for study

BRICS · scientific and health cooperation

BRICS · STI · Life Sciences and Health · TCIM · South–South Cooperation

MULTILATERAL COOPERATION · SCIENCE-TECHNOLOGY-INNOVATION · LIFE SCIENCES AND HEALTH · TCIM · SOUTH–SOUTH COOPERATION

Multilateral Cooperation

BRICS cooperation in science, technology and health combines ministerial bodies, thematic working groups, technical networks and joint initiatives. In Science, Technology and Innovation (STI), the Memorandum of Understanding signed in 2015 completed ten years in 2025; the 13th STI Ministerial Meeting, held in Brasília on 25 June 2025, recorded a decade of thematic working-group meetings, young-scientist forums, innovation awards and joint research calls.

In health, the 16th Meeting of BRICS Health Ministers, held in Chandigarh, India, in July 2026, adopted a ministerial declaration under the theme Building for Resilience, Innovation, Cooperation and Sustainability and consolidated cooperation mechanisms in universal health coverage, emergency preparedness, digital health, regulation of medical products, collaborative research, mental health, healthy lifestyles and Traditional, Complementary and Integrative Medicine.

Transversal learning. BRICS makes it possible to observe a cooperation architecture in which high-level political decisions coexist with technical groups, scientific networks, operational documents and thematic initiatives. This multiplicity of scales is relevant to understanding how multilateral agendas can acquire institutional continuity across rotating presidencies.

Science, Technology and Innovation

The BRICS Working Group on Science, Technology, Innovation and Entrepreneurship Partnership (STIEP WG) — the Working Group on Science, Technology, Innovation and Entrepreneurship Partnership — organises innovation and technological-cooperation initiatives. In 2025, the group prepared the BRICS Action Plan for Innovation 2025–2030, subsequently endorsed at the 13th STI Ministerial Meeting.

The 2025 agenda highlighted artificial intelligence, quantum technologies, sustainability, integration of big data and technologyforesight, alongside instruments such as the Young Scientists Forum, Young Innovators Prize, joint research calls and technology-transfer mechanisms.

Key concept for study. Technology foresight broadens the function of science policy: in addition to responding to present problems, it enables scenario-building, identification of emerging technologies, anticipation of needs and orientation of research and innovation priorities under conditions of uncertainty.

Life Sciences and Health

The BRICS Working Group on Biotechnology and Biomedicine — including Human Health and Neuroscience — held its 6th meeting on 14 and 15 May 2025 at the Brazilian Center for Research in Energy and Materials (CNPEM), in Campinas. Delegations from Brazil, Russia, India, China, the United Arab Emirates and Iran participated. The agenda included multicentre clinical trials, pandemic preparedness, mental and cognitive disorders, technologies for emerging diseases, bioethics, neuroethics, agricultural biotechnology and food security.

Among the outcomes documented by CNPEM was advancement of a neuroscience cooperation project led by Russia. The attribution is retained here as stated in the institutional communication published by CNPEM in May 2025.

The BRICS health agenda also came to include regulatory and digital dimensions. In 2026, the BRICS Good Practices (GxP) White Paperwas published, consolidating experiences and technical approaches related to good regulatory practices, including principles of good manufacturing, distribution, laboratory and clinical practices. The same agenda supported creation of the BRICS Network of Centres of Excellence on Mental Wellness, coordinated by the National Institute of Mental Health and Neuro Sciences (NIMHANS), India.

Transversal learning. The Life Sciences block shows how multicentre research, ethics, neuroscience, regulation, mental health, emergency preparedness and data infrastructure may form part of a multilateral agenda without constituting a single scientific programme. Unity lies in cooperation across related problems while preserving the specificity of each front.

Traditional Medicine · TCIM

The 16th BRICS Health Ministers' Declaration, adopted in 2026, included for the first time a specific section devoted to Traditional, Complementary and Integrative Medicine (TCIM) and supported establishment of a specialised group on the subject. The agenda encompasses collaborative and multicountry studies, exchange of scientific methodologies and research experience, documentation of good practices, clinical validation, evidence generation, quality, safety, toxicity assessment and pharmacovigilance.

The digital dimension includes knowledge platforms, repositories, databases, interoperability and emerging technologies, including artificial intelligence. BRICS also encourages registration of TCIM clinical trials in registries recognised by WHO and relates its agenda to the WHO Global Traditional Medicine Strategy 2025–2034 and WHO Global Traditional Medicine Centre.

Transversal learning. TCIM appears simultaneously as a theme of research, quality and safety, digitalisation, regulatory cooperation and exchange among knowledge systems. This framing reinforces the need to treat evidence generation and preservation of the diversity of medical systems as complementary dimensions.

The 16th BRICS Health Ministers' Meeting took place in Chandigarh, India, on 23–24 July 2026, under India's BRICS 2026 presidency and the theme "Building for Resilience, Innovation, Cooperation & Sustainability". It was preceded, on 21–22 July, by the BRICS Meeting on TCIM, coordinated by India's Ministry of Health and Family Welfare and Ministry of Ayush, with delegations from Brazil, China, Egypt, Ethiopia, India, Iran, Russia, South Africa and the United Arab Emirates, resulting in the Terms of Reference for the specialised TCIM group. The Brazilian delegation participated in the discussions, with a public statement on the challenges of incorporating integrative and complementary medicine into primary care in SUS, a system covering approximately 200 million people. The 2026 BRICS Health Working Group agenda brought together nine priority areas, including digital-health architecture for continuity of care in remote areas and diseases determined by social factors of health, alongside TCIM.

South–South Cooperation · Transportability · Comparability

The diversity of health systems, medical traditions, populations, biodiversity, scientific infrastructures and regulatory environments among BRICS countries creates a particularly rich field for studying transportability and external validity: in which populations and contexts does a result remain comparable, under what implementation conditions, and what adaptations are required across different environments.

Harmonisation and transportability. Harmonisation refers to building shared minimum elements — operational definitions, datasets, quality requirements, analytical criteria, pharmacovigilance and procedures — sufficient to enable comparison. Transportability asks to what extent findings, interventions or models preserve validity when moving from one context to another. The two concepts are related but address distinct scientific problems.

Transversal learning. In multicountry networks, comparability does not require erasing diversity. On the contrary: differences among health systems, populations, products, practices, regulations and territories become relevant variables for understanding external validity, effect heterogeneity and implementation conditions.

Key official sources for study

IFRC · operational learning and humanitarian systems

IFRC · Preparedness · anticipatory action · operational learning · community resilience

PREPAREDNESS · ANTICIPATION · RESPONSE · LEARNING · RESILIENCE · CLIMATE · LOCAL ACTION

The International Federation of Red Cross and Red Crescent Societies (IFRC) brings together 191 National Societies. Its permanent presence in territories, before, during and after crises, makes it possible to observe preparedness and response as continuous processes linked to local action, community health, risk reduction, early warning, recovery and adaptation.

Preparedness architecture · Framework → PER

The IFRC National Society Preparedness Framework establishes a common basis for strengthening preparedness, readiness and response capacity of National Societies. The document emphasises learning, adaptation and coordination and guides incorporation of preparedness into institutional strategies and operations, while remaining relevant to different local contexts.

This architecture is operationalised through the Preparedness for Effective Response (PER)approach, which provides tools and processes to transform preparedness principles into assessment, prioritisation, planning and capacity strengthening. Preparedness thus appears as a continuous institutional process open to revision.

Key concept for study. A framework and an operational mechanism perform distinct and complementary functions: one organises principles and guidance; the other structures processes for assessing and developing preparedness in the concrete context.

Anticipatory action · risk → trigger → pre-agreed action

IFRC defines anticipatory action as actions intended to prevent or mitigate potential disaster impacts before a shock or before its acute effects are felt. The Operational Framework for Anticipatory Action 2021–2025 systematised this agenda, linking disaster-risk management and climate adaptation.

Within the anticipatory pillar of the Disaster Response Emergency Fund (IFRC-DREF), risk analysis, impacts of previous events, vulnerability data and weather forecasts are used to define triggers. National Societies predefine actions in Early Action Protocols or simplified protocols; when the trigger is reached, the financial mechanism allows resources to be mobilised before the expected impact.

Transversal learning. Anticipation shifts part of the decision from already observed harm to estimated risk. This makes explicit a researchable chain: information → forecast → decision threshold → pre-agreed action → outcome → learning.

Operational learning · feedback · adaptation

The IFRC GO platform maintains an Operational Learning area dedicated to systematising lessons generated in crisis and operations management. The system uses information from IFRC-DREF final reports, Emergency Appeals and other operational sources to support learning about resource allocation, decision-making, communication and protocols.

The IFRC-DREF architecture also incorporates feedback processes and operational reviews. In 2025, the organisation recorded expansion of the operational-learning dashboard, harmonisation of lessons-learned methodologies across anticipatory and response pillars and mechanisms for National Societies' contributions to feed back into procedures and planning.

Transversal learning. Preparedness can be observed as adaptive capacity built over time: preparedness → anticipation → response → recording → learning → adaptation → new preparedness. The scientific value of this sequence lies in the existence of explicit feedback cycles, not merely in the chronological succession of operations.

Health · climate · territory · resilience

IFRC adopts a multi-hazard approach to natural hazards, epidemics, technological accidents, population displacement and risks intensified by climate change, urbanisation and emerging and re-emerging infectious diseases. National Societies articulate disease prevention and control, disaster-risk reduction, early warning and action, and community preparedness and response.

The Global Climate Resilience Platform organises local climate action around three principal fronts: early warning and anticipatory action; nature-based solutions; and shock-responsive social-protection networks. The platform connects risk management, climate adaptation, communities and territory and includes attention to risks such as extreme heat and community warning systems.

Key concept for study. Resilience can be examined as a dynamic property of social and territorial systems facing disturbances: capacity to anticipate, absorb, respond, maintain relevant functions, recover and adapt. IFRC documentation also makes visible that vulnerability, exposure, local capacity and territorial characteristics modify this dynamic.

Localisation · community capacity · continuity

The IFRC humanitarian architecture gives centrality to National Societies and local action. Their permanent presence in communities makes it possible to connect territorial knowledge, preparedness, early warning, response and recovery. The institutional principle is that action should be as local as possible and as international as necessary.

This temporal continuity — before, during and after emergencies — makes it possible to observe how institutional and community capacity, trust, information, coordination and resources relate to readiness and adaptation. Preparedness ceases to be merely a condition immediately preceding the event and becomes part of a trajectory of capacity development.

Transversal learning. Localisation encompasses geographical proximity, decision-making capacity, contextual knowledge, relationships of trust, permanent structures and the capacity to convert information into action relevant to the territory.

Key official sources for study

Africa · TCIM · health · biodiversity · knowledge · scientific capacity

Territorial reading. Africa is observed as a plural continent, composed of countries, peoples, institutions, health systems and knowledge traditions with their own histories and provenances. This nucleus brings together regional frameworks and documented trajectories without turning a national, cultural or individual experience into representation of the whole continent.
Africa · traditional medicine · research · regulation · health systems

WHO AFRICA · EVIDENCE · QUALITY · SAFETY · BIODIVERSITY · TRADITIONAL KNOWLEDGE · UNIVERSAL COVERAGE

The WHO Regional Office for Africa follows traditional medicine as a relevant component of care systems in the Region and structures its agenda around national policies, research and development, quality and safety, regulation, integration into health systems, conservation of medicinal plants, protection of traditional knowledge and equitable benefit-sharing. The Action Plan for the Third Decade of African Traditional Medicine broadens this reading to scientific capacity, local production, innovation, partnerships and universal health coverage.

African research · priorities · ethics · regional coordination

In September 2025, the WHO Regional Office for Africa convened, in Addis Ababa, Ethiopia, two consecutive meetings devoted to defining research priorities, ethical frameworks and regional coordination mechanisms for traditional medicine. The transition from broad agendas to ordered priorities, ethical governance, research capacity and coordination is directly relevant to transforming complex problems into executable research programmes.

Quality · safety · circulation of traditional medicines

WHO regional guidelines for registration of traditional medicines propose criteria for pharmaceutical quality, safety of use and therapeutic efficacy and are directed at regulatory authorities, manufacturers, practitioners and research and development institutions. This framework makes it possible to observe the transition among knowledge and product, characterisation, evaluation, regulation and responsible circulation.

WHO Africa · Traditional Medicine ↗ · WHO Africa · Guidelines for Registration of Traditional Medicines ↗

Nigeria · TCAM · public policy · research and development

NIGERIA · FEDERAL MINISTRY OF HEALTH · TCAM · R&D · INTEGRATION · CULTURAL HERITAGE

Nigeria's Federal Ministry of Health and Social Welfare has maintained, since 2018, a Department of Traditional, Complementary and Alternative Medicine (TCAM), with a mandate to develop and monitor policies, promote Nigerian traditional medicine, support research and development and advance its integration into the national health system. The policy infrastructure includes the national traditional-medicine policy and the Strategic Implementation Plan 2025–2029.

Transversal learning. The Nigerian case makes it possible to observe, within a specific national context, relationships among cultural heritage, research, product development, regulation, quality, integration into care and institutional capacity.

Nigeria Federal Ministry of Health and Social Welfare · TCAM Department ↗ · Nigeria · TCAM Policies ↗

Nigeria · HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu · Abidoba Oyekenu · Air Ambulance · intergenerational circulation

NIGERIA · SCIENCE · EDUCATION · KNOWLEDGE TRANSLATION · DISASTER PREPAREDNESS · AEROMEDICAL EVACUATION

The trajectory of HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu, initially educated in Nigeria and further developed in international scientific and educational environments, offers the Observatory a concrete trajectory of knowledge circulation across Neuroscience, Pharmacology, Education, health management and disaster preparedness. Her scientific entry remains within the Neuroscience and health-innovation nucleus; here, the territorial reading follows relationships among African training, international circulation, capacity development and knowledge translation.

Air Ambulance · disaster preparedness · youth training

In 2022–2023, HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu, Abidoba Oyekenu and collaborators developed Air Ambulance Service Models for Disaster Preparedness, a proof of concept proposal linking aeromedical evacuation, telemedicine, health, engineering, Education and disaster preparedness. AWIS San Diego documentation records, along the same trajectory, remote training of 44 adolescents in work experiences in science, health, law and Education, with students participating in construction of Air Ambulance models.

Translational relevance. The project makes it possible to decompose emergency preparedness into population, scenario, response time, clinical capacity, logistics, technology, communication, safety, cost, training and implementation conditions. Collaboration with Abidoba also makes intergenerational circulation across scientific communication, translation, Education and solution design observable.

Historical documentary source: OYEKENU, Abidoba O. et al. Air Ambulance Service Models for Disaster Preparedness: Public Lecture and Project Proposal. 2022. ISBN 978-1-4716-9202-4. · AWIS San Diego · Fall 2022 Newsletter ↗

Global South · TCIM · biodiversity · Planetary Health · knowledge systems · situated innovation

Global South as a relational scale. This nucleus follows how different territories build evidence, regulate practices, protect knowledge systems, mobilise biodiversity and translate care experiences into research, public policy and health systems. Africa, the Americas, India, China, Brazil and other contexts preserve their own histories, institutions, rationales and priorities; bringing them into relation enables investigation of shared problems, transportability and cooperation while keeping the specificities of each context visible.
Americas · regional research priorities in TCIM · PAHO/WHO · BIREME

LATIN AMERICA AND THE CARIBBEAN · INDIGENOUS PEOPLES · RESEARCH · EVIDENCE · HEALTH SYSTEMS · KNOWLEDGE INFRASTRUCTURE

In June 2025, PAHO/WHO, BIREME and the WHO Global Traditional Medicine Centre held in São Paulo the Regional Consultation for Prioritisation of Research in Traditional, Complementary and Integrative Medicine in the Americas. The process brought together ministry representatives, researchers, specialists, organisations and Indigenous leaders to discuss gaps, infrastructure, methodologies, evidence for decision-making, protection and transmission of traditional knowledge, regulation, financing and capacity development.

The region also participates in the global TCIM knowledge infrastructure: the WHO Traditional Medicine Global Library was developed by BIREME/PAHO in coordination with the WHO GTMC, linking traditional knowledge, scientific evidence and digital transformation.

Transversal learning. The Americas experience makes it possible to observe the transition among regional diversity, participation, priority-setting, information infrastructure and construction of research agendas capable of dialoguing with health systems.

PAHO/WHO · Regional Consultation · Research Priorities in TCIM · 2025 ↗ · PAHO/BIREME · WHO Traditional Medicine Global Library · 2025 ↗

India · Ayush · research, evidence and health systems

INDIA · AYUSH · RESEARCH · EVIDENCE · NATIONAL INSTITUTES · REGULATION · DATA · HEALTH SYSTEMS

India maintains its own national architecture for Ayush systems, linking the Ministry of Ayush, national institutes, central research councils and regulatory bodies for Ayurveda, Yoga and Naturopathy, Unani, Siddha, Sowa-Rigpa and Homeopathy. This infrastructure makes it possible to observe, at national scale, relationships among training, practice, research, standardisation, safety, regulation and provision of care, while preserving the specificities of each system.

In the evidence and data dimension, the Ayush Research Portal, developed by the Ayush Grid/Ministry of Ayush and updated in May 2026, brings together structured, curated and validated research information on Ayush systems. For the Programme, this infrastructure is relevant as a comparative object for evidence organisation, classification, transparency, access and quality of scientific information.

The India–WHO relationship constitutes a layer distinct from the national architecture. In 2023, India signed a five-year agreement to support WHO technical work in traditional, complementary and integrative medicine. In 2024, it committed US$85 million for 2022–2032 as part of the estimated US$250 million investment intended for establishment, infrastructure and operations of the WHO Global Traditional Medicine Centre in Jamnagar. GTMC is presented here as WHO global infrastructure hosted in India, with mandate and governance belonging to the World Health Organization.

Transversal learning. The Indian case makes it possible to distinguish national system, research infrastructure, digital organisation of evidence and global cooperation, situating India simultaneously as the national context of Ayush systems and host country of GTMC.

Ministry of Ayush · Ayush Research Portal · 2026 ↗ · WHO–Ministry of Ayush · technical agreement · 2023 ↗ · WHO · India commits US$85 million to GTMC · 2024 ↗ · WHO GTMC · About us · India’s investment ↗

China · TCM 2026–2030 · national system, research and implementation

CHINA · TCM · 15TH FIVE-YEAR PLAN · RESEARCH · MODERNISATION · STANDARDISATION · IMPLEMENTATION

China's plan for revitalisation and development of Traditional Chinese Medicine for 2026–2030, approved by the State Council, reaffirms the joint importance of TCM and Western medicine, respect for TCM's own characteristics, continuity between inheritance and innovation, modernisation and expansion of its international presence.

Within the Programme, China is observed as a national system with capacity to articulate research, standardisation, guidelines, clinical evaluation, training, care networks, technology and implementation. Chinese standards, draft guidelines and clinical applications are examined in other Observatory nuclei as specific objects of Research Design and Translation to Action; this card fixes their territorial and systemic position within the Global South reading.

Transversal learning. Comparison with Brazil, India and other contexts preserves differences among rationales, institutions and integration models and examines how each system transforms clinical specificity, evidence, regulation and institutional capacity into decisions and implementation.

China · NATCM/NDRC · 15th TCM Five-Year Plan · 2026–2030 ↗ · State Council · TCM development plan · 2026 ↗

India ↔ China · bilateral dialogue between traditional-medicine systems · documented framework

INDIA · CHINA · AYUSH · TCM · BILATERAL COOPERATION · RESEARCH · REGULATION · STANDARDISATION · PHARMACOPOEIAS · TRAINING

India and China have a specific bilateral framework for cooperation in traditional medicine. On 12 August 2019, India's Ministry of Ayush and China's National Administration of Traditional Chinese Medicine (NATCM) signed, in Beijing, a Memorandum of Understanding for cooperation in medical services, education, scientific research and culture, based on mutual benefit and equality.

The instrument provides for communication on traditional-medicine policies, regulation and administration; cooperation in standardisation and internationally acceptable parameters of product quality and safety; support for collaborative studies in universities and scientific institutions on use, safety and efficacy; harmonisation of pharmacopoeial standards; short-term training opportunities for managers, researchers and professionals; documentary exchange and bilateral meetings to evaluate cooperative programmes. The agreement therefore constitutes a formal reciprocal channel between the national traditional-medicine architectures of the two countries, while preserving the specificities of their clinical and epistemological systems.

Circulation in two directions. Available documentation makes it possible to observe distinct movements. In India, the trajectory of Dr Bejoy Kumar Basu, a member of the Indian Medical Mission to China, is associated with introduction and dissemination of Chinese acupuncture after his return to the country; in March 2026, the Consulate-General of China in Kolkata participated in a seminar devoted to this history and expressed support for deepening collaboration in traditional medicine. In the opposite direction, historical-scientific literature documents circulation of Indian medical and Ayurvedic knowledge into medical traditions practised in China over historical periods, alongside contemporary research comparing preparations, medicinal materials and pharmacopoeial standards of the two countries.

Scientific reading. For the Observatory, India ↔ China constitutes a bilateral relationship in its own right, distinct from the national India/Ayush and China/TCM nuclei and also from BRICS and WHO frameworks. The analysis investigates how different systems enter into dialogue: which concepts retain specificity; where shared medicinal materials or uses exist; how safety, quality, pharmacopoeias, clinical research and regulation can be compared; and which outcomes arise from institutional cooperation mechanisms.

Documentary status. The 2019 Memorandum established an initial five-year term and the possibility of extension by agreement between the parties. Indian government sources from 2025 continue to list the instrument among Ayush international agreements. The document is used as a record of the bilateral architecture instituted in 2019; legal status after the initial period requires a specific extension act for updated characterisation.

India Ministry of External Affairs · MoU Ayush–NATCM · 12 Aug. 2019 ↗ · Government of India · Ayush international agreements · 2025 ↗ · Consulate-General of China in Kolkata · Dr Basu / National Acupuncture Day · 2026 ↗ · Journal of Ethnopharmacology · Ayurveda and traditional medicines in China · 2022 ↗ · Journal of Ethnopharmacology · China–India medicinal materials · 2024 ↗

China–Latin America and the Caribbean · health and traditional-medicine cooperation · monitored agenda

CHINA · LATIN AMERICA AND THE CARIBBEAN · PUBLIC HEALTH · TRADITIONAL MEDICINE · REGULATION · COOPERATION

China's third policy paper on Latin America and the Caribbean, released on 10 December 2025 — succeeding the 2008 and 2016 papers — includes, within health cooperation, strengthening traditional medicine, exchanges on medicines regulation, dialogue on public-health policies, cooperation among health institutions and sharing experience in disease prevention and control.

Monitored agenda. For the Observatory, this framework opens a documentary front for following how cooperation commitments are converted into participating institutions, projects, scientific exchange, training, regulation, research and verifiable outcomes. Its function is prospective and comparative: to follow the transition from diplomatic guidance to observable scientific and health cooperation.

China · Policy Paper on Latin America and the Caribbean · Dec. 2025 ↗

WHO Global Traditional Medicine Centre · Indigenous Knowledge and Biodiversity

BASED IN JAMNAGAR, INDIA · INDIGENOUS KNOWLEDGE · BIODIVERSITY · GOVERNANCE

Traditional, Indigenous Knowledge and Biodiversity Unit (TIB)

The WHO Global Traditional Medicine Centre (GTMC), based in Jamnagar, India, since 2022, maintains a Traditional, Indigenous Knowledge and Biodiversity Unit dedicated to promoting respectful knowledge exchanges with Indigenous Peoples on medicinal plants, biodiversity conservation and equitable access and benefit-sharing. The unit situates its activities in relation to the United Nations Declaration on the Rights of Indigenous Peoples (UNDRIP), the 2024 WIPO treaty on intellectual property, genetic resources and associated traditional knowledge, biodiversity COP16 (Colombia), the Kunming–Montreal Global Biodiversity Framework and the One Health approach.

In August 2026, WHO published the final unedited version of the Participatory Framework for Respectful Engagement with Indigenous Peoples on Biodiversity, Health and Traditional Knowledge Systems, developed through participatory processes with Indigenous Peoples from the seven Indigenous socio-cultural regions. The framework translates internationally recognised rights into practical guidance for self-determination, free, prior and informed consent, Indigenous data sovereignty, reciprocity, shared governance, safeguards and accountability. Its governance relevance lies in translating rights into practices of participation, self-determination, consent, reciprocity, data sovereignty and accountability, while preserving the protocols, institutions and decisions of the peoples and communities involved.

Transversal learning. Mapping biodiversity associated with traditional medical systems, documenting ecological resources and policies for equitable access make relationships among biodiversity, territory, knowledge, rights and governance observable.

Global Traditional Medicine Summit and Global South dialogue

The first WHO Global Traditional Medicine Summit took place in Gujarat, India, in August 2023, producing the Gujarat Declaration as a multisectoral agenda. The event brought together policy-makers, practitioners, Indigenous Peoples, academics and private-sector representatives, with repercussions in forums such as the UN General Assembly, G20, BRICS and biodiversity COP16. In May 2026, during the 79th World Health Assembly, side events explicitly addressed the intersection among traditional medicine, climate, biodiversity and land restoration, and Indigenous youth leadership — with participation, among other actors, of representatives of the Global Indigenous Traditional Medicine Alliance (GITMA).

Transversal learning. The concentration of anchor events in the international TCIM agenda in Global South countries — including India and Colombia in recent agendas — makes visible the participation of these contexts in contemporary governance production around TCIM and biodiversity.

Planetary Health · territory · biodiversity · governance

Planetary Health · biomes · climate · biodiversity · health technology

NATURAL SYSTEMS · EXPOSURES · BIOMES · CLIMATE · WATER · FIRE · MATERIALS · TECHNOLOGY · HEALTH

Planetary Health examines how human health depends on the integrity and transformation of natural systems. In the Observatory, this lens brings together land-use change, biodiversity, climate, water, fire, production systems, material chains and technological infrastructure when these processes modify exposures, vulnerabilities, resources, outcomes or the response capacity of health systems.

Biomes · territory · land use · fire and water

The Cerrado is a particularly relevant Brazilian case for observing relationships among biodiversity, native-vegetation loss, fire, water, production, territories and health. DETER recorded 5,119.46 km² under deforestation alerts in the August 2025–July 2026 cycle, a 7.8% reduction compared with the previous period. Environmental indicators of this kind do not function as clinical outcomes: they characterise territorial pressures and contexts that may be related to exposures and results through appropriate designs.

Key concept for study. In Planetary Health, the unit of analysis may shift from the individual to relationships among population, territory and natural systems. Inference requires temporality, spatial scale, exposure pathways and plausible mechanisms compatible with the question.

One Health · Public/Collective Health · Planetary Health

The three perspectives may meet in concrete problems while focusing on distinct relationships. Public/Collective Health investigates population, social, political and territorial processes and health systems; One Health emphasises interdependencies among human, animal, plant and environmental health; Planetary Health broadens observation to changes in natural systems and their consequences for health and habitability. The distinction makes it possible to select units, indicators and methods coherent with each question.

Critical minerals · materials · medical technologies

Health technologies also have environmental materiality. Gadolinium, neodymium, lutetium and other critical minerals participate in imaging, magnets, lasers, electronics, semiconductors and therapeutic applications. Mining, processing, manufacturing, supply, maintenance, recycling and disposal connect biomedical innovation to material and environmental dependencies.

Transversal learning. A technology can be analysed simultaneously through clinical performance and through its material chain. These scales answer different questions but make externalities, supply risks, circularity and technological resilience visible.

Cannabis · plant, territory and production systems

Cannabis sativa L. is an example of a plant whose observation can cut across health, biodiversity, agriculture, materials, economy and territory. In Brazil, the 5th National Environmental Conference in 2025 recorded Appeal Motion No. 79 concerning public policy for environmental incentives for recovery of degraded areas, bioeconomy and a Cannabis seed bank by collectives and traditional communities.

The record of the 5th National Environmental Conference documents the presence of Cannabis/hemp in the participatory public agenda on recovery of degraded areas, bioeconomy and seed banks. Questions concerning ecological effectiveness, phytoremediation, biodiversity, carbon balance and agronomic performance remain research hypotheses to be examined through dedicated studies, with comparators, environmental indicators and assessment of biomass and the production chain.

Key official sources for study
Biodiversity · natural resources · bioproducts · quality

IDENTITY · PROVENANCE · COMPOSITION · QUALITY · SAFETY · TRACEABILITY · BENEFIT-SHARING

Natural resources become reproducible scientific objects when their identity, origin, composition, processing and exposure are sufficiently characterised. Biodiversity enters research as living heritage and as a source of biological, chemical, ecological, cultural and productive variability requiring situated and traceable documentation.

Medicinal plants · Phytotherapy · Farmácia Viva

The National Policy on Medicinal Plants and Phytotherapeutics and Farmácia Viva document, in Brazil, a technical-care chain spanning cultivation/collection, processing, storage, preparation, quality control, dispensing and pharmaceutical care. This chain makes it possible to turn each link into a question: botanical identity → environment and cultivation → composition → processing → stability → dose/exposure → safety → use.

Fungi · Applied Mycology · mycotherapeutic preparations

Medicinal fungi are biological resources in their own right. In preparations of Hericium erinaceus, for example, cultivation method, species/strain, use of mycelium or fruiting body, substrate, extraction, chemical profile, stability and contaminants may alter the object under investigation. Characterisation precedes interpretation of any biological or clinical effect.

Key concept for study. The experimental unit of a natural product requires identifiable material and measurable exposure; identity, origin, composition, processing and other relevant attributes support reproducibility.

Characterisation · Data Quality · traceability

The minimum qualification chain may include identity/authenticity → chemical composition → batch → contaminants → stability → analytical method → provenance → traceability. Object quality and data quality are connected problems: a highly complete clinical database does not correct a poorly characterised exposure.

Transversal learning. Data Quality begins before the spreadsheet. In bioproduct research, part of data quality is determined by the quality of the sample, material, batch and production chain.

Traditional knowledge · genetic heritage · benefit-sharing

When Brazilian genetic heritage or associated traditional knowledge forms part of research or technological development, governance of access becomes part of the scientific architecture. Law No. 13,123/2015, Decree No. 8,772/2016 and SisGen organise access, registration/notification and benefit-sharing; international frameworks such as the Nagoya Protocol and ILO Convention No. 169 add references on rights and participation where applicable.

The reading can be organised as origin/provenance → knowledge holders → applicable consent or consultation → access and registration → sample/data governance → benefit → feedback.

Key official sources for study
Community Governance of Data, Knowledge and Traditional Practices

SELF-DETERMINATION · FPIC · DATA SOVEREIGNTY · RECIPROCITY · SHARED GOVERNANCE · SAFEGUARDS · BENEFIT-SHARING

Research involving Indigenous Peoples, Quilombola communities, traditional peoples and communities or other legitimate knowledge holders requires simultaneous attention to collective rights, context, authorship, custody, circulation of knowledge, purpose, benefits and data governance. Scientific information is not separate from the rights regime that organises its access and use.

WHO 2026 · respectful engagement and rights

The WHO Participatory Framework for Respectful Engagement with Indigenous Peoples on Biodiversity, Health and Traditional Knowledge Systems, published in final unedited version in August 2026, translates internationally recognised rights into practical guidance. The framework emphasises self-determination, free, prior and informed consent (FPIC), Indigenous data sovereignty, reciprocity, shared governance, safeguards and accountability.

Key concept for study. Participation is examined through representation, decision-making power, control over knowledge and data, consent, return and benefit-sharing, in addition to presence in activities.

Brazil · research ethics · genetic heritage · traditional knowledge

Research involving human participants observes Law No. 14,874/2024, Decree No. 12,651/2025 and relevant ethical rules; Humanities and Social Sciences designs observe, where applicable, CNS Resolution No. 510/2016. Access to genetic heritage and associated traditional knowledge is governed by Law No. 13,123/2015, Decree No. 8,772/2016 and SisGen, including prior informed consent where provided for knowledge of identifiable origin.

Traditional practices and religious contexts

In traditional or religious practices, documentation, research and data sharing need to preserve meaning, context, purpose and their own rules for access to and circulation of knowledge. Ayahuasca organisations provide a Brazilian example in which safety, religious freedom, research, community practices and information governance meet under specific frameworks, including CONAD Resolution No. 1/2010.

Key official sources for study

Translational neuroscience · SBMT · Neuroscience20 · Brain Mapping · neurotechnology · clinical interfaces

SBMT · Society for Brain Mapping and Therapeutics

The Society for Brain Mapping and Therapeutics (SBMT), founded in 2004, brings together brain science, engineering, imaging, devices, neurosurgery, neurotechnology and areas related to investigation, diagnosis, treatment and rehabilitation of neurological conditions. The organisation maintains scientific congresses, legislative initiatives, international programmes and environments oriented towards translating technologies into clinical practice.

Therapeutics · terminological precision

In the institutional language of SBMT and Neuroscience20, Therapeutics is used broadly, encompassing devices, applied imaging, neurotechnology, cell therapies, neuromodulation, procedures and platforms related to diagnosis, treatment and rehabilitation. Precision of the term helps interpret the technological and clinical breadth of agendas associated with brain mapping.

The global governance published in 2026 identifies Dr Stefano M. Sinicropi as the 24th President of SBMT. Dr Babak Kateb remains founder, Founding Chairman of the Board, Chief Executive Officer and Scientific Director, with activity also in the World Brain Mapping Foundation (WBMF) and innovation structures associated with the ecosystem.

Brain mapping · measurement, integration and intervention

Brain mapping may combine structural and functional neuroimaging, electrical and magnetic signals, neurophysiology, anatomy, computation, engineering and clinical information. The value of each modality depends on the question, spatial and temporal resolution, acquisition context and information gain it adds to inference or decision.

Key concept for study. A multimodal architecture gains strength when it preserves provenance, temporality, resolution, uncertainty and function of each information source, making it possible to reconstruct how different modalities contributed to a conclusion or decision.

WBMF · BTIP · NCNBE · related structures

World Brain Mapping Foundation (WBMF). Foundation linked to the international brain-mapping ecosystem, scientific education and awards, dissemination and resource mobilisation.

Brain Technology and Innovation Park (BTIP). Structure oriented towards bringing neurotechnology, innovation, development and environments capable of accelerating the passage of solutions between research and application closer together.

National Center for Nano-BioElectronics (NCNBE). Structure associated with convergence among nanoscale science, bioelectronics, devices, imaging and technologies applicable to neuroscience.

Transversal learning. Translational ecosystems may distribute functions among scientific societies, foundations, technology centres, innovation environments and policy initiatives. Identifying the institutional function of each component improves the reading of capacity, governance and stage of maturity.

Brain Mapping Day · science and legislative environments

Brain Mapping Day is a series of interlocutions between scientific communities and legislative environments. In 2026, the 13th edition at the United States Congress brought together neurotechnology, artificial intelligence, neuro-oncology, neurodegenerative diseases, molecular neuroimaging and other fronts of brain science.

Transversal learning. The circulation of evidence in legislative environments can be studied through actors, language, prioritised themes, synthesis mechanisms, recommendations and subsequent public-decision trajectories.

SBMT · Board of Directors ↗ · SBMT · President ↗ · Brain Mapping Day 2026 ↗

SBMT Latin America · regional circulation · network formation

SBMT Latin America articulates neuroscience, neurotechnology, education, innovation and science policy at regional scale. Its recent trajectory includes Neuroscience20 Argentina 2018, Neuroscience20 Brazil 2024 and SBMT Neurotech Forum Brazil 2025, in Campina Grande, alongside activities intended to bring researchers, laboratories, start-ups, clinical services and international networks closer together.

Transversal learning. Regional networks can be characterised by temporal continuity, diversity of competencies, circulation of people and technologies, participating institutions and capacity to originate training, projects, infrastructure or scientific cooperation.

Paraíba 2025–2026 · Campina Grande and João Pessoa · scientific territory

Campina Grande hosted the SBMT Neurotech Forum Brazil in July 2025. On 2 and 3 March 2026, the Federal Institute of Paraíba (IFPB), in partnership with SBMT, held Neurotech Innovation at the João Pessoa and Campina Grande campuses. The meeting brought together specialists from Brazil, China and Canada to discuss artificial intelligence in health, brain function and technologies for diagnosis and treatment.

The programme documented by IFPB included Eve Chung Tsai, University of Ottawa; Yonghong Wang, Shanxi Bethune Hospital; and Daniel Almeida, Secretary for Technological Development and Innovation at Brazil's Ministry of Science, Technology and Innovation.

Transversal learning. A scientific territory can be observed through the density of institutions, training, services, technological competencies, international circulation and innovation policies. These components condition local capacity to produce research, validate technologies and sustain implementation.

IFPB · Neurotech Innovation 2026 ↗ · SBMT Latin America ↗

SBMT Brazil · interdisciplinary architecture of capacities

The public structure of SBMT Brazil brings together executive leadership, scientific leadership, innovation and technology, law, ethics and public policy, editorial board and public relations, alongside thematic departments of neurosurgery, neurology, psychiatry and mental health, and rehabilitation and neuroplasticity. This organisation makes observable a distribution of competencies spanning clinical work, engineering, innovation, regulation, scientific communication and functional recovery.

Published governance and thematic departments

Executive Leadership: Ana Isabel Alves da Cunha. Scientific Leadership: Francis Silveira and Gabriel Coimbra. Innovation and Technology: Li Min and Maria Eduarda Franklin. Law, Ethics and Public Policy: Renata Esteves. Editorial Board and Public Relations: Danubia Sá Caputo.

Neurosurgery: Marcos Wagner. Neurology: Cesar Andraus and Maria Andraus. Psychiatry and Mental Health: Daniel Americo and Rodrigo Borghi. Rehabilitation and Neuroplasticity: Veviane Spergue and Anny Catharine.

Key concept for study. Interdisciplinary structures can be analysed by capacity: who produces knowledge, who measures, who intervenes, who regulates, who implements, who follows function and who translates knowledge among professional and decision-making communities.

SBMT Brazil · leadership and thematic departments ↗

Neuroscience20 · N20 · science-policy and neurohealth

Neuroscience20 (N20) is an international SBMT initiative dedicated to brain, spine and mental health in dialogue with G20 cycles. SBMT historical documentation places the initiative's conception/pioneering in 2013, when it was called the G20+ World Brain Mapping & Therapeutic Initiative; the first summit under the format that consolidated the Neuroscience20 name took place in Brisbane in 2014. The agenda brings together neuroscience, technology, health economics, regulation, international cooperation, access, financing, technology transfer, neurotrauma, neurodegenerative diseases and mental health.

Neuroeconomics · data · financing · sustainability

N20's public agenda includes policy harmonisation, data standardisation, neuroeconomic evaluation of disease impact, diagnosis and prevention, regulation of trials and drug-device combinations, new financing models and integration of technologies such as artificial intelligence, supercomputing, multimodal brain mapping/MEG, neurophotonics, devices, cell therapies and nanotechnology.

Neuroeconomics. This dimension makes it possible to observe disease burden, care costs, access, financing, reimbursement, investment and technology sustainability together, connecting clinical outcomes to implementation conditions and scale.

Transversal learning. Data standardisation and harmonisation constitute scientific and regulatory problems in their own right in multimodal and multicentre environments. Comparability depends on metadata, provenance, quality controls and levels of standardisation capable of preserving clinical and contextual heterogeneity.

N20 Brazil 2024 · Parliament · access · ageing · neurotrauma

The 11th Neuroscience20 Summit took place in Rio de Janeiro on 16–17 November 2024. The scientific programme listed Dr Marcos Wagner de Sousa Porto as SBMT Board Member and President N20-Brazil and included forums on cerebrovascular disease, neurotrauma, neurotechnology, artificial intelligence, ageing, neuropsychiatry and neurohealth policy.

On 13 November 2024, the Social Affairs Committee of the Federal Senate held a hearing on accessibility and innovations in neuroscience. The official record brought together, among other participants, Ana Cristina Veiga, Li Li Min, Marcos Wagner and Veviane Spergue, creating public documentation of the circulation of neuroscientific issues into a legislative environment.

Transversal learning. Science–policy can be studied as a translation chain: problem → evidence → synthesis → public language → prioritisation → participation → institutional agenda → regulation or funding → implementation → evaluation.

SBMT · N20 Brazil 2024 ↗ · Federal Senate · verbatim record 13/11/2024 ↗

Dr Babak Kateb · Brain Mapping · Neurotechnology · Innovation Ecosystems · Science–Policy

Dr Babak Kateb is a neuroscientist and founder of the Society for Brain Mapping and Therapeutics, where he serves as Founding Chairman of the Board, Chief Executive Officer and Scientific Director. He chairs the World Brain Mapping Foundation (WBMF) and is associated with the leadership of the Brain Technology and Innovation Park (BTIP) and the National Center for Nano-BioElectronics (NCNBE).

SBMT · WBMF · BTIP · three distinct institutional statuses

Current institutional documentation distinguishes three complementary legal and operational functions within the same ecosystem: SBMT as a scientific and professional society; WBMF as a philanthropic foundation focused on training, education, access and social impact; and BTIP as a joint SBMT+WBMF initiative oriented towards translation, integration and commercialisation of neurotechnologies — BTIP's own documentation uses the notion of the "valley of death" to designate the gap between scientific discovery and clinical availability. Each structure retains its own legal nature and operational function, composing a complementary ecosystem.

Institutional origins and formalisation

SBMT's institutional biography traces its origins to a 2003 meeting at NASA/JPL, bringing together scientists affiliated with NASA/JPL, USC-Keck School of Medicine and Caltech, co-organised by Wolfgang Fink, John George and Babak Kateb. The organisation was formally established in 2004 and adopted its current name, Society for Brain Mapping and Therapeutics, in 2011.

Its institutional trajectory connects brain mapping, neurosurgery, imaging, neurotechnology, artificial intelligence, devices, nanoneuroscience, neurophotonics, innovation and dialogue between science and policy. The ensemble makes it possible to follow how emerging fields can organise congresses, technology programmes, scientific networks and channels of dialogue with decision-making environments.

Neurotechnology · engineering · translational environments

The convergence of neural measurement, engineering, devices, computation and clinical application creates validation problems of its own: technical performance, safety, usability, generalisability, compatibility with clinical workflows, regulation and measurable benefit.

Transversal learning. Biomedical innovation can be described through maturation trajectories in which science, engineering, clinical practice and the health system progress according to different metrics. Making these metrics explicit reduces premature inferences about readiness.

N20 · chronology and international circulation

SBMT's historical documentation places the conception of the G20+ World Brain Mapping & Therapeutic Initiative in 2013 under Kateb's leadership; the first summit in the format that consolidated the Neuroscience20 name took place in Brisbane in 2014. The documented international sequence includes, among other milestones, Brisbane 2014, Hangzhou 2016, Rio de Janeiro 2024, South Africa 2025 and Miami 2026, demonstrating continuity of an international agenda concerning the brain, spine, mental health, neurotechnology and science policy.

China · Neuroscience20 · Hangzhou

On 4 September 2016, Babak Kateb chaired the 3rd Neuroscience20 Summit as Summit Chair in Hangzhou, Zhejiang, with Dr Dong Zhou as Vice-Chair. The record constitutes a documented precedent for circulation between the N20 ecosystem and China.

Transversal learning · translational ecosystems

The documented trajectory linking brain mapping, engineering, neurotechnology, devices, innovation and science–policy makes it possible to observe how a scientific object traverses different regimes of development and validation. From technological conception to clinical investigation, regulation, implementation and access, each transition requires its own evidence and decision criteria.

Translational question. What conditions allow technological convergence to become responsible translational innovation while preserving the distinction between technological development, scientific validation, implementation and access?

SBMT · Board of Directors ↗ · SBMT · President ↗

Dr Marcos Wagner de Sousa Porto · Neurosurgery · Neurotechnology · Global Neurosurgery · SUS · Science–Policy

Dr Marcos Wagner de Sousa Porto is a neurosurgeon, holds a Master's degree and is a doctoral candidate in Neurotechnology and Biomaterials at the Federal University of Campina Grande (UFCG), is a Full Member of the Brazilian Society of Neurosurgery (SBN) and a former President of the Northeastern Society of Neurosurgery. His curriculum records work in vascular neurosurgery, neuro-oncology, neurotrauma, spinal surgery, microsurgical techniques, cisternostomy, artificial intelligence in health, Global Neurosurgery, neurosurgical education, equity and access to specialised care.

His international trajectory includes training experience in Saint Petersburg undertaken jointly with Dr Fábio Pontes, recalled by both for the learning in anatomy, as well as academic collaborations with neurosurgeons and institutions in Latin America and Asia. His curriculum records an invitation to collaborate with educational initiatives related to the World Federation of Neurosurgical Societies (WFNS).

SBMT · N20 · neurosurgery and science policy

SBMT institutional sources list Marcos Wagner as SBMT Board Member and President N20-Brazil in the 2024 Brazilian programme. SBMT Brazil's current structure identifies him within the Department of Neurosurgery. His participation in N20 includes forums dedicated to cerebrovascular disease, neurotrauma and impacts on the Brazilian health system.

Transversal learning. Clinical neurosurgery, education, technology and science policy make complementary scales of highly complex problems visible. Analysis can follow how technical capacity, training, infrastructure, territorial organisation and institutional decision-making relate to access, time to care and outcomes.

SUS · regionalisation · access · Global Neurosurgery

In May 2025, the Brazilian Society of Neurosurgery recorded Marcos Wagner's participation in an institutional mission in Brasília to present proposals from the SBN+SUS programme to the Ministry of Health, encompassing strengthening neurosurgery in the public network, professional training, infrastructure, access to technologies, reduction of care gaps and expansion into underserved regions.

In August 2025, a further SBN agenda at the Ministry of Health addressed the expansion and regional distribution of neurosurgery, medical training and residency, accreditation of services, distribution of specialists and updating of care pathways. SBN documentation also places him in activities of the Time SBN SUS initiative. In April 2022, an official Ministry of Health agenda had already recorded a meeting with Marcos Wagner, then president of the Northeastern Society of Neurosurgery, on expanding and decentralising neurosurgical care.

Key concept for study. In highly complex care, the distribution of specialists, time to care, installed capacity, diagnostic and surgical infrastructure, transfer between services and continuity of rehabilitation may form part of the causal chain of the outcome.

Transversal learning · access and scale. This trajectory makes it possible to investigate the transition between specialised neurosurgical capacity, installed capacity, regionalisation and neurohealth policy. When a neurosurgical innovation or screening strategy moves from the specialised environment towards the scale of health-service delivery, the question broadens to include performance, population, territory, temporality, professionals, infrastructure, evidence, safety, priority, cost and sustainability of incorporation. Along this pathway, access and equity become dimensions of the translational problem itself.

Neurotechnology · biomaterials · AI in health

Postgraduate stricto sensu training in Neurotechnology and Biomaterials broadens observation towards interfaces between neurosurgery, materials, devices, artificial intelligence and technology assessment. Translation of these technologies requires characterisation of the object, performance, safety, integration into clinical workflow and adoption criteria.

SBMT Brazil ↗ · N20 Brazil 2024 ↗

Prof. Li Li Min · Neurology · Neuroimaging · BRAINN (Brazilian Research Institute for Neuroscience and Neurotechnology) · Innovation · Public Health

Li Li Min is a neurologist, a graduate of the Federal University of Paraná (1989) and PhD graduate of McGill University (2000), with a thesis on the static and dynamic properties of epileptogenic lesions. He is Full Professor in the Department of Neurology at the Faculty of Medical Sciences of the State University of Campinas (UNICAMP) and is a member of the Innovation and Technology Directorate of SBMT Brazil.

The FAPESP profile page records that he served as Science Dissemination Coordinator of the CInAPCe and BRAINN (Brazilian Research Institute for Neuroscience and Neurotechnology) programmes, both funded by the Foundation. He also leads the UNICAMP Research Group on Innovation and Health Management. The Federal Senate verbatim records of November 2024 document his role as innovation coordinator at the Ibrachina/Ibrawork Research, Development and Innovation Centre in the UNICAMP Technology Park.

His trajectory brings together neurology, epilepsy, neuroimaging, digital health, innovation, neurotechnology, science dissemination and the organisation of stroke-care networks. FAPESP documentation also records his work in implementing UNICAMP's Stroke Patient Care Programme and creating a regional stroke-care network in Campinas.

BRAINN · neuroscience, technology and multidisciplinary organisation

The BRAINN (Brazilian Research Institute for Neuroscience and Neurotechnology / Instituto Brasileiro de Neurociência e Neurotecnologia) is a Research, Innovation and Dissemination Centre (CEPID) funded by FAPESP and based at the Faculty of Medical Sciences of the State University of Campinas (UNICAMP), in Campinas, São Paulo. It brings together researchers in neurology, genetics, neurobiology, pharmacology, neuroimaging, computer science, physics and engineering, with research focused particularly on epilepsy and stroke. It constitutes a documented reference for multidisciplinary organisation capable of articulating clinical problem, mechanism, measurement, research infrastructure, dissemination and technology transfer.

FAPESP · CEPID BRAINN ↗ · BRAINN · institutional website ↗

Stroke · temporality · technology · care pathway

In acute cerebrovascular disease, recognition, triage, transport, imaging, decision and intervention form a time-dependent pathway. The integration of digital technologies, protocols and care networks can be studied through timings, information losses, eligibility, outcomes and implementation capacity.

Transversal learning. In time-dependent conditions, temporality is both a clinical and a system variable. Design gains precision when it records where each item of information was produced, how long it took to circulate and in which decision it was used.

FAPESP · Li Li Min ↗ · Federal Senate · neuroscience hearing ↗ · SBMT Brazil ↗

Prof. Danubia de Sá Caputo · Biophysics · Mechanical Vibrations · Integrative Practices · Function

Danubia da Cunha de Sá Caputo is a physiotherapist, professor at UERJ and coordinator of the Laboratory of Mechanical Vibrations and Integrative Practices (LAVIMPI), linked to the Department of Biophysics and Biometrics of the Roberto Alcântara Gomes Institute of Biology and to the Piquet Carneiro University Polyclinic. She is a member of the Editorial Council and Public Relations of SBMT Brazil.

UERJ documentation records LAVIMPI research on Whole-Body Vibration Therapy and integrative practices in conditions including obesity, chronic obstructive pulmonary disease, osteoarthritis, narcolepsy and fall risk in older people, as well as collaborations involving neuromodulation, autism, cannabidiol, tissue repair and low back pain. The institutional record characterises the ensemble as translational research and clinical trials.

Biophysics · dose of physical intervention · reproducibility

Physical interventions can be described by frequency, amplitude, intensity, duration, posture, device, number of sessions, intervals and context of application. These parameters define the exposure and condition comparability, safety and interpretation of results.

Key concept for study. Dose also characterises physical and neuromodulatory interventions: stimulation parameters and context of application need to be specified sufficiently to allow replication and response analysis.

Function · ageing · rehabilitation

Studies of functional capacity and fall risk bring Biophysics, rehabilitation and Gerontology into proximity. Strength, balance, mobility, fear of falling, exposure to the stimulus and individual characteristics may constitute related variables while preserving the specificity of each construct.

Transversal learning. A low-cost technology gains translational relevance when its exposure is well characterised, its outcomes are clinically meaningful and its implementation can be evaluated in real-world care settings.

UERJ Pró-SUS · LAVIMPI ↗ · UERJ/IBRAG · LAVIMPI ↗ · SBMT Brazil ↗

Duda Franklin · Orby.co · Neuroengineering · Neurotechnology · Data · Rehabilitation

Maria Eduarda “Duda” Franklin is a biomedical engineer and neuroscientist, with Master's degrees in Neuroengineering and in Science, Technology and Innovation, both from the Federal University of Rio Grande do Norte. Co-founder and CEO of Orby.co, she is a member of the Innovation and Technology Directorate of SBMT Brazil. Her work converges Neuroengineering, non-invasive neuromodulation, functional electrical stimulation, sensors, connectivity, software, artificial intelligence, rehabilitation, functional recovery and development of medical technologies. Recognised in Forbes Under 30 2023 in the Science and Education category, she won HackBrazil, organised by the Brazil Conference at Harvard & MIT, and follows a path of scientific entrepreneurship that takes Brazilian neurotechnology research from academic training to company creation, product development and implementation strategy.

She is co-author of the study Development and Validation of an IoT Neurostimulator for the Treatment of Neurogenic Bladder, published in Sensors in 2023, which documents planning, manufacturing, experimental validation and clinical application of the device in the context studied, including electromedical safety requirements, remote programming and monitoring. UNCTAD documentation (2023) describes the Ortech platform as a solution connecting stimulators and sensors via Wi-Fi/Bluetooth with integration of follow-up data, recording TRL 6 and a pilot test towards the next level at the Edmond and Lily Safra International Institute of Neuroscience/Santos Dumont Institute. Records from the Santos Dumont Institute Neuroengineering Symposium document earlier participation in the development of kinematic bases and systems for electrostimulation protocols. Orby emerged from this Neuroengineering ecosystem and has been articulating research, hardware, software, data and technology entrepreneurship around functional rehabilitation.

Scientific entrepreneurship · neurotechnology industry

Duda's trajectory also makes visible a strategic dimension of Brazilian innovation: the transition from scientific training and applied research to the establishment of a technology-based company, medical-hardware development, technological ownership, production and market entry. In public debate on artificial-intelligence regulation and neo-industrialisation, she has also argued for attention to robotics and the high-value-added hardware industry, situating neurotechnology at the intersection of science, innovation policy, industrial capacity and technological sovereignty.

Technological maturity · clinical validation · Data Quality

TRL, technical performance, safety, usability, signal quality, connectivity stability, data completeness and functional benefit represent related dimensions with their own maturation trajectories.

Transversal learning. The documented Orby/Ortech trajectory makes it possible to observe Neuroengineering as a translational interface between Neuroscience, technological development and clinical application. Functional electrical stimulation, sensors, connectivity, software, artificial intelligence and monitoring produce different layers of information and articulate engineering development, technical validation, safety, data quality, clinical evaluation and functional benefit. This interface offers a concrete field for investigating how neurotechnologies move through conception, prototyping, measurement, validation, rehabilitation and application in real-world care contexts.

Adaptive neurotechnology · signals · stimulation · decision

Ortech's technological trajectory articulates electrical stimulation, sensing, connectivity and data management applied to rehabilitation, reaching, in its more recent developments, interfaces with biomechanical sensing, artificial intelligence and temporal adaptation of stimulation. This trajectory opens a particularly fertile field for Research Design and Evidence Architecture within the Programme, including synchronisation between stimulus, signal and response; data quality and provenance; temporality and latency; intra-individual variability; computational traceability; safety; and relationships between technological performance, functional response and clinical meaning.

Research Design · Evidence Architecture. The interface between neuroengineering, stimulation, sensing and computational processing makes it possible to formulate specific methodological problems concerning characterisation of intervention parameters, definition of states and outcomes, temporal integration of signals and progression criteria between technical performance, functional response and clinical meaning. Within the Programme, these questions expand the capacity to design evidence architectures suited to adaptive and multimodal systems.

Transversal learning. The Orby/Ortech trajectory broadens dialogue between Neuroengineering, Neurotechnology, Data Science, rehabilitation and translational research, contributing to the formulation of empirically investigable questions and the development of evidence architectures suited to adaptive systems.

Sensors (2023) · development and validation of an IoT neurostimulator ↗ · UNCTAD · Maria Eduarda Franklin / Orby ↗ · Orby.co ↗ · SBMT Brazil ↗

Dr Fábio Pontes · Microneurosurgery · Vascular Neurosurgery · Skull Base · Neurotechnologies · Clinical Neurosciences

Fábio Teixeira Giovanetti Pontes is a neurosurgeon, graduated from the State University of Western Paraná, with residency in Neurosurgery at the State University of Londrina and specialisation in Vascular Neurosurgery at Escola Paulista de Medicina/UNIFESP. His complementary training includes an observership in Skull Base Neurosurgery at Hospital Evangélico de Curitiba, an observership in Vascular Neurosurgery at Barrow Neurological Institute (Phoenix, USA) and Helsinki University Hospital, a fellowship in Skull Base Neurosurgery at the National Hospital for Neurology and Neurosurgery, Queen Square, London, as well as training experience in Saint Petersburg undertaken jointly with Dr Marcos Wagner de Sousa Porto and recalled by both for the learning in anatomy.

He works at Hospital de Base do Distrito Federal and the Centro de Aneurisma Cerebral do Distrito Federal and directs NeuroStart DF, concentrating his practice on cerebrovascular diseases, intracranial aneurysms, vascular malformations, brain tumours and skull-base surgery.

In March 2026, he participated as a speaker at the 3rd Congress of Yaşargil Microneurosurgery Academy, in São Paulo, presenting Anterolateral Approaches in the seminar Craniocervical Tumors: How to manage. The activity adds to his contemporary trajectory scientific experience directly related to microneurosurgical anatomy, surgical approaches and management of highly complex craniocervical regions.

His indexed scientific production includes Tactics for the surgical handling of neurogenic sacral tumors (Arquivos de Neuro-Psiquiatria, 2012; DOI 10.1590/S0004-282X2012000600016; PMID 22699547), a study devoted to surgical strategies for sacral neurogenic tumours and consistent with a line of interest in anatomy, approach selection and surgical decision-making.

Microneurosurgery · anatomy · decision

In vascular lesions, tumours and skull-base pathologies, the relationship between individual anatomy, lesion topography, surgical approach, operative exposure and functional preservation constitutes a decision problem that can be formalised. Indication, patient selection, operative strategy, complications, and clinical and functional outcomes form core variables for comparison between strategies.

Neurotechnologies · perioperative information

Vascular and skull-base neurosurgery constitutes a particularly informative field for studying how imaging, anatomy, planning, navigation and neurophysiological information participate in clinical and operative decision-making. Resolution, spatial or temporal registration, signal quality, interoperability and integration into the clinical context condition the reliability and usefulness of this information across the perioperative pathway.

High complexity · real-world system

The pathway from diagnosis and referral to imaging, indication, availability of team and infrastructure, procedure, intensive care, follow-up and rehabilitation constitutes an observable trajectory. Timings, care transitions, technological availability, adverse events and outcomes can be studied as components of real-world effectiveness.

Key concept for study · multimodal neurosurgical decision-making

A process through which anatomical, clinical, imaging, neurophysiological and contextual information is integrated to define indication, strategy, execution and evaluation of a neurosurgical intervention, preserving traceability between available information, the decision taken and the observed outcome.

Transversal learning. Neurosurgical decision-making offers a model for investigating multimodal integration oriented by the scientific question: different sources of information gain value when they modify selection, strategy, safety, functional preservation or prognosis and when their contribution can be traced across the clinical pathway. The same logic makes it possible to interrogate data quality, temporality, provenance, multimodal integration and decision criteria in other translational problems.

Dr Fábio Pontes · professional curriculum ↗ · Yaşargil Microneurosurgery Academy · official 2026 programme ↗ · PubMed · PMID 22699547 ↗

Experimental neuroscience · sleep · memory · cognition · ICe/UFRN

Brain Institute · UFRN · Neuroscience · Translational Research · Training

The Brain Institute of the Federal University of Rio Grande do Norte (ICe/UFRN), founded in 2011, brings together research, training and extension activities in Neuroscience. Its institutional trajectory was conceived around advanced research, human-resources training and social transformation, constituting a Brazilian ecosystem in which basic investigation, human and animal experimentation, education and clinical interfaces can be observed in continuity.

Among its areas of work, the Sleep, Dreams and Memory Laboratory investigates molecular, electrophysiological and psychological mechanisms of memory, sleep and dreams, including educational interventions involving sleep, psychedelics, effects of Cannabis use on sleep and dreams, and effects on cognition in older people, with attention to mild dementia and quality of life.

ICe/UFRN · 15 years and institutional trajectory ↗ · Dreams Lab · research lines ↗

Prof. Sidarta Ribeiro · Sleep · Dreams · Memory · Plasticity · Cannabis · Neuroeducation

A neuroscientist and full professor at UFRN's Brain Institute, Sidarta Ribeiro works in neuroethology, molecular neurobiology and systems neurophysiology. His research interests include memory, sleep and dreams, neuronal plasticity, computational psychiatry, neuroeducation, psychedelics and drug policy.

At the Sleep, Dreams and Memory Laboratory, these lines extend to experimental problems connecting neural mechanisms, cognition, education and the life course. The agenda includes investigation of the effects of Cannabis on sleep and dreams and on cognition in older people; in 2025, a dissertation supervised by Sidarta evaluated cannabinoids in cognition, mood, sleep and quality of life in long-lived patients with mild to moderate dementia syndrome.

Transversal learning. The convergence between sleep, memory, plasticity and the effects of cannabinoids on cognition in long-lived patients with mild to moderate dementia syndrome offers a common observable object for Neuroscience and Gerontology, while preserving the different evidential statuses of basic neurophysiology research and applied clinical investigation.

ICe/UFRN · scientific profile ↗ · Dreams Lab · research ↗ · UFRN · dissertation defence on cannabinoids and longevity ↗

Neurotechnology · brain–machine interface · neurorehabilitation · Brazil–China

Prof. Miguel Nicolelis · Neurophysiology · Brain–Machine Interface · Neurorehabilitation · Brazil–China

A Brazilian neuroscientist whose trajectory centres on neurophysiology of neuronal populations and brain–machine interfaces, Miguel Nicolelis has developed translational research aimed at converting neural signals into device control and neurorehabilitation strategies, including the Walk Again Project.

Documented Brazil–China cooperation. In 2018, Xuanwu Hospital, affiliated with Capital Medical University, became the first Asian institution to join the Walk Again Project in cooperation with Nicolelis. Chinese institutional documentation situates this collaboration within an agenda articulating brain–machine interface, neuroimaging, artificial intelligence, connectomics and clinical translation, offering a concrete precedent for international circulation of neurotechnology between research, engineering and rehabilitation.

Transversal learning. The adoption of the Walk Again Project by a Chinese institution makes it possible to observe how brain–machine interfaces circulate between research, engineering and rehabilitation across different health systems, while preserving the specific infrastructure, regulation and care capacity of each context.

Capital Medical University · Walk Again Project at Xuanwu Hospital ↗ · Beijing Municipal Health Commission · BCI and clinical translation at Xuanwu Hospital ↗

Neuroethics · global frameworks
UNESCO · Recommendation on the Ethics of Neurotechnology (2025)

Reference: UNESCO · 43rd session of the General Conference, Samarkand · adopted by acclamation on 11/11/2025 · Recommendation on the Ethics of Neurotechnology.

Core elements: first global normative framework for the entire neurotechnology life cycle — from design to disposal. It addresses neural data, mental privacy, consent, transparency, protection of children and vulnerable groups, and responsible use outside clinical contexts.

Gerontology · Gerontechnology · Function · Healthy Ageing

WHO/ICOPE · Integrated Care for Older People, 2nd edition (2025)

Reference: World Health Organization · ICOPE, 2nd edition · launched on 29/01/2025 · implementation guide for integrated care for older people.

Core elements: reorients health services towards person-centred care, optimising intrinsic capacity and functional ability. A four-step pathway — basic assessment, in-depth assessment, personalised care plan, implementation and monitoring. Intrinsic-capacity domains: cognition, mobility, vitality, vision, hearing and psychological capacity; the 2nd edition adds a specific care pathway for urinary incontinence and expands the focus at community level.

Translational relevance: offers an architecture for treating Gerontology as a relationship between intrinsic capacity ↔ functional ability ↔ environment ↔ person ↔ community ↔ primary care ↔ continuum of care. Gerontechnology enters as a transversal capacity articulated with autonomy, prevention, rehabilitation and participation.

Chinese documents already present in the Scientific, Normative and Regulatory Collection — National Health 15th Five-Year Plan (life course, geriatric medicine, community care) and Traditional Chinese Medicine Revitalization and Development Plan (geriatrics/health preservation in TCM) — are additional references observed for this section, without duplication of content.

WHO · ICOPE · vitality, measurement and intrinsic capacity
WHO · ICOPE · vitality, mobility, nutrition and musculoskeletal function

ICOPE 2nd edition organises assessment and care in four steps — basic assessment, in-depth assessment, personalised plan and implementation/monitoring — and includes mobility and vitality among the domains of intrinsic capacity. WHO implementation materials address sarcopenia, frailty, nutrition and exercise as related but non-equivalent components.

Translational relevance: this architecture offers a common functional language for following strength, mobility, nutritional status and the capacity to live independently, without requiring a specific diagnosis to be converted into a general ageing index.

Official sources: WHO · ICOPE 2nd edition ↗ · WHO/ICOPE · Vitality · sarcopenia, frailty, nutrition and exercise ↗.

WHO · ICOPE · measurement oriented towards capacity, care and context

ICOPE organises care around detection of declines in intrinsic capacity, identification of social needs and construction of a personalised plan. Its training programme maintains dedicated modules for locomotor capacity, vitality, cognition, vision, hearing, psychological capacity, social support, caregiver support and age-friendly environments.

Translational relevance: this separation helps prevent sarcopenia from being used as a synonym for ageing, frailty or disability. A protocol can measure muscle and strength while simultaneously observing mobility, activities, autonomy and participation.

WHO · ICOPE 2nd edition ↗ · WHO · ICOPE Training Programme ↗

WHO · ICOPE · mobility, intrinsic capacity and personalised plan

ICOPE 2nd edition organises assessment of declines in intrinsic capacity, social needs and personalised care in primary and community care. Mobility and vitality form part of the assessment pathway, and implementation is adapted to the local context with monitoring over time.

Translational relevance: mobility can be followed as capacity, performance and a condition for participation in everyday life. Connection with falls, strength, nutrition, cognition, vision, environment and social support makes it possible to construct longitudinal models centred on function.

WHO · ICOPE 2nd edition ↗

Brazil · SUS · policies, instruments and organisation of care for older people
Brazil · PNSPI · function, autonomy and longitudinal care in SUS

The National Health Policy for Older People guides SUS towards comprehensive, integrated care centred on function, with promotion of healthy ageing, prevention of health problems, reduction of disability, multidimensional assessment and articulation among the care network, family, community and other sectors. The Health Record for Older People is used for continuous follow-up and development of care plans oriented towards maintaining or recovering functional capacity.

Comparability between contexts: the Brazilian emphasis on autonomy, functional independence, multidimensional assessment and coordinated care converges in some respects with ICOPE and with Chinese healthy-ageing documents, while preserving the organisation, instruments and responsibilities specific to SUS.

Translational relevance: function can operate as an outcome, stratification criterion and organising axis of care, allowing interventions to be evaluated beyond the simple presence or absence of diagnoses.

Official sources: Ministry of Health · Health of Older People ↗ · Actions for older people · Health Record and care plan ↗.

Brazil · Osteoporosis PCDT · 2025/2026 update · diagnosis, treatment and follow-up

The Ministry of Health updated the Clinical Protocol and Therapeutic Guidelines for Osteoporosis through Joint Ordinance SAES/SECTICS No. 22/2025, with an annex updated in January 2026. The PCDT structures national criteria for diagnosis, treatment, monitoring and follow-up and results from technical-scientific assessment and deliberation by Conitec.

Translational relevance: the PCDT provides the necessary Brazilian counterpart for Chinese findings on diet, bone–muscle relationships, exercise and prevention to be analysed in dialogue with a real SUS infrastructure. The relevant comparison concerns which variables, outcomes, risks and care components are common, which are specific to each system, and which can generate implementation or clinical-research questions in the Brazilian context.

Key concept for study: osteoporosis can be examined simultaneously as a disease with its own diagnostic and therapeutic criteria and as part of a functional trajectory involving muscle, falls, mobility, nutrition, medicines and environment. These layers should remain distinguishable in the design.

Official sources: Ministry of Health · Osteoporosis PCDT · 2026 update ↗ · Joint Ordinance SAES/SECTICS No. 22/2025 ↗.

Brazil · PHC/e-SUS · IVCF-20 and functional longitudinality

In 2025, the Ministry of Health advised inclusion of the Clinical-Functional Vulnerability Index (IVCF-20) in the e-SUS APS Citizen Electronic Health Record. The instrument supports timely identification of risk of functional decline, interprofessional planning and longitudinal follow-up. The Brazilian Health Record for Older People organises clinical conditions, habits, medicines, vulnerabilities, self-care and social information across follow-up.

Translational relevance: SUS already has a recording infrastructure capable of bringing research, implementation and real-world care into closer relation. Specific measures of strength or performance can dialogue with clinical-functional vulnerability without turning IVCF-20 into a diagnosis of sarcopenia.

Key concept for study: vulnerability screening, sarcopenia screening, diagnosis, performance measurement and functional outcome perform different functions; interoperability begins by preserving these differences.

MS · Information Note No. 2/2025 · IVCF-20 in PEC e-SUS APS ↗ · MS · Brazilian Health Record for Older People ↗

Brazil · Padi Brasil · home care, eMulti and territory

Ordinance GM/MS No. 9,584, of 22 December 2025, established the Home Care Programme for Older People — Padi Brasil and defined an additional financial incentive for Multiprofessional Teams — eMulti — in Primary Health Care. The programme is directed especially at people aged 60 years or older who are homebound, with functional limitations, chronic conditions, frailty or greater clinical and social vulnerability.

Care articulates multiprofessional home visits, multidimensional assessment, development and monitoring of the care plan, guidance for families and caregivers, and connection with other levels of SUS and with the intersectoral network in the territory.

Translational relevance: the home constitutes a structured environment for care and longitudinal production of functional information. Mobility, falls, strength, capacity for everyday activities, nutrition, cognition, medicines, caregiver support and territorial conditions can be followed close to real life.

Ministry of Health · Ordinance GM/MS No. 9,584/2025 ↗ · MS · Home care in PHC · Padi Brasil ↗

Brazil · e-SUS APS · function across health record, territory and home

IVCF-20 is incorporated into the Citizen Electronic Health Record and into e-SUS Território, allowing recording during home visits. Ministry guidance provides for periodic application and longitudinal history, while the system offers follow-up of older people and filters by the index.

For Padi Brasil, the Ministry of Health establishes recording in the e-SUS APS Strategy of home-care encounters carried out by eMulti professionals, linking place of care, older person and care activity.

Translational relevance: health record, territorial visit and home care form a public digital infrastructure capable of supporting longitudinal observation, implementation evaluation and research under real-world care conditions.

Transversal learning: clinical, functional, social, territorial and intervention data gain value when temporality, acquisition context and the meaning of each measure remain traceable.

MS · e-SUS Território · home visit and IVCF-20 ↗ · MS · Joint Technical Note No. 77/2026 · Padi Brasil ↗

Brazil · 2026 Health Record · five years of continuity of care

The Brazilian Health Record for Older People 2026 organises follow-up over five years and brings together personal, social and family information, health conditions, lifestyle habits, medicines, vulnerabilities and self-care. IVCF-20 forms part of the instrument, which also incorporates social determinants, family ties and community support.

Translational relevance: temporal continuity favours questions about trajectories of function, response to interventions, transitions in vulnerability and maintenance of autonomy. Participation by the older person, family and caregivers broadens the dimensions of shared care and contextual data quality.

Ministry of Health · Brazilian Health Record for Older People · 2026 ↗

Function, prevention, rehabilitation and care environment
China · sarcopenia 2026 · operational screening and functional follow-up

The Chinese dietary guidance (食养) for sarcopenia transforms “muscle loss” into an operational set of observations. It recommends annual screening in older people and cites grip strength, calf circumference, SARC-F, 6-metre walking speed and/or the five-times sit-to-stand test, as well as activities of daily living, stair-climbing ability, food intake, weight change and, where available, vitamin D.

Translational relevance: the combination of simple, repeatable measures makes it possible to distinguish risk, performance and trajectory in clinical, community and home settings without relying on a single body measure.

Transversal learning: strength, circumference, gait, chair-stand, nutrition and activities of daily living belong to related but distinct dimensions; longitudinal repetition may reveal change before functional loss becomes more difficult to recover.

National Health Commission · 成人肌少症食养指南 · 2026 ↗

Brazil · rehabilitation of older people · gait, strength and prevention of functional loss

The Ministry of Health's Guide to Rehabilitation Care for Older People recognises sarcopenia in relation to progressive reduction in muscle strength and mass, loss of mobility, falls, dependency and frailty, and presents walking speed as a simple measure useful for identifying people who require a clinical approach. Rehabilitation aimed at strength gain appears as a component of prevention and management.

Translational relevance: continuity is possible between PHC, functional assessment and rehabilitation. This favours designs in which the relevant result is not only body composition but observable change in mobility, strength, falls and independence.

Ministry of Health · Guide to Rehabilitation Care for Older People ↗

Brazil · falls 2026 · strength, balance, environment and autonomy

In 2026, the Ministry of Health published specific national material for prevention of falls in older people and maintains an updated care protocol for risk assessment and harm prevention. The approach articulates fall history, muscle strength, balance, vision, feet and footwear, physical activity, medicines, home safety and everyday participation.

Translational relevance: falls condense multiple observable dimensions into a clinically relevant outcome. Mobility, sarcopenia, osteoporosis, medication effects, cognition, fear of falling, environment and support can be followed in distinct trajectories and related to loss or recovery of autonomy.

Key concept for study: “fall” can be treated simultaneously as an event, a safety outcome, a marker of functional transition and a trigger for investigation of modifiable factors.

Ministry of Health · Prevention of falls in older people · 2026 ↗ · MS · Falls Prevention Protocol · 2026 update ↗

Home · environmental risk · assistive technology · rehabilitation

The Guide to Rehabilitation Care for Older People organises fall prevention around personal, environmental and occupational factors, including fall history, cognition, sensory and physical capacities, housing safety, availability of assistive technology, performance in activities of daily living and participation. Balance and strengthening exercises, multifactorial interventions and environmental adaptations form part of this care architecture.

Translational relevance: the home offers a particularly informative field for studying person–environment interaction. Sensors, gait assessment, assistive technology, ergonomics, lighting, grab rails and activity patterns can be investigated as components of safety and function.

Ministry of Health · Guide to Rehabilitation Care for Older People ↗

Stroke · Brazil and China · continuity, rehabilitation and functional recovery

In Brazil, the Stroke Care Pathway organises health promotion, prevention, emergency care, treatment, rehabilitation and continuity of care within a network. The Guidelines for Rehabilitation Care for People with Stroke structure multiprofessional assessment, recovery from deficits, functional compensations, autonomy in activities of daily living and social reintegration.

In China, recent public documents reinforce early and multidisciplinary rehabilitation after clinical stabilisation. National guidance from 2025 includes physiotherapy, occupational therapy, speech/swallowing therapy and psychological care; the principles for construction and management of Stroke Centers — 2026 edition — incorporate functional assessment and early Rehabilitation Medicine intervention, multimodal monitoring and information sharing between services.

Translational relevance: stroke offers a longitudinal model in which time, lesion, deficit, intervention, neuroplasticity, motor performance, cognition, language, swallowing, participation and autonomy can be followed at different levels of the health system.

Transversal learning: functional recovery is a trajectory. Repeated measures and care context make it possible to distinguish neurological change, compensation, adaptation, response to rehabilitation and everyday participation.

Brazil · Ministry of Health · Stroke Care Pathway ↗ · Brazil · Stroke Rehabilitation Guidelines ↗ · China · NHC · World Stroke Day 2025 ↗

Healthcare Innovation · R&D&I · Science Diplomacy · Knowledge Translation

HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu · Neuroscience · Pharmacology · HRM Queen Kondwelani I
HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu · Neuroscience · Pharmacology · Anaesthesia · Healthcare Innovation

NEUROSCIENCE · PHARMACOLOGY & PHARMACOKINETICS · ANAESTHESIA · HEALTHCARE MANAGEMENT · KNOWLEDGE TRANSLATION · INTERCULTURAL COOPERATION

HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu is a Neuroscience researcher, with a B.Sc. in Biochemistry from Olabisi Onabanjo University and an M.Sc. in Pharmacology & Therapeutics, specialising in Pharmacokinetics, from the University of Ibadan, Nigeria. Her doctoral trajectory began at the University of Leicester in Cell Physiology and Pharmacology, specialising in Neuroscience, and continued to a Doctor of Business Administration (DBA) in Healthcare Management and Leadership from California Intercontinental University. Her work articulates biomedical research, Pharmacology, healthcare management and innovation, Education and knowledge translation.

She is also recognised — including in her own public authorial identity — as HRM Queen Adesewa I of Ayegbe Kingdom, Nigeria, and HRM Queen Kondwelani I, an honorary title conferred by the Chichewa Tribe of Malawi in recognition of her work as a Goodwill Ambassador, now linked to the Queen Kondwelani Royal Charity. The two planes of recognition — scientific and traditional leadership — compose her public trajectory with their own provenance and meanings.

In professional and editorial sources, her scientific work encompasses themes such as trauma, neonatal brain repair, anaesthesia, pain management, health innovation and rapprochement between biomedical research, management and social applications. This combination makes her trajectory particularly relevant for observing how pharmacological and neuroscientific knowledge can be translated between research, care, Education and innovation.

Anaesthetic pharmacology · multilingual medical translation · collaboration with Brazil

The editorial production derived from Anaesthetic Pharmacology 101 mobilised medical translation and Education for healthcare professionals in different languages, with documented editions in Brazilian Portuguese and Yoruba.

This translation work is embedded in a broader international network: on the occasion of World Humanitarian Day 2026, the HRM Queen Kondwelani I Award for Humanitarian Service (Language Translation category), under the leadership of HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu (HRM Queen Kondwelani I), recognised teachers and translators of 20 languages — Arabic, Bengali, Brazilian Portuguese, Chichewa, Chinese, English, Filipino, French, German, Hausa, Hindi, Idoma, Igbo, Italian, Sinhala, Spanish, Swahili, Tamil, Ewe/Togolese, Turkish and Yoruba — among whom Glória Moura Alves represented Brazilian Portuguese.

Documented publications include Pharmacological Explanation for the Observed Gender Difference in Recovery from Anaesthesia · Portuguese Language for Healthcare Workers · Anaesthetic Pharmacology 101 and the multilingual edition Yoruba Language and Brazilian Portuguese Language for Healthcare Workers · Anaesthetic Pharmacology 101.

Lulu · Brazilian Portuguese edition ↗ · Lulu · Yoruba–Brazilian Portuguese edition ↗

Knowledge Translation · science, language and social use of knowledge

The multilingual experience offers a concrete case of knowledge translation: preserving technical content, making it linguistically intelligible and facilitating its circulation among professionals, languages and cultural contexts. This work brings scientific communication, Health Education, safety of technical-clinical information and professional training into proximity.

Scientific reading of the trajectory. The articulation between Pharmacology, Neuroscience, Anaesthesia, management, Education and intercultural translation makes it possible to observe circulation of biomedical knowledge as a component of implementation, safety and capacity for use.

Author profile and catalogue · Lulu ↗

Wendy Noren’s · Knowledge Translation & Healthcare Innovation

RESEARCH · KNOWLEDGE TRANSLATION · HEALTHCARE INNOVATION · HEALTHCARE MANAGEMENT

As CEO and Principal Investigator of Wendy Noren’s, HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu works at the intersection of medical research, knowledge translation, innovation and healthcare-sector applications. This area brings together circulation among scientific production, Education, management, innovation and professional audiences.

Official author profile · Lulu ↗

Selected works · Pharmacology, leadership and healthcare management

Her authorial production brings together Pharmacology, Health Education, leadership, management and innovation. Selected works include Anaesthetic Pharmacology 101, Keys to Successful Leadership in Healthcare Settings, Risk Management in Healthcare Settings, Strategic Management for Global Business Leaders and Economic Evaluation and Marketing for Healthcare Professionals.

The ensemble demonstrates a line of work oriented towards translation and circulation of knowledge between biomedical research, professional training and healthcare management.

Catalogue of works · Lulu ↗

Air Ambulance · Board Chair · Air Ambulance Service Models for Disaster Preparedness

AEROMEDICAL EVACUATION · TELEMEDICINE · DISASTER PREPAREDNESS

According to professional documentation available in her author profile on the Lulu platform (Lulu · author profile), HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu is identified as Board Chair of Air Ambulance. In 2022–2023, she, her daughter Abidoba Oyekenu and collaborators developed Air Ambulance Service Models for Disaster Preparedness, a proof of concept proposal articulating aeromedical evacuation, telemedicine, health, engineering, Education and disaster preparedness.

Abidoba Oyekenu · intergenerational collaboration · scientific translation · Air Ambulance

Abidoba Oyekenu, daughter of HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu, is documentarily part of this trajectory of scientific and educational collaboration. Before the disaster-preparedness project, she participated in the international circulation of Anaesthetic Pharmacology 101: in the 2021 English edition she is credited for the photographs and, in the Spanish and French editions, for translation. These contributions situate her participation at the interface between scientific communication, language and Health Education.

In 2022, Abidoba appears among the authors of Air Ambulance Service Models for Disaster Preparedness: Public Lecture and Project Proposal (ISBN 978-1-4716-9202-4). The proposal was developed in the context of an initiative bringing together disaster preparedness, aeromedical evacuation, telemedicine, health, engineering and youth training. AWIS San Diego recorded, in the same year, the collaboration led by HRM Queen Adesewa I Dr Yewande Okunoren-Oyekenu for remote training of 44 adolescents in work-experience activities in science, health, law and Education, with students participating in construction of Air Ambulance models for disaster preparedness.

Translational relevance: Abidoba's participation makes visible an intergenerational dimension of the pathway: biomedical knowledge, translation, visual representation and conception of emergency solutions circulate among research, Education and capability development. Her presence forms part of the concrete genealogy of the project and its intergenerational dimension.

Lulu · English edition · photographic contribution by Abidoba ↗ · Lulu · Spanish edition · translation by Abidoba ↗ · AWIS San Diego · Fall 2022 Newsletter ↗

The project also forms part of the Africa · Nigeria cluster of this Observatory, where its territorial, intergenerational and disaster-preparedness dimensions are examined in relation to circulation of knowledge, capability development and translation between science, Education and emergency response.

Lulu · author profile, co-authorship with Abidoba Oyekenu ↗

Data · Data Quality · AI · health information systems

Transversal learning. Data quality and quality of representation belong to the same information chain. Provenance, completeness, consistency, temporality, analytical transformation and visualisation choices condition what becomes visible and what can support a decision.
N20 · multimodal harmonisation · multicentre comparison

International neurotechnology agendas, including Neuroscience20, explicitly identify challenges of data harmonisation and standardisation in multimodal and multicentre environments. This field makes it possible to investigate which metadata, quality controls, provenance rules and levels of standardisation support comparison between centres while preserving clinical and contextual heterogeneity.

Methodological connection. The same question traverses neuroimaging, neurophysiological signals, devices, clinical data and artificial-intelligence models: which transformations make distinct sources comparable without erasing the information that differentiates populations, acquisition contexts and care trajectories?

Neuroscience20 · official aims and agenda ↗

Prof. Henrique Pereira Alves · Clinical Neuroscience · Data Science · Data Quality · AI
Trajectory and work

NATURAL SCIENCES · CLINICAL NEUROSCIENCE · DATA SCIENCE · DATA QUALITY · ARTIFICIAL INTELLIGENCE · HEALTH INFORMATION SYSTEMS · SYSTEMS THINKING

A Natural Scientist, Specialist in Clinical Neuroscience and holder of an MBA in Artificial Intelligence, Prof. Henrique Pereira Alves has worked at the Oswaldo Cruz Foundation (Fiocruz) and the UNA-SUS Network (Open University of the Brazilian Unified Health System) with Data Analysis since 2014, including teaching in courses for researchers, lecturers and teams from Fiocruz and the UNA-SUS Network.

The UNA-SUS Network forms part of the Open University System of the Brazilian Unified Health System, created within the Ministry of Health for training and continuing education of SUS workers. It is a collaborative network of public higher-education institutions that provides and disseminates health education, articulating teaching, service and educational technologies.

UNA-SUS · About UNA-SUS ↗

Henrique's trajectory includes work on epidemiological and nutritional surveillance projects in articulation with UNICEF and the Food and Nutrition Surveillance System (SISVAN), within SUS.

Data · Quality · Monitoring · Decision

Henrique's work in this field includes Data Quality, production and qualification of indicators, construction of monitoring dashboards and support for data-informed decision-making in public health.

This trajectory brings together, in the same professional experience, data analysis, information systems, surveillance, indicator monitoring and translation of information for decision-making processes in Public/Collective Health.

Data Quality constitutes scientific infrastructure between data production and decision: data produced → completeness, consistency and validity → provenance → standardisation → interoperability → analysis → inference → decision. Care, epidemiological or community datasets have their own purposes and structures. Their scientific use depends on qualification of records, indicators, metadata, temporality, provenance and biases relevant to each question.

Interdisciplinary Training · Homeopathy · Clinical Psychoanalysis

Henrique's training also includes Homeopathy and Clinical Psychoanalysis, adding experience in different models of care and interfaces with mental health and Traditional, Complementary and Integrative Medicine.

Eleanor Lutz · Biology · Data Science · Scientific Visualisation · Information Design

Eleanor Lutz is a biologist, data scientist and information designer. She holds a B.S. in Cell & Molecular Biology and a Ph.D. in Biology: Data Science from the University of Washington. Her trajectory connects biological investigation, computational analysis and construction of visualisations capable of making complex scientific structures legible without losing data provenance.

In her authorial project Tabletop Whale, she develops data-based scientific infographics and visualisations. Her professional trajectory includes work as a Graphics Editor at The New York Times and the Dutch newspaper de Volkskrant, as well as independent work in information design.

Disciplinary integration · Biology, data, code and scientific communication

Eleanor Lutz's trajectory traverses Biology, animal behaviour, programming, Data Science, cartography, information design and scientific communication. She reports having originally learnt Python during postgraduate study while processing video recordings of mosquito behaviour, and subsequently using it extensively in data management and design; she also taught Data Science for Biologists at the University of Washington.

In her visualisation projects, data treatment, modelling and graphical choices form part of the same workflow. In the Atlas of Space, for example, public astronomy datasets are combined, cleaned, transformed and represented using computational methods appropriate to the scale of the problem. This practice offers a reference for how analytical rigour and visual intelligibility can coexist in the translation of complex systems.

Tabletop Whale · Atlas of Space and methodological pathway ↗

An Orbit Map of the Solar System · data, visualisation and provenance

Published on 10 June 2019, An Orbit Map of the Solar System represents the orbits of more than 18,000 asteroids. Eleanor Lutz describes the use of public NASA data, cleaning and integration of different datasets, generation of orbital trajectories with NASA HORIZONS and a logarithmic radial scale to make objects distributed across very different scales simultaneously visible.

Eleanor Lutz's work demonstrates how public data, computational transformation and information design can produce visualisations that preserve provenance and complexity without losing intelligibility — a principle applicable to representation of biomedical, territorial and clinical data in multimodal designs.

Visual reference: LUTZ, Eleanor. An Orbit Map of the Solar System, 2019. View the original work on Tabletop Whale ↗

Tabletop Whale · work and methodology ↗ · Open-source code and tutorial ↗

Visual identity · attribution and licence

The Observatory's visual entrance reproduces the original work, without graphic intervention, preserving Eleanor Lutz's composition in full. The author makes An Orbit Map of the Solar System available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International — CC BY-NC-ND 4.0licence.

Reproduction of the work within the scientific content of this publication remains subject to the conditions of the CC BY-NC-ND 4.0licence: attribution, non-commercial use and no derivative work. The work is presented with author, title, year, source and licence, without being used as an autonomous graphic identity for the Programme.

Reference for the work (ABNT): LUTZ, Eleanor. An Orbit Map of the Solar System. Tabletop Whale, 10 Jun. 2019. Available at: Tabletop Whale ↗. Accessed: 23 Aug. 2026. Licence: CC BY-NC-ND 4.0 ↗.

Tabletop Whale · official website ↗ · Curriculum Vitae · Eleanor Lutz ↗

Biotechnology · Strategic Communication · Social Technology · Innovation · R&D&I

Transversal learning. In applied biotechnology, the identity of the organism or material, production process, analytical method, performance and context of use form a characterisation chain. The transition from a laboratory finding to a bioinput or technological solution depends on traceability between these stages.
Prof. Dr Carlos Emanoel Vieira Flores Soares · Biotechnology · Microbiology · Bioinputs · R&D&I

A biologist, researcher and scientific consultant, with a Doctorate in Chemical and Biological Technologies from the University of Brasília (UnB) and postdoctoral training in Microbial Bioprocesses, Soil Microbiology and Bioinputs, and in Genomic Sciences and Biotechnology. His Research, Development and Innovation trajectory brings together Biochemistry, Biotechnology and Microbiology, with experience in yeast physiology, fermentation processes, molecular biology of microorganisms, and microbial identification and characterisation.

Microbiology · bioprocesses · bioinputs

His scientific work encompasses agricultural microbiology, microbial bioprocesses, soil microbiology and development of bioinputs, including research on microorganisms of biotechnological interest and processes applicable to agriculture and sustainability.

CES My Tech · R&D&I and applied biotechnology

As CEO of CES My Tech, he works at the interface between research, technological development and innovation in biotechnology. Production associated with the ecosystem includes work on bioinputs, microbial processes, biotechnology and applications of Industry 4.0 technologies to agriculture and food.

Microbial characterisation · analytical methods

His methodological experience includes identification and characterisation of microorganisms by MALDI-TOF mass spectrometry and DNA sequencing using the Sanger method, connecting applied microbiology, analytical characterisation and biotechnological development.

CONBIOTEC · scientific profile ↗ · OWL Journal · publication in biotechnology and agriculture ↗

Amanda Tavares de Andrade · Strategic Communication · Social Technology · Innovation · Social Impact

Strategic communication and social technology. Amanda Tavares de Andrade is a communication professional, graduated in Social Media Management, whose work focuses on purpose-driven communication, social impact and digital inclusion. In a 2023 publication, she is identified as Social Media professional and undergraduate research student in the Digital Business Management Department at CES My Tech, being co-author, with Maria Helena Krueger and Carlos Emanoel Vieira Flores Soares, of the article Industry 4.0 and its revolutions in the biotechnology and agriculture sectors.

Her work brings together strategic communication, digital transformation, social technology, content production and investigation of innovation environments, with participation in initiatives focused on entrepreneurship, social impact and digital applications.

OWL Journal · article and author biographies ↗

Communication as social technology

Amanda Tavares de Andrade works as a communication strategist and entrepreneur, with practice oriented towards the intersection of communication, innovation and social impact. Her work starts from an understanding of communication as social technology, applied to strengthening scientific initiatives and impact businesses — strategic positioning, narrative construction and participation in programmes supporting innovation and research. She is developing the COMMUNATA agency, currently in its structuring phase, aimed at creating applicable and accessible methodologies to strengthen the digital presence of ethical and conscious initiatives. This work situates scientific communication as a component of the circulation, intelligibility and adoption of knowledge in innovation ecosystems.

CES My Tech · building the startup from conception

Linked to CES My Tech since 2023 as an independent service provider. Participation from the conception of the startup — which develops biotechnological solutions for agriculture — collaborating in definition of strategic objectives, development of the business plan and construction of the value proposition. Documented contributions include direct involvement in project ideation and structuring of the business model, as well as support in applications to and approval by acceleration calls.

Digital communication · Armarinho da Edna · Handicrafts Fair

Provision of digital-communication services for Armarinho da Edna, focused on content strategy, social-media management and production of promotional actions. Responsible for planning and delivering the Handicrafts Fair, integrating active listening, metrics analysis and delivery of digital solutions aimed at strengthening the brand and local impact.

Transversal learning. Amanda's trajectory allows the Observatory to observe communication as a translational capacity related to intelligibility, circulation, social appropriation and implementation of knowledge and innovation, articulating communication, strategy and development of initiatives in ecosystems of science, innovation and social impact.

Lattes Curriculum: 4723527250922477 ↗

Cannabis · transversal object · therapeutics · associativism · real-world evidence

National associations · networks · territories · actors

Expandable panorama of associations, networks and actors followed by the Observatory, preserving documented relationships and allowing selective deepening without lengthening the main reading.

Associação Brasileira do Pito do Pango (Abrapango) · Brasília/DF · social access · clinical care · research · quality

Abrapango is a non-profit association based in Brasília/DF, dedicated to safe and humanised access to medicinal Cannabis. Its work brings together patient reception, access to therapeutic preparations, associative guidance, social-access initiatives, clinical follow-up and dialogue with scientific research.

Social Clinic · access · equity · continuity of care

In 2026, Abrapango structured a Medicinal Cannabis Social Clinic in Brasília aimed at people in economic vulnerability registered in the Federal Government's Unified Registry for Social Programmes (CadÚnico). The initiative provides for social screening, in-person consultations and the possibility of remote care, with announced capacity to receive new patients each month.

The care design articulates vulnerability assessment, association membership, professional follow-up and mechanisms to reduce economic barriers. The association's Social Access Programme provides for full or partial exemption from annual fees and discounts proportional to socioeconomic circumstances, which may reach 100% in eligible cases.

Key concept for study. Financial barriers, availability of professionals, continuity of consultations, access to the prescribed preparation and retention in care can be treated as measurable components of the therapeutic trajectory, allowing investigation of equity, access and continuity under real-world conditions.

UnB · extraction · characterisation · quality control · scientific training

In 2025, the University of Brasília (UnB) formalised a Technical Cooperation Agreement with Abrapango for research on extraction processes and quality control of Cannabis-based therapeutic products. The cooperation involves characterisation of cannabinoids and terpenes, development and validation of analytical methods, process improvement, laboratory infrastructure and student training.

Abrapango supplies samples used in academic projects, while UnB provides students, infrastructure and technical-scientific support. University documentation also records the creation of the Brazilian Interdisciplinary Cannabis Observatory, with planned work ranging from analytical methods to evaluation of therapeutic effects on patients' health.

Key concept for study. Identity, composition, batch, analytical method, extraction process and stability constitute characterisation layers that can be linked to dose, safety and clinical response when the provenance of each preparation is preserved.

Social clinic · quality · RWE · pharmacovigilance

The coexistence of social access, clinical follow-up, associative dispensing, laboratory characterisation and university cooperation offers an observable field for real-world studies. Possible questions include who can initiate and maintain treatment, how vulnerability and cost interfere with continuity, how composition, dose, co-exposures and temporality relate to response and safety, and which minimum data support pharmacovigilance and effectiveness assessment.

Transversal learning. The trajectory vulnerability → access → clinical assessment → prescription → characterised preparation → dispensing → follow-up → safety → response → continuity of care → data production brings social assistance, clinical care, pharmaceutical quality, pharmacovigilance, RWE and translational research into proximity within a traceable chain.

Abrapango · Social Access Programme ↗ · UnB · cooperation for research and quality control ↗

Ítalo Henrique Nascimento and Mônica Barcelos · Abrapango · presidency · executive board · regulation

Ítalo Henrique Nascimento is identified by Abrapango itself as president and Mônica Barcelos as executive director. In January 2026, Mônica also represented the association at a public meeting of Anvisa's Collegiate Board devoted to regulatory debate on Cannabis.

Associação Tijucanna Cannabis Terapêutica · Ituiutaba/MG

Founded in 2022, in Ituiutaba/MG, by Adriana Gomes de Moraes and Adriano Oliveira, Tijucanna organises reception, information, access to treatment, legal assistance and agronomic guidance in the field of therapeutic Cannabis. The association brings associative experience, whole preparations, access, community care, real-world data, social participation and dialogue with research and public policy into proximity.

Adriana Gomes de Moraes · Tijucanna · Agronomy · associativism · public policy

Adriana Gomes de Moraes is an agronomist, founder and president of Associação Tijucanna. Her documented public work brings together access to therapeutic Cannabis, cultivation, research, regulation and participation of associations in shaping health policy. In public hearings of the Legislative Assembly of Minas Gerais, she is identified as a Tijucanna leader and participant in scientific and regulatory debate on medicinal Cannabis.

Santa Cannabis · Medical Cannabis Association of Santa Catarina

Founded in 2019, in Santa Catarina, Santa Cannabis works on access to medicinal Cannabis and brings together associative care, research, development, national production and academic dialogue. In 2026, it entered into a Technical Cooperation Agreement with the Federal University for Latin American Integration (UNILA), formalising an interface between associativism, research and training.

Pedro Luis Sabaciauskis Pereira · Santa Cannabis · associativism · research · regulation

Pedro Luis Sabaciauskis Pereira is the founder and president of Santa Cannabis. His trajectory begins with a family care experience and expands into patient organisation, therapeutic access, associative cultivation, dialogue with university research and participation in public debates on regulation of medicinal Cannabis. In 2026, he appears as the association's institutional representative in the cooperation agreement with UNILA.

Associação Canábica Maria Flor · Marília/SP · access · research · education · One Health

Established in 2020, Associação Canábica Maria Flor works in reception, information, access to Cannabis care and production of knowledge in Marília/SP. The organisation's trajectory has also become an object of academic research in Sociology. In 2026, the association expanded educational and technical-scientific interfaces, including training in veterinary medicinal Cannabis and activities on cultivation, research and health applications.

Caroline Marroni Cremonez · Pharmacy-Toxicology · scientific direction

Institutional documents from Maria Flor identify Caroline Marroni Cremonez as president and pharmacist-toxicologist; technical-pharmaceutical documentation also identifies her as scientific director. The presence of pharmaceutical and scientific leadership makes observable interfaces between associative reception, characterisation of preparations, pharmaceutical services, safety and data production.

Fernanda Peixoto and Cláudia Marin · origin trajectory and associativism

Academic research on the association's history records Fernanda Peixoto and Cláudia Marin among the protagonists of its creation and initial mobilisation. The pathway documents how family experiences of care, reception and access can become associative organisation, social participation and knowledge production, opening questions about care, access, collective organisation and evidence production.

Fernanda Peixoto · Cláudia Marin · Alceu Alves · Maria Flor · management, reception and research

The board re-elected in 2024 kept Fernanda Peixoto as president and Cláudia Marin Castelazi as vice-president. Cláudia also works in reception and publicly participates in educational activities and debates on access to medicinal Cannabis.

Alceu Alves is a pharmacist-biochemist, researcher and technical officer of Associação Canábica Maria Flor since 2022; in 2026, his academic training includes doctoral study in Agronomy investigating Cannabis sativa L. and environmental and nutritional factors related to the production of phytocannabinoids and flavonoids.

APEPI · Association for Support of Research and Medicinal Cannabis Patients

The APEPI emerged in 2014 from the mobilisation of Margarete Brito and Marcos Langenbach around the treatment of their daughter Sofia and became established as an association focused on access, reception, education, cultivation and research in medicinal Cannabis. Its institutional trajectory includes Fazenda Sofia Langenbach, training activities through APEPI Escola and cooperation with research institutions, composing one of the historical landmarks of Brazilian Cannabis associativism.

Margarete Brito and Marcos Langenbach · APEPI · access · education · research

Margarete Brito and Marcos Langenbach are founders of APEPI. The family experience with medicinal Cannabis for the treatment of Sofia Langenbach unfolded into mobilisation for access, judicial decisions, associative organisation, cultivation, training and knowledge production. APEPI's own institutional chronology records, in 2014, the seminar on medicinal Cannabis at UNIFESP organised by Elisaldo Carlini, connecting the association's history to the scientific and social genealogy of Cannabis in Brazil.

Fênix 33 · poetry · singing · marijuana therapeutics · right to health

Fênix 33. A poet and singer, she works in the field of marijuana therapeutics and health rights, articulating lived experience, art, social participation, access to care and critique of the medicalisation of life. Her authorial production transforms experiences of illness, care itineraries, institutional violence, inequality and survival into poetic and musical language.

Art, lived experience and the language of care

In works shared by Fênix 33 herself, the first person constitutes a language of experience and situated elaboration. Hospital, medicine, suffering, street, housing, inequality, Cannabis, art and resistance appear as elements of a situated narrative. For the Observatory, this voice makes it possible to study how health needs and consequences of care systems can become visible even before they take form in technical categories.

Authorial production · poetry and song
Novela Mexicana · music

An autobiographical song in which Fênix 33 articulates childhood, violence, illness, hospital pathways, prolonged exposure to pharmacological treatments, encounter with Cannabis and reconstruction of purpose. The narrative works with rebirth, survival and critique of the forms of care experienced along her trajectory.

Fênix 33 · authorial work. Full text in the author's channels.

Inferno Colorido · poetry

A poem about exhaustion, functional limitations, precarious housing, social inequality, rights and everyday persistence. The writing refuses to romanticise pain and presents poetry as a language of elaboration and resistance.

Fênix 33 · authorial work. Full text in the author's channels.

Decriminalised for whom? In the neighbourhood, it's still the same story!

A political poem about the Brazilian Supreme Federal Court's 2024 decision concerning possession of Cannabis for personal use, read through racial, territorial and class inequalities. The work brings decriminalisation, therapeutic access, patient associations, imprisonment, the anti-asylum movement and the right to health into proximity.

Fênix 33 · authorial work. Full text in the author's channels.

Inquisition

A poetic text relating illness experience, therapeutic use of Cannabis, critique of medicalisation and institutionalisation, ancestral knowledge, coloniality and bodily autonomy. The image of the Phoenix organises the narrative of resistance and reconstruction.

Fênix 33 · authorial work. Full text in the author's channels.

Purpose 4:20

An autobiographical text on physical suffering, institutionalisation, therapeutic experience with Cannabis, freedom and reconstruction of meaning. The work presents 'Purpose 4:20' as an axis of rebirth, activism and affirmation of one's own trajectory.

Fênix 33 · authorial work. Full text in the author's channels.

Voice and authorial production · channels and records
Transversal learning · experience, rights and translation between languages

Lived experience and scientific evidence retain their own statuses and may enter into relation. Poetry and song make perceptible vocabularies of suffering, autonomy, stigma, access, medicalisation, territory and rights that can inform listening, social participation and formulation of investigable questions. The methodological operation is to translate without erasing: preserve the originating voice, make explicit what is report, and construct, where pertinent, pathways of investigation, care and Translation to Action.

The works of Fênix 33 condense, in poetic and activist language, experiences and interpretations concerning criminalisation, class, race, institutionalisation, therapeutic access, patient associations, the anti-asylum movement and autonomy. Their transversal strength lies in making audible questions, conflicts and needs that can guide listening, research, social participation and care.

FACT · Federation of Therapeutic Cannabis Associations — national articulation, social participation and regulatory policy

The Federation of Therapeutic Cannabis Associations (FACT) works in national and inter-associative articulation, constituted through organisation of associations from different Brazilian regions, forming networks, supporting associativism and social participation in processes related to access, regulation and public policies on therapeutic Cannabis.

This dimension has documented institutional expression in national spaces of regulatory formulation and debate. This includes participation in a directed consultation by the Working Group of the National Council on Drug Policies (CONAD) concerning regulation of Cannabis for therapeutic use, contribution to a participatory process related to revision of the National Drug Policy Plan, and a statement before the Collegiate Board of the Brazilian Health Regulatory Agency (Anvisa) in regulatory discussion on Cannabis in January 2026.

The federative scale makes it possible to examine a broader problem than that observed in isolated associations: how to transform heterogeneous experiences of care, access and associative production into comparable information without erasing territorial, clinical, productive and organisational differences. This problem involves defining minimum datasets, information quality and provenance, traceability of preparations, pharmacovigilance, terminologies, interoperability and governance, as well as distinguishing data suitable for care, surveillance, research and public-policy formulation.

At federative scale, problems of multicentricity, minimum harmonisation of databases, pharmacovigilance, interoperability and governance become observable across organisations with distinct contexts, preparations and routines.

Regulation · Brazilian framework 2026 (RDC 1,011–1,015/ANVISA)

In February 2026, ANVISA published a set of five resolutions reorganising the regulatory framework for medicinal Cannabis in Brazil, in response to a Superior Court of Justice (STJ) decision (Nov/2024) on the legality of production exclusively for medicinal and/or pharmaceutical purposes. Each resolution has its own object and effective date — they do not constitute a single reform.

2026 RDCs individually
RuleEffective dateObject
RDC 1,011/202604/08/2026Update to Annex I of Ordinance SVS/MS No. 344/1998 (controlled-substance lists)
RDC 1,012/202604/08/2026Cultivation of Cannabis exclusively for scientific research, subject to Special Authorisation
RDC 1,013/202604/08/2026Cultivation of Cannabis sativa L. with THC ≤0.3% for medicinal, pharmaceutical or research purposes; Art. 9 separately addresses cultivation within the same THC range intended for export
RDC 1,014/202604/08/2026Regulatory Sandbox — experimental environment for non-profit patient associations, with monitoring, quality control and traceability
RDC 1,015/202604/05/2026Health Authorisation for manufacture and import of Cannabis products for human medicinal use — formally revokes RDC No. 327/2019

Establishments cultivating Cannabis by judicial decision have until 05/08/2027 to comply with RDCs 1,012 and 1,013. RDC 1,015 has been in force since May 2026; RDCs 1,012, 1,013 and 1,014 came into force in August 2026. Updating of the lists under Ordinance SVS/MS No. 344/1998 is continuous: after RDC 1,011/2026, further updates occurred, including RDC 1,023/2026 and RDC 1,036/2026, identified by Anvisa as the current version of the list in July 2026.

Biomedicine · Acupuncture, TCM, Cannabis and professional frameworks

Documentary consultation map. This cluster brings together rules directly pertinent to biomedical practice and to the interface between Acupuncture/TCM, professional follow-up, research and Cannabis. Reading must always consider registered qualification, the scope of the rule currently in force and applicable health legislation.

Acupuncture · national legal framework and biomedical recognition

Law No. 15,345/2026. Regulates professional practice of Acupuncture in Brazil. Those authorised include higher-education health professionals with a specialist title in Acupuncture recognised by the respective federal council. The law also provides for consultation, assessment and treatment by Acupuncture; organisation of services; auditing, consulting and opinions; participation in planning and care plans; harm prevention and health education.

CFBM Resolution No. 292/2018. Recognises Acupuncture as a specialty of Biomedicine.

CFBM Normative Act No. 001/2016. Forms part of the specific normative genealogy of biomedical acupuncturist activity.

TCM, Phytotherapy and requesting tests · operational interface

CFBM Resolution No. 347/2022. Provides for requesting laboratory tests required for professional follow-up, among other activities/qualifications, in Phytotherapy, Traditional Chinese Medicine, Ozone Therapy and Aesthetic Biomedicine; determines updated technical-scientific criteria and integrated assistance within the multiprofessional team. The resolution itself notes that these tests are not intended to establish nosological diagnosis.

Cannabis · recent regulatory change

CFBM Resolution No. 365/2023. Previous framework concerning prescription of traditional herbal products based on cannabidiol.

CFBM Resolution No. 427/2026. Recent rule on competencies and duties of biomedical professionals in the productive, analytical and research chain, and clinical-laboratory follow-up of Cannabis for medicinal and scientific purposes. Because it changes the recent professional framework, it should be read directly in its current wording before any inference about prescription or clinical autonomy.

Ozone Therapy · professional rule and regulatory limit

CFBM Resolution No. 321/2020. Recognises biomedical professional practice in Ozone Therapy. The scope effectively authorised also depends on legislation and health regulation in force; professional recognition should therefore not be read in isolation as unrestricted authorisation for clinical applications.

Reading rule. The Observatory distinguishes professional training/qualification, competence provided for by a professional council, federal legislation and health authorisation. These levels may overlap, but they are not equivalent.
Official sources · regulatory consultation
Data, Quality and Pharmacovigilance in Associative Ecosystems

ANVISA RDC No. 1,014/2026 · DATA QUALITY · MINIMUM DATASET · PHARMACOVIGILANCE · TRACEABILITY · RWD/RWE

Cannabis associative ecosystems produce follow-up records, information on preparations, exposures, perceived responses, clinical outcomes and adverse events. From a scientific perspective, these records vary in structure, purpose, completeness and traceability.

Key concept for study. The transition from a care record to research data requires definition of a minimum dataset, dictionary and terminologies, product/batch identification, dose and exposure, adherence, temporality, outcomes, adverse events, provenance, missingness rules and governance. When design and quality are adequate, longitudinal data can support real-world safety and effectiveness analyses.

Cannabis sativa L. · transversal object across plant, knowledge, mechanisms, clinical care, society and territory

PLANT · HISTORY · KNOWLEDGE · PHARMACOLOGY · eCBome · PNEI · MICROBIOTA · CLINICAL CARE · REGULATION · TERRITORY · BIOECONOMY

Cannabis sativa L. functions in the Observatory as a transversal object: the same species can generate independent or connected questions in botany, pharmacognosy, pharmacology, neuroscience, public/collective health, traditional knowledge, regulation, associativism, agriculture, materials, bioeconomy and Planetary Health. Integration between domains occurs when the scientific question specifies an investigable relationship.

Scales of observation · plant, mechanisms, care, society and territory

The cluster follows Cannabis across different scales — plant, history, biological mechanisms, therapeutics, associativism, regulation, social participation, production systems and territory — and brings together scientific and social references whose relationship to each object is made explicit in the card itself.

History · traditional, cultural and medicinal uses

The history of Cannabis brings together medicinal, food, fibre, cultural, religious and psychoactive uses across different societies and periods. Historical and ethnobotanical investigation distinguishes community, territory, temporality, part of the plant, preparation, purpose and documentary source. This granularity is especially important when studying traditional knowledge, African diasporas, Indigenous peoples and popular practices in Brazil.

Key concept for study. “Ancestral use” designates situated traditions. The historical question gains precision by identifying who used what, how, where, when and with what meaning.

Scientific genealogy · Carlini ↔ Mechoulam · CBD and epilepsy

Collaboration between Brazilian researchers and Raphael Mechoulam occupies a relevant place in the contemporary history of cannabinoids. In 1978, Mechoulam and Elisaldo Carlini published Toward drugs derived from cannabis; in 1980, Cunha, Carlini, Brazilian collaborators, N. Lander and Mechoulam published a double-blind clinical trial with cannabidiol in volunteers and people with epilepsy, DOI 10.1159/000137430. These studies precede by decades the contemporary expansion of CBD as a therapeutic object.

Learning for study. The genealogy shows how natural-products chemistry, pharmacology, psychobiology, neurology and clinical investigation can form a long scientific trajectory, with subsequent changes in methods, regulatory standards and levels of evidence.

PubMed · Cunha, Carlini, Mechoulam et al. · 1980 ↗

Brazilian social genealogy · Father Ticão · education and access

In the East Zone of São Paulo, Father Ticão brought community mobilisation and education on medicinal Cannabis into proximity. UNIFESP documentation records that the extension course on therapeutic use of Cannabis sativa L. was created in 2017 by the Ermelino Matarazzo popular movement led by Father Ticão, with support from Prof. Elisaldo Carlini. The trajectory connects science communication, families, peripheral communities, university and public debate on access.

UNIFESP · SIEX · course on therapeutic use of Cannabis sativa L. ↗

Endocannabinoidome — eCBome · a network beyond the classical ECS

The classical endocannabinoid system is usually described in terms of endocannabinoids such as anandamide (AEA) and 2-AG, CB1/CB2 receptors, and synthesis and degradation enzymes. The concept of the endocannabinoidome (eCBome) expands this architecture to related lipid mediators, enzymes and additional molecular targets, including receptors and channels participating in metabolic, neural and immune networks.

The eCBome exists as an endogenous signalling system independently of Cannabis use. Phytocannabinoids are exogenous modulators capable of interacting with different components of this network and also with targets outside it.

Iannotti & Di Marzo · The endocannabinoidomes · 2025 ↗

eCBome ↔ PNEI · neuroimmune-endocrine regulation

Psychoneuroimmunoendocrinology (PNEI) studies relationships among psychological processes, the nervous system, immunity and endocrine regulation. The eCBome participates in pathways distributed across these systems, involving stress, nociception, sleep, appetite, inflammation, metabolism, barriers and adaptive responses. In multimodal designs, endocannabinoid mediators, inflammatory markers, hormones, autonomic measures, sleep, behaviour and clinical outcomes can be observed jointly.

Key concept for study. Mechanistic inference requires temporality, dose/exposure, mediation, control of confounding, marker specificity and biological plausibility; covariation among systems constitutes relational evidence to be interpreted within this ensemble.

eCBome ↔ microbiota–gut–brain

The microbiota–gut–brain axis describes bidirectional communication among microbiota, intestinal barrier, immune system, metabolism, enteric nervous system and central nervous system. Recent literature examines reciprocal relationships between gut microbiota and the eCBome and investigates how diet, physical activity, inflammation, microbial metabolites and lipid mediators participate in these interactions.

A 2025 systematic review found only nine clinical/observational studies on Cannabis, cannabinoids and microbiota across varied contexts, with heterogeneous results. This makes the field promising for investigation but still dependent on exposure characterisation, longitudinal design, control of confounding, diet, medicines and clinical context.

Transversal learning. Bidirectional networks require designs capable of testing direction and temporality; identification of precedence or mediation requires temporal measures and analytical models compatible with the hypothesis.

Wang et al. · microbiota–eCBome · 2025 ↗ · Thu et al. · systematic review · 2025 ↗

Therapeutic use · phytocomplex · safety · real-world evidence

In clinical care, Cannabis can be investigated as a medicinal plant, source of phytocannabinoids, complex preparation or regulated product. Interpretation depends on composition, relationships among cannabinoids, terpenes and other constituents, concentration, dose, route, batch, stability, adherence, indication, comorbidities, concomitant medicines, adverse events and selected outcomes.

Longitudinal data produced in services and associations can contribute to pharmacovigilance and real-world evidence when their provenance, temporality, traceability and quality are compatible with the question.

Beyond therapeutic use · agroecology · biomaterials · bioeconomy

Varieties of Cannabis sativa L. are also studied for fibres, seeds, biomass, materials, bioenergy, production systems and environmental applications. At the 5th National Environment Conference, Motion No. 79 placed recovery of degraded areas, bioeconomy and a Cannabis seed bank on the national participatory agenda. Scientific analysis of these possibilities requires differentiation of varieties, cultivation conditions, contaminants, environmental balances, biomass destination and final-product performance.

Key concept for study. The same plant species can give rise to distinct experimental objects. Medicinal Cannabis, industrial hemp, biomass for materials and cultivation for environmental research require their own questions, exposures, regulations and outcomes.

MMA · 5th CNMA · Motion No. 79 ↗

Psychedelics · States of Consciousness · Neurosciences · Public/Collective Health

Brazil · contemporary clinical research · UFRN / Brain Institute

The Brain Institute of the Federal University of Rio Grande do Norte maintains a contemporary research line on psychedelics spanning clinical trial, neuropsychopharmacology, neurophysiology, consciousness, sleep and longitudinal follow-up. The 2026 institutional register includes clinical evaluation of vaporised N,N-dimethyltryptamine (DMT) in treatment-resistant depression and a study of classic psychedelics in people with severe distress, with explicit focus on safety, feasibility and clinical outcomes.

Projects registered in 2024–2026 also include DMT in healthy volunteers, comparison of EEG patterns induced by ayahuasca with sleep stages, mindfulness associated with ayahuasca and preclinical investigations of DMT. Recent production includes 12-month follow-up after an open-label phase 2A clinical trial with vaporised DMT and qualitative evaluation of a non-directive protocol of physical and psychological support in a clinical environment.

Translational relevance: the ensemble makes it possible to observe psychedelics as a field in which molecule, administration context, support, safety, subjective experience, functioning, follow-up and clinical infrastructure need to be studied jointly rather than reducing the intervention to the acute pharmacological effect.

Institutional sources: UFRN · research projects · Dráulio Barros de Araújo ↗ · UFRN · recent defences and protocols ↗.

DMT · consciousness · dreams · neurophysiology · subjective experience

Recent UFRN production also examines states of consciousness beyond the psychiatric outcome. In 2026, work developed at the Brain Institute investigated relationships between DMT and lucid dreams; institutional projects follow perception, imagination, suggestibility, EEG, sleep and subjective alterations of consciousness.

Key concept for study: altered states of consciousness can be investigated at multiple scales — phenomenology, cognition, behaviour, neurophysiology, context and subsequent effects. These scales are complementary when they answer the question, without converting subjective experience into a mere substitute for a neurophysiological signal or vice versa.

Sources: UFRN · DMT and lucid dreams · 2026 ↗ · Brain Institute · research on DMT and consciousness · 2026 ↗.

Jurema · sciences, care and protection · encounter between knowledge systems

In May 2026, researchers from the Brain Institute/UFRN participated in the II Seminar on Ancestral Jurema Medicines: sciences, care and protection, held in the Truká Tapera Indigenous Territory, Pernambuco, organised to bring together the Indigenous community, university and different perspectives on Jurema. The programme brought pajés, juremeiros and scientists into proximity without reducing these positions to a single language of knowledge.

Transversal learning: scientific research on molecules present in traditional practices does not exhaust the practice, its history, territory or its own regimes of care and meaning. Responsible documentation and investigation require provenance, participation, rights, knowledge governance and attention to power relations in the production and circulation of evidence.

Institutional source: Brain Institute/UFRN · Seminar on Ancestral Jurema Medicines · 2026 ↗.

Ayahuasca · religious/traditional use and research · distinct Brazilian frameworks

CONAD Resolution No. 1/2010 consolidated deontological principles for religious use of ayahuasca in Brazil and incorporated recommendations from the Multidisciplinary Working Group, including encouragement of research in pharmacology, biochemistry, clinical science, psychology, anthropology and sociology and attention to environmental protection of the plant species used in preparations.

This regime has its own nature and is not equivalent to clinical research on isolated substances. In contemporary health regulation, DMT, psilocybin, psilocin and other psychedelics appear on lists of substances subject to special control under Ordinance SVS/MS No. 344/1998 and its updates; research and medical or scientific work depend on the applicable authorisation regimes.

Key concept for study: religious or traditional use, plant preparation, isolated substance, clinical trial and medicine are different legal, cultural and scientific categories. Quality of analysis depends on keeping these differences visible.

Official sources: CONAD · Resolution No. 1/2010 · ayahuasca ↗ · Anvisa · current list of substances subject to special control ↗.

Public/Collective Health · drug policies · care · harm reduction

In Brazilian Public/Collective Health, policies concerning psychoactive substances are also analysed through their population, social and health effects. Literature in the field discusses access to services, criminalisation, imprisonment, violence, harm reduction, discrimination, care models and the possibility of scientific investigation of substances currently controlled.

Transversal learning. Psychedelics can open questions about care, medicalisation and demedicalisation, relationships with diagnoses, autonomy, function and prolonged use of psychotropic medicines; these questions have no single predetermined answer. A new intervention may reduce certain treatment burdens in some contexts and, in others, create new devices of medicalisation, institutional dependency, unequal access or commercialisation. The field requires clinical as well as social, functional and implementation outcomes.

Translational relevance: evaluating psychedelics in public health systems requires observing efficacy and safety together with professional training, infrastructure, time for care, selection of people, follow-up, equity, harm reduction, regulation and implementation capacity.

Reference: Gomes-Medeiros et al. · Drug Policy and Public/Collective Health: necessary dialogues · Cadernos de Saúde Pública · 2019 ↗.

UNILA · psychedelic science and social observation in the Triple Frontier

The Medicinal Cannabis and Psychedelic Science Laboratory (LCP/UNILA), already documented in the Collection, brings together research, training and extension activities in Cannabis and psychedelic science. The project RESPA — Extension and Social Observation Network on Psychoactive Substances in the Brazil–Paraguay–Argentina Triple Frontier was institutionally formalised in 2026 and is linked to an extension and drug-policy structure with CAPES/MJSP/SENAD participation.

Translational relevance: the experience broadens observation of psychoactive substances beyond the pharmacological trial, including cross-border territory, access to rights, university extension, drug policy and social production of knowledge.

Official source: UNILA · Ordinance SACT No. 9/2026 · RESPA ↗.

Biomedical professionals in action · science · public/collective health · education · professional representation

Dr Edgar Garcez Junior · Presidency of CFBM · Biomedicine · Ethics · Professional Regulation

Federal Council of Biomedicine. A biomedical professional who graduated in 1987 from Fundação Hermínio Ometto, he serves as President of the Federal Council of Biomedicine (CFBM) for the 2024–2028 term. His trajectory includes technical leadership in laboratory medicine, participation in CRBM-1, work on an ethics committee and associative representation of Biomedicine.

Institutional dimension. The Presidency of CFBM operates within regulation and professional development of Biomedicine at federal level, including rules, ethics, education, inspection and institutional organisation of the profession.

CFBM · Executive Board · 2024–2028 term ↗ · CFBM · election of the 2024–2028 administration ↗

Prof. Lídia Maria Pinto de Lima · Biomedical Acupuncturist – TCM · Molecular Biology · Public Health · PICS · Teaching

Biomedical trajectory. Graduated in Biomedicine in 1974, she completed 50 years since graduation in 2024. She moved to Brasília for a Master's degree in Molecular Biology at the University of Brasília and built a career in the Federal District Health Department, working at the Federal District Central Public Health Laboratory (Lacen-DF).

Acupuncture, TCM and PICS. Her public academic curriculum identifies her as a Biomedical Acupuncturist, with complementary training in electroacupuncture, laser acupuncture and applications of Acupuncture in Gynaecology and Obstetrics. She is a member of the Advisory Committee on Integrative and Complementary Health Practices (PICS) of CRBM-3 for the 2023–2027 four-year term and has academic production related to Traditional Chinese Medicine and Acupuncture.

Council and teaching. She is a CRBM-3 council member and has a long teaching trajectory, including work at the Catholic University of Brasília, as well as experience in Microbiology, Virology, Bacteriology and public-health laboratories.

CRBM-3 · 50 years since graduation in Biomedicine ↗ · CRBM-3 · PICS Advisory Committee 2023–2027 ↗ · UCB · Traditional Chinese Medicine and Acupuncture ↗

Dr Crismédio Vieira Costa Neto · Gerontology · Human Rights · Public Policy
Dr Crismédio Vieira Costa Neto · Gerontology, Human Rights and Public Policy

BIOMEDICINE · GERONTOLOGY · HUMAN LONGEVITY SCIENCES · SOCIOLOGY · PUBLIC HEALTH · HUMAN RIGHTS · PUBLIC POLICY

Dr Crismédio Vieira Costa Neto is a biomedical professional, gerontologist, sociologist and Doctor of Human Longevity Sciences from the University of Aveiro, Portugal, with an interdisciplinary trajectory dedicated to human ageing, longevity, public health, Gerontology and defence of the human rights of older people. His work articulates scientific and gerontological knowledge, social participation, mobilisation of civil society and public-policy advocacy related to ageing and longevity.

His institutional trajectory includes work in the Pastoral da Pessoa Idosa and full representation of the organisation on the National Council for the Rights of Older People (CNDI), placing Dr Crismédio in national spaces of participation and social oversight related to formulation, monitoring and defence of policies and rights concerning the older population. Documentation submitted to the Chamber of Deputies also records work in coordination of the Pastoral da Pessoa Idosa in Alagoas from 2008.

In 2022, Dr Crismédio was awarded the Zilda Arns Prize by the Chamber of Deputies, a national recognition for people and institutions that actively contribute to defence of the rights of older people. The distinction forms part of a trajectory oriented towards valuing ageing, confronting age discrimination, citizen participation and recognition of older people as rights holders.

Dr Crismédio's contemporary production and work articulate Gerontology, Human Longevity Sciences, public health, human rights, social education and public policy, encompassing biological, psychological, social, cultural and political dimensions of ageing processes and diverse experiences of old age.

Scientific reading of the trajectory. The documented trajectory articulates ageing, rights of older people, social protection, social participation, public policy and age-friendly environments. These themes can be scientifically described using variables, indicators, contexts and units of analysis appropriate to the question, in dialogue with international references on healthy ageing, intrinsic capacity, functional ability and enabling environments.

Analytical scope. The gerontological, social and institutional interface articulates dimensions specific to healthy ageing, with measurement and designs suited to each construct and to the capabilities actually mobilised.

National Movement Vidas Idosas Importam

HUMAN RIGHTS · COMBATING AGEISM · DIVERSITY OF OLD AGE · SOCIAL EDUCATION · MOBILISATION · CITIZEN PARTICIPATION

The National Movement Vidas Idosas Importam, conceived by Dr Crismédio Vieira Costa Neto and created on 10 December 2020, is a social-mobilisation initiative dedicated to defending the human rights of older people and valuing the plurality of ageing processes and diverse forms of old age.

Created in the context of the COVID-19 pandemic, a period that exposed and intensified vulnerabilities, inequalities, age discrimination and rights violations affecting older people, the Movement works to confront ageism, promote dignity, autonomy, inclusion and citizen participation, and strengthen the protagonism of older people.

Interdisciplinary and intersectoral in nature, the Movement articulates professionals, civil society, institutions and different social actors in mobilisation, education and rights-defence activities. Its activities include campaigns and initiatives aimed at disseminating knowledge, dismantling stereotypes about old age and ageing, and strengthening social participation.

The work of Vidas Idosas Importam incorporates a plural understanding of human ageing, recognising differences in trajectories, living conditions and social contexts and articulating Gerontology, human rights, social education, citizen participation, community mobilisation and public advocacy.

Longevity and life course · rights · participation and social implementation

Dr Crismédio Vieira Costa Neto's trajectory articulates Gerontology, Sociology, human rights of older people, social participation and public policy. This combination makes it possible to examine ageing beyond the chronological marker, incorporating function, autonomy, social protection, ageism, violence, participation and territorial conditions that modulate the capacity to live and age with dignity.

Interface with healthy ageing and public policy

Documented work in spaces of representation and rights defence makes it possible to observe relationships among gerontological knowledge, citizen participation, public policy, healthy ageing, functional ability, enabling environments and inequalities among different experiences of old age.

Chamber of Deputies · Zilda Arns Prize 2022 · nomination documentation ↗

Prof. Aline Kelen Vesely Reis · Biomedicine · Epidemiology · Public/Collective Health · Education · Professional Representation

Documented trajectory. Biomedical professional, coordinator and lecturer on the Biomedicine degree programme at IESB; Master's degree in Epidemiology Applied to Health Services and specialist in Public/Collective Health/Health Education. She worked as a technical adviser at Anvisa and provides technical advisory support at the Ministry of Health in meningitis surveillance.

Biomedicine in the Federal District. She forms part of the history of founding the Association of Biomedical Professionals of the Federal District (ABMDF) and serves as its president. Her documented public work includes professional recognition and updating, participation in the Chamber of Biomedical Women and initiatives aimed at protecting biomedical women professionals against harassment in the workplace.

IESB · coordination of Biomedicine and professional trajectory ↗ · ABMDF · presidency · 2026 ↗

Prof. Liliane Ribeiro de Oliveira (Liliane Rioli) · Pedagogy · Biomedicine · Health Education · Political Advisory Work

Biomedical professional, pedagogue and higher-education lecturer in Biomedicine, working at the interfaces of biomedical education, Acupuncture – Traditional Chinese Medicine (TCM), integrative health, health education, project management and social mobilisation. Her trajectory brings together coordination of social and health projects, team leadership, process supervision and training of multipliers.

Integrative health · education · community mobilisation

Her work in integrative health includes Acupuncture – TCM and health-promotion activities in community contexts. Documented production includes co-authorship of the book Nova Era da Saúde (2025), with a chapter on the role of acupuncture in integrative health, as well as coordination of and participation in collective health actions in the Federal District.

Biomédicos Salvando Vidas — BSV

Biomédicos Salvando Vidas (BSV), an initiative conceived by Prof. Liliane, articulates biomedical training, health education, social responsibility and mobilisation for blood donation. Documented work includes university campaigns, training of multipliers, activities with the Blood Centre, community actions and participation in academic-scientific events.

Pedagogy · knowledge translation · implementation

The combination of Pedagogy, Biomedicine, teaching and health education offers an observational case on translating biomedical content into training processes, health literacy, professional mobilisation and community participation.

Documentary source: declared professional information · August 2026.

Institutional participation. In 2026, she reports work in political advisory activity, extending to this context the experience in mobilisation, professional representation and public communication already documented in her trajectory.

Prof. Denise C. Braga · Applied Biophysics · Trichology · Biophysical Diagnosis · Neurophysiology

Biomedical professional, trichologist and lecturer. Her trajectory brings together laboratory practice, Trichology, biophysical diagnosis, neurophysiology and careful use of functional technologies, with attention to the distinction between measurement, clinical association and mechanistic inference.

Trichology · clinical practice · authorship

She works in Trichology and hair health, with clinical and instrumental assessment. She is the author of Terapia Capilar: Manual de Instruções, published by Editora Senac-DF, a work devoted to assessment and techniques used in the field.

Senac · Terapia Capilar: Manual de Instruções ↗

TreeBios · biophysical diagnosis · functional technologies

Her public work includes the TreeBios/Happy Hair Lab — Biophysical Diagnosis Centre, as well as InSallus Centro de Terapia Capilar. This field includes digital trichoscopy, biophysical analysis, functional protocols and integration of different signals in clinical follow-up.

InSallus ↗

Histology · technical pathology · laboratory trajectory

Her professional trajectory includes experience beginning in a histology laboratory and later development in Trichology and investigation of systemic changes related to hair health. This laboratory basis helps situate her reading of biological signals, tissues, imaging and clinical context.

Applied biophysics · neurophysiology · functional mapping

In the biophysical and neurofunctional field, she works with technologies for acquisition and follow-up of functional responses and biofeedback. Scientific reading preserves the distinction between the signal obtained, its clinical association and any inference about mechanism.

Dr Carlos Roberto de Souza Filho · Biomedicine · Trade-Union Representation · Health Workforce · Professional Policies

Documented institutional work. President of the Union of Biomedical Professionals of the Federal District (SINDBIOMÉDICOS-DF), with public participation in agendas for professional recognition, working conditions, salary floor and defence of biomedical areas of practice. This work documents working conditions and the biomedical workforce as observable determinants of implementation capacity in health.

Transversal learning. Biomedical trade-union representation makes visible how working conditions, remuneration and professional recognition function as variables of implementation capacity in health, alongside infrastructure, clinical protocol and scientific evidence.

SINDBIOMÉDICOS-DF · presidency 2024–2026 ↗ · Collective Labour Agreement 2025–2026 · signature of the Presidency ↗

Prof. Valissa Gama de Melo · Clinical Analysis · Laboratory Diagnosis · Quality and Biosafety

Prof. Valissa Gama de Melo is a biomedical professional qualified in Clinical Analysis, with practical experience in a Clinical Pathology laboratory in the Federal District public network. Her experience encompasses Haematology, Microbiology, Urinalysis and Parasitology, as well as pre-analytical, analytical and post-analytical routines, collection of biological material, microscopic analysis, support for release of reports, quality control and biosafety.

Laboratory diagnosis · quality · traceability

Her laboratory experience encompasses stages that condition the quality of empirical protocols: preparation and collection, sample processing, pre-analytical control, biosafety, traceability, consistency of results and laboratory interpretation, including interfaces with biomarkers, Microbiology, Haematology and Urinalysis.

Complementary training and areas of practice

Her curriculum records complementary training in interpretation of tests and release of reports, molecular diagnosis of SARS-CoV-2 and other respiratory viruses, collection of biological material and first aid. Declared areas of practice include Microbiology, Urine Culture, Biochemistry/Urinalysis, control and treatment of tuberculosis and leprosy, and Morphology/Haematology.

Translational research · systems science · One Health

Documented academic-professional interests include translational research, systems science and the One Health approach, at the interface with laboratory diagnosis, quality, biosafety and public health.

Oral health · clinical Dentistry · life course · territory

Amanda Andrade · Dentistry · Oral Health · Life Course · Community Care

Clinical dentistry and care across the life course. Dental surgeon, graduated between 2016 and 2021, with documented experience caring for children, adults, people with special needs and older populations. Her practice brings together preventive and restorative procedures, extractions, prophylaxis, sealants, fluoride-varnish application, oral-hygiene guidance, prosthetic care and support for dental diagnosis and planning.

Oral health · prevention · function

Clinical experience offers the Observatory a concrete interface among oral health, pain, nutrition, function, ageing, quality of life and continuity of care. Prosthetic and preventive care adds questions concerning maintenance of function, self-care, access and follow-up across the life course.

Community experience · Kayapó Kokokuedja Village

Her trajectory includes voluntary work as a dentist in the Kayapó Kokokuedja Village, providing dental care for adults and children. For the Observatory, this experience broadens observation of situated care, territory, access and sociocultural context. Research projects that may involve Indigenous peoples incorporate specific governance, substantive participation, consent and ethical, cultural and data safeguards from the design stage.

Transversal learning. Oral health adds to the Programme a clinical dimension related to prevention, function, life course, geriatrics, special needs and community care, with potential to generate multiprofessional questions about comprehensive health, longitudinality and territory.

Confluences in formation · TCM/Acupuncture · Cannabis · Environment · Biomedicine in training

Thomas Antonio Rodrigues de Sousa (Thomaz Enlazador) · TCM/Acupuncture · Cannabis · Environmental Management · Permaculture · Biomedicine in training

Thomas Antonio Rodrigues de Sousa (Thomaz Enlazador) brings together public work in Environmental Management, permaculture, socio-environmental education, integrative practices, Acupuncture/TCM and the Cannabis movement. He is presented by Instituto Biorregional do Cerrado as a Master in Environmental Policy and Management from the Federal University of Pernambuco (UFPE), permaculturist, social educator and integrative acupuncturist therapist, with participation in creating socio-environmental initiatives and agroecology networks. In a public professional presentation, he states that he is an undergraduate student in Biomedicine; this training is recorded as an academic pathway in progress.

In 2026, CEATA lists Thomaz as an instructor in in-person training dedicated to the interface between Cannabis and Traditional Chinese Medicine. The convergence among TCM/Acupuncture, Cannabis, Environmental Management, permaculture and socio-environmental education offers an object of situated translational characterisation at the interface between clinical rationale, integrative therapeutics, territory and living systems. Ongoing biomedical training adds a contemporary dimension to the trajectory and expands its interfaces with Health Sciences, integrating the currently documented training pathway.

Authorial integrative practice · characterisation of components and translational questions

The practice can be characterised in observable components — rationale, materials and preparations, mode of application, training required, dose/exposure where pertinent, context, safety, comparators and outcomes — allowing formulation of questions of feasibility, acceptability, mechanism and effectiveness while preserving its trajectory, language and context.

Instituto Biorregional do Cerrado · socio-environmental trajectory ↗ · CEATA · Cannabis and TCM · 2026 ↗ · Cannabis Acupuncture · declared training and trajectory ↗

Education · Integrative Practices · Human Development · Communities · Implementation

Transversal learning. Educational and community processes can be observed through participation, continuity, contextual adaptation, authorship, relationships, developed capacities and forms of feedback. These elements help transform situated experiences into implementation questions while preserving territory, language and meaning.
Symbolic Psychology · alterity · art · language

From symbol to practice · a Brazilian lineage of dialogue

This cluster follows contributions concerning symbol, alterity, body, art, language and critique of reductionism. The references preserve their own schools, contexts and statuses, allowing observation of distinct forms of language, experience and production of meaning.

Reading pathway: symbolic-Jungian lineage → artistic and community transmission → Matizes Dumont and developments → digital implementation.

Prof. Dr Carlos Amadeu Botelho Byington · Jungian Symbolic Psychology · symbol · alterity · critique of reductionism

Psychiatrist and Jungian analyst, trained at the C. G. Jung Institute in Zurich, co-founder of the Brazilian Society of Analytical Psychology and creator of Jungian Symbolic Psychology. His production sought to articulate objective and subjective knowledge, symbol, culture, clinical practice and interdisciplinarity, offering a particularly fertile reference for examining reductionism and communication between specialised fields.

Educational relationship with the author. Prof. Glória Moura Alves was his student on the course Byington na Prática while the professor was still alive. This experience forms part of her clinical and intellectual genealogy, especially in attention to symbol, the Self, alterity and critique of reductionism.

Teaching memory. The author preserves from his classes the formulation that “reductionism is the cancer of Humanity”. The formulation is recorded as an oral teaching memory; its exact wording remains distinguished from a bibliographic quotation until a verifiable primary source is available.

Maria Helena R. Mandacarú Guerra · Analytical Psychology · body · alterity · culture

Psychologist and Jungian psychotherapist, Master's in Clinical Psychology, lecturer in Analytical Psychology and author. Her production includes reflection on the archetype of alterity in an age of big data, as well as work with Jungian Symbolic Psychology and a body-based approach. In the Observatory, her contribution is of interest at the encounter among alterity, culture, technology, symbol and embodied experience.

Lino Bertrand · art · Jungian Psychology · Art Therapy · transmission

Visual artist, specialist in Jungian Psychology and Art Therapy and founder of Jung na Prática. His work articulates artistic language, symbol, training and everyday application of Jungian concepts.

Jung na Prática · Jungian knowledge in accessible and applied language

Project founded by Lino Bertrand for study, deepening and application of Analytical Psychology in everyday life and professional practice, seeking simplicity of language without abandoning conceptual depth.

Byington na Prática · living library of Symbolic Psychology

Library/video archive dedicated to Symbolic Psychology developed by Carlos Byington. The collection includes content recorded by the professor himself during his lifetime, including responses to questions from the community, constituting a bridge of transmission among work, teaching and application.

Prof. Bia Rossi · Biology · intuition · body · Jungian Psychology

Biologist, therapist and lecturer, she develops studies bringing Biology, intuition, Jungian Psychology and Chinese Medicine into proximity. Her trajectory broadens the reading of interfaces among body, experience, symbolisation and different knowledge systems.

Transversal learning. The rapprochement among Biology, intuition, Jungian Psychology and Chinese Medicine makes it possible to observe how different knowledge systems describe body and experience, preserving the origin, language and criteria specific to each field as a source of new scientific and epistemological questions.

Matizes Dumont · Art · Education · Health · Community · Human Development
Grupo Matizes Dumont · Art · Embroidery · Literature · Human Development

Grupo Matizes Dumont is formed by members of a family from Pirapora, Minas Gerais, dedicated for more than three decades to visual and graphic arts and human development. The group presents spontaneous hand embroidery as an artistic language and instrument of social and cultural transformation, creating new possibilities for free and spontaneous embroidery inspired by nature and the diversity of Brazilian culture.

The history published by the group itself recognises Antônia Zulma Diniz Dumont as its origin and the generation formed by Demóstenes, Ângela, Marilu, Martha and Sávia. The third generation of embroiderers includes Luana, Maria Helena, Tainah and Paula; family continuity also reaches a fourth generation.

The artistic pathway brings together canvases, national and international exhibitions, Literature and illustration of works by authors such as Jorge Amado, Ziraldo, Manoel de Barros, Thiago de Mello, Rubem Alves, Carlos Rodrigues Brandão and Marina Colasanti. The group received the Jabuti Prize for Illustration twice.

Grupo Matizes Dumont brings together experience in human development, community art, education and health promotion across different territories, offering references for understanding processes of care, connection, autonomy and social participation. Embroidery, as an expressive and community language, constitutes a case of practice spanning art, education, human development and health, whose observation can generate questions about care, participation and autonomy.

Grupo Matizes Dumont · Our History ↗ · Official website ↗

ICAD · Instituto de Promoção Cultural Antônia Diniz Dumont · Art · Culture · Education · Health · Environment

The Instituto de Promoção Cultural Antônia Diniz Dumont — ICAD was created by Grupo Matizes Dumont to promote and disseminate Brazilian popular culture and mobilise Art in human-development processes. Its documented trajectory brings together health promotion and healthy environments, environmental education, social inclusion, culture, group processes and experiences in which embroidery acts as a poetic-visual language.

The psychopedagogical experience (A)Bordar o Ser uses embroidery as a language and expressive tool in practices of sharing, interaction, authorship, creativity, autonomy, solidarity, trust and humanisation. In Serra Pelada, Pará, the project Bordando a Paz has documented since 2023 a territorial experience with women from the community involving embroidery, listening, memory, citizenship, Art and autonomy.

ICAD's documented community experience brings together interfaces among Art, Education, health promotion, human development, environment, work, community and territory.

ICAD · official presentation ↗ · Brazilian Embroidery Meeting · ICAD ↗

Prof. Ângela Dumont Teixeira · in memoriam · Education · Public Health · Health Promotion · Art · Community

An educator, researcher and art educator, Prof. Ângela Dumont Teixeira articulated Education, Public Health, Health Promotion, Art, community and human development. In Grupo Matizes Dumont and in different academic and social initiatives, she developed experiences in which creation, language, care and social transformation met in practice.

In the author's educational trajectory, she was her Didactics lecturer during the Languages degree. This relationship is recorded as an educational and intellectual reference.

Matizes Dumont · trajectory and projects ↗

Prof. Luana Dumont · Psychology · Gestalt Therapy · Pedagogy · Integrative Art Therapy · Art

Gestalt-oriented psychologist, pedagogue, integrative art therapist and artist linked to the contemporary continuity of the Matizes Dumont family. Luana belongs to the third generation of embroiderers identified by the group itself and participates in activities and meetings where embroidery, Art, conviviality, learning and human development meet.

Her trajectory articulates Art, expression, subjectivity, relationships, educational processes, community, territory and human development. In Serra Pelada, Pará, she develops community work with women in biopsychosocial vulnerability, using embroidery in processes of expression, capability strengthening, autonomy and possibilities for income generation.

Matizes Dumont · Our History ↗ · IV Brazilian Embroidery Meeting ↗

Prof. Tainah Dumont · Art · Embroidery · Integrative Art Therapy · Human Development

Visual artist and integrative art therapist, Prof. Tainah Dumont belongs to the third generation of embroiderers identified by Grupo Matizes Dumont and participates in contemporary continuity of workshops, meetings and experiences in which embroidery is lived as artistic language, authorship, creation, conviviality and human development.

Her trajectory brings together Art as language, memory, intergenerational transmission, creative processes, learning and collective production of meaning.

Matizes Dumont · Our History ↗ · IV Brazilian Embroidery Meeting ↗

Prof. Verônica da Silva · Education · Art Therapy · Storytelling · Community

Integrative teacher, pedagogue, art therapist and storyteller, she works with children, educators and communities, including social work with low-income children in community contexts. She articulates education, Art Therapy, literature, orality, playfulness, bodily expression, music and storytelling. Her integrative work reaches socio-emotional and psychosocial dimensions of human development, mobilising different languages and forms of expression in processes of learning, relationship, participation and shared construction of meaning.

Art Therapy, expression, psychosocial dimension and community development

In her practice, image, word, voice, body, rhythm, literature, music, play and imagination constitute different pathways for expression and elaboration of experience. Integration of these resources makes it possible to work with cognitive, emotional, psychosocial and cultural dimensions, especially in activities developed with children, educators and communities, favouring expression, relationships, participation and collective forms of learning and conviviality.

Prof. Adriana Cecília Reis · Integrative Therapies · Emotional Development · Community

Teacher and integrative therapist, with studies in Neurosciences and Bioenergetics and training in people management. Her experience articulates education, human development and integrative practices, with activities focused on emotions, autonomy, self-esteem and human relationships, especially in meeting spaces and community experiences with women.

Emotions · psychosocial dimension · community experience

In lectures, meetings and initiatives such as Projeto Café com Fé, she addresses emotions, self-perception, human relationships and everyday life. The work brings education and integrative practices into proximity with psychosocial dimensions of human development, creating collective spaces for reflection, strengthening autonomy and building personal and community resources. These experiences offer an observable context for investigating participation, continuity and psychosocial outcomes in community care spaces.

Prof. Lindemberg Rocha Aguiar · Technology and Web Systems · Digital Implementation

Technologist in Systems Analysis and Development and lecturer in technology, with experience in development and maintenance of web environments, system implementation and support, digital interfaces and content organisation.

Technology, digital implementation and inclusion

His work brings together web development, usability, technological support and digital solutions applicable to organising, disseminating and circulating knowledge. He also develops technology training and capacity-building activities, including socio-educational actions with people experiencing socioeconomic disadvantage, aimed at developing digital skills, autonomy, inclusion and broader opportunities for social and professional participation.

Scientific thinking · epistemology

Transversal learning. Epistemological references influence formulation of questions, categories of analysis, relationships considered relevant and limits of inference. Making these assumptions explicit favours comparable, traceable designs sensitive to the provenance of concepts mobilised.
Prof. Maria José Esteves de Vasconcellos · New-Paradigmatic Systems Thinking · Epistemology

Psychologist, retired professor of the Federal University of Minas Gerais (UFMG) and author of Pensamento Sistêmico: o Novo Paradigma da Ciência. The new-paradigmatic formulation articulates complexity, instability and intersubjectivity and constitutes a central reference for thinking about relationships, contexts, transformations and production of knowledge.

Thinking systemically shifts focus from isolated elements to relationships, including relationships of the system with context and with the person who describes it. This perspective articulates epistemology, formulation of questions and empirical design.

VASCONCELLOS, Maria José Esteves de. Pensamento sistêmico: o novo paradigma da ciência. 10th ed. Campinas: Papirus, 2013. 269 p. · Article by the author · complexity, instability and intersubjectivity ↗ · Review · Revista Brasileira de Educação Médica · DOI ↗

Ailton Krenak · Indigenous Thought · Ancestrality and Future

Writer, thinker and Indigenous leader of the Krenak people, active in the Brazilian Indigenous movement from a young age and part of the articulation that secured the chapter “Dos Índios” in the 1988 Constitution. Author of Futuro Ancestral (Companhia das Letras, 2022), in which he proposes that the future, when it exists, is ancestral — it was already present in ways of life preceding the logic of progress that now threatens the Earth. In 2023, he became the first Indigenous person elected to the Brazilian Academy of Letters.

The work addresses relationships among humanity, nature and time, territory, biodiversity and possible futures from Indigenous thought.

KRENAK, Ailton. Futuro ancestral. São Paulo: Companhia das Letras, 2022.

Antônio Bispo dos Santos (Nêgo Bispo) · Confluence · Counter-colonisation

Philosopher, writer and Quilombola leader (1959–2023), born in Quilombo Saco-Curtume, Piauí. He worked in the National Coordination for Articulation of Black Rural Quilombola Communities (CONAQ) and formulated, from Quilombola oral tradition, the concepts of confluence — coexistence among different forms of life within the same cosmos — and counter-colonisation, presented in Colonização, Quilombos: Modos e Significados (2015) and developed in A Terra Dá, a Terra Quer (2023).

The thought developed articulates concepts concerning territory, traditional knowledge, ways of life, confluence and counter-colonisation.

SANTOS, Antônio Bispo dos. Colonização, quilombos: modos e significados. 2015. · A terra dá, a terra quer. 2023.

Scientific training · new generations of researchers

Isaac Moura Alves · Biological Sciences · University of Brasília (UnB)

Undergraduate student in Biological Sciences at the University of Brasília, he has worked for approximately a year and a half as a monitor at the UnB Biology Museum and undertakes undergraduate scientific research (PIBIC) at Embrapa. His academic interests include Entomology, Mycology, Ornithology and Ecology. In 2026, his work “Monocultures and the dispersal of invasive species” was selected for presentation at the XLIII National Meeting of Biology Students (ENEB), in Teresina, Piauí. ENEB is a national meeting organised within the Biology student movement; the 2026 edition, hosted by the Federal University of Piauí, brings together academic training, socio-environmental debate and exchange among students from different regions of the country.

UFPI · XLIII ENEB · Teresina 2026 ↗

Éden Cândido dos Santos Gama · Geology · University of Brasília (UnB)

Undergraduate student in Geology at the University of Brasília, she is part of the Laboratory of Magnetic Studies in Geosciences (LEMAG), with research focused on determination, characterisation and analysis of linear features from aeromagnetic data in structural geology. Her academic interests include critical minerals, rare-earth elements and their interfaces with geoscientific investigation.

Giovanni de Paula Mesquita · Biological Sciences · University of Brasília (UnB)

Undergraduate student in Biological Sciences at the University of Brasília, he has worked for approximately a year and a half as a monitor at the UnB Biology Museum and is developing training experience as an intern at the UnB Arachnids Laboratory. His academic interests include Arachnology and Mycology.

Research contribution

The programme demonstrates a research-design function that can work with domain specialists by structuring the interfaces between scientific questions, evidence requirements, data, protocols, governance and translational decisions.

Complex-problem structuring

Decompose scientific problems into researchable questions, constructs, units of analysis, comparators, outcomes and decision points.

Protocol qualification

Translate mature questions into protocol concepts and progressively executable study specifications.

Evidence architecture

Define what evidence is needed, where it comes from, how it is traced and what decision it is intended to support.

Data quality & governance

Specify minimum datasets, metadata, provenance, traceability, safety and decision-relevant quality requirements.

Maturity & progression

Use explicit maturity and progression criteria to identify what is ready to advance and what still requires refinement.

Interdisciplinary interfaces

Build study architectures that allow clinical, laboratory, engineering, data, technology and health-system expertise to work around a common scientific question.

Academic and scientific profile

Glória Valéria Corrêa Moura Alves works across teaching, clinical care, scientific writing and translational research. Her academic background includes degrees in Natural Sciences, Biomedicine, and a Licentiate Degree in Languages and Literature — Portuguese and English.

Brazilian professional context. Professional designations are presented according to Brazilian registration and training. They are not translated into protected professional titles of other jurisdictions.

Biomedical areas of practice and qualification — Brazil

Sanitarian practice, Teaching and Research (Psychobiology), Pharmacology, Gerontology and Acupuncture/Traditional Chinese Medicine, alongside other integrative-health qualifications documented in the Brazilian professional context.

Scientific work

Translational research, Research Design, Evidence Architecture, study and protocol qualification, temporal and data architecture, Data Quality, provenance and traceability, safety and progression criteria, and technical-scientific documentation across clinical, laboratory, data, technology and health-system interfaces.

Experimental and laboratory training

Supervised practical and laboratory training connected with Biophysics, Neurophysiology and Pharmacology, including pharmacovigilance, biological and pharmacological mechanisms, biomarkers, multimodal neurophysiological signals and translational interpretation.

Teaching and scientific communication

Teaching since 2000, including undergraduate and postgraduate higher education since 2008 across different institutions and periods; Portuguese and English language education, technical and official writing, scientific communication, and more recent university seminars in Life Sciences, Biomedicine and Gerontology.

ORCID: 0009-0009-6842-2123 · Affiliation: Instituto Natural

Source programme, version and citation

This page is an international research overview derived from the Portuguese V4.20 programme. It does not replace the source programme and does not alter the status, maturity or provenance of its scientific components.

Source: Programa de Pesquisa Translacional: Neurociências e Medicinas Tradicionais, Complementares e Integrativas (TCIM) · Version V4.20

Zenodo DOI: https://doi.org/10.5281/zenodo.22048972

Author: Glória Valéria Corrêa Moura Alves · Instituto Natural

Language of this overview: British English (`en-GB`).